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Abstract
Ion beam therapy (IBT) is a promising treatment option in radiotherapy. The character-
istic physical and biological properties of light ion beams allow for the delivery of highly
tumour conformal dose distributions. Related to the sparing of surrounding healthy tissue
and nearby organs at risk, it is feasible to escalate the dose in the tumour volume to reach
higher tumour control and survival rates. Remarkable clinical outcome was achieved with
IBT for radio-resistant, deep-seated, static and well fixated tumour entities. Presumably,
more patients could benefit from the advantages of IBT if it would be available for more fre-
quent tumour sites. Those located in the thorax and upper abdominal region are commonly
subjected to intra-fractional, respiration related motion. Different motion compensated dose
delivery techniques have been developed for active field shaping with scanned pencil beams
and are at least available under experimental conditions at the GSI Helmholtzzentrum für
Schwerionenforschung (GSI) in Darmstadt, Germany.
High standards for quality assurance are required in IBT to ensure a safe and precise dose
application. Both underdosage in the tumour and overdosage in the normal tissue might
endanger the treatment success. Since minor unexpected anatomical changes e.g. related to
patient mispositioning, tumour shrinkage or tissue swelling could already lead to remarkable
deviations between planned and delivered dose distribution, a valuable dose monitoring sys-
tem is desired for IBT. So far, positron emission tomography (PET) is the only in vivo, in
situ and non-invasive qualitative dose monitoring method applied under clinical conditions.
It makes use of the tissue autoactivation by nuclear fragmentation reactions occurring along
the beam path. Among others, β+-emitting nuclides are generated and decay according to
their half-life under the emission of a positron. The subsequent positron-electron annihilation
creates two 511 keV photons which are emitted in opposite direction and can be detected as
coincidence event by a dedicated PET scanner. The induced three-dimensional (3D) β+-
activity distribution in the patient can be reconstructed from the measured coincidences.
Conclusions about the delivered dose distribution can be drawn indirectly from a comparison
between two β+-activity distributions: the measured one and an expected one generated by
a Monte-Carlo simulation. This workflow has been proven to be valuable for the dose moni-
toring in IBT when it was applied for about 440 patients, mainly suffering from deep-seated
head and neck tumours that have been treated with 12C ions at GSI.
In the presence of intra-fractional target motion, the conventional 3D PET data processing
will result in an inaccurate representation of the β+-activity distribution in the patient. Four-
dimensional, time-resolved (4D) reconstruction algorithms adapted to the special geometry of
in-beam PET scanners allow to compensate for the motion related blurring artefacts. Within
this thesis, a 4D maximum likelihood expectation maximization (MLEM) reconstruction
algorithm has been implemented for the double-head scanner Bastei installed at GSI. The
proper functionality of the algorithm and its superior performance in terms of suppressing
motion related blurring artefacts compared to an already applied co-registration approach
has been demonstrated by a comparative simulation study and by dedicated measurements
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with moving radioactive sources and irradiated targets. Dedicated phantoms mainly made up
of polymethyl methacrylate (PMMA) and a motion table for regular one-dimensional (1D)
motion patterns have been designed and manufactured for the experiments. Furthermore,
the general applicability of the 4D MLEM algorithm for more complex motion patterns
has been demonstrated by the successful reduction of motion artefacts from a measurement
with rotating (two-dimensional moving) radioactive sources. For 1D cos2 and cos4 motion,
it has been clearly illustrated by systematic point source measurements that the motion
influence can be better compensated with the same number of motion phases if amplitude-
sorted instead of time-sorted phases are utilized. In any case, with an appropriate parameter
selection to obtain a mean residual motion per phase of about half of the size of a PET crystal
size, acceptable results have been achieved. Additionally, it has been validated that the 4D
MLEM algorithm allows to reliably access the relevant parameters (particle range and lateral
field position and gradients) for a dose verification in intra-fractionally moving targets even
from the intrinsically low counting statistics of IBT-PET data.
To evaluate the measured β+-activity distribution, it should be compared to a simulated one
that is expected from the moving target irradiation. Thus, a 4D version of the simulation
software is required. It has to emulate the generation of β+-emitters under consideration
of the intra-fractional motion, their decay at motion state dependent coordinates and to
create listmode data streams from the simulated coincidences. Such a revised and extended
version that has been compiled for the special geometry of the Bastei PET scanner is
presented within this thesis. The therapy control system provides information about the exact
progress of the motion compensated dose delivery. This information and the intra-fractional
target motion needs to be taken into account for simulating realistic β+-activity distributions.
A dedicated preclinical phantom simulation study has been performed to demonstrate the
correct functionality of the 4D simulation program and the necessity of the additional, motion-
related input parameters.
Different to the data evaluation for static targets, additional effort is required to avoid a
potential misleading interpretation of the 4D measured and simulated β+-activity distribu-
tions in the presence of deficient motion mitigation or data processing. It is presented that in
the presence of treatment errors the results from the simulation might be in accordance to the
measurement although the planned and delivered dose distribution are different. In contrast
to that, deviations may occur between both distributions which are not related to anatomical
changes but to deficient 4D data processing. Recommendations are given in this thesis to
optimize the 4D IBT-PET workflow and to prevent the observer from a mis-interpretation of
the dose monitoring data. In summary, the thesis contributes on a large scale to a potential
future application of the IBT-PET monitoring for intra-fractionally moving target volumes
by providing the required reconstruction and simulation algorithms. Systematic examina-
tions with more realistic, multi-directional and irregular motion patterns are required for
further improvements. For a final rating of the expectable benefit from a 4D IBT-PET dose
monitoring, future investigations should include real treatment plans, breathing curves and
4D patient CT images.
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Zusammenfassung
Die Ionenstrahltherapie (englisch: ion beam therapy, IBT) ist eine vielversprechende Be-
handlungsoption im Bereich der Strahlentherapie. Die charakteristischen physikalischen und
biologischen Eigenschaften der Ionenstrahlen werden genutzt, um tumorkonformale Dosis-
verteilungen zu erzeugen. Die verbesserte Schonung des an den Tumor angrenzenden Nor-
malgewebes und eventuell naheliegender Risikoorgane ermöglicht eine Dosissteigerung im
Zielgebiet und somit potentiell höhere Tumorkontroll- und Überlebensraten. Für tiefliegende,
gegenüber konventioneller Strahlung resistente, statische und gut fixierte Tumore wurden be-
reits beachtliche klinische Resultate erzielt. Wahrscheinlich könnten noch mehr Patienten von
den Vorteilen der IBT profitieren, wenn diese auch für häufiger auftretende und intrafraktio-
nell bewegliche Tumore uneingeschränkt nutzbar wäre. Verschiedene bewegungskompensierte
Bestrahlungsmethoden wurden entwickelt und stehen zumindest unter experimentellen Be-
dingungen für weitere Untersuchungen am GSI Helmholtzzentrum für Schwerionenforschung
(GSI) in Darmstadt zur Verfügung.
Um eine sichere und präzise Dosisapplikation in der IBT zu ermöglichen, werden hohe
Anforderungen an die Qualitätssicherung gesetzt. Sowohl auftretende Überdosierungen im
Normalgewebe als auch Unterdosierungen im Tumor können den Therapieerfolg gefährden.
Da bereits kleine, unerwartete anatomische Veränderungen, zum Beispiel durch Fehlpositio-
nierung des Patienten, Schrumpfung des Tumors oder Schwellungen, zu erheblichen Abwei-
chungen zwischen geplanter und applizierter Dosisverteilung führen können, gibt es Bestre-
bungen, die applizierte Dosis zumindest qualitativ zu verifizieren. Die Positronen-Emissions-
Tomografie (PET) ist derzeit die einzige, bereits klinisch erprobte Methode für ein in vivo,
in situ und nicht-invasives qualitatives Dosismonitoring. Diese Methode ist im Stande, die
Autoaktivierung des bestrahlten Gewebes zu erfassen, welche aufgrund von Kernfragmen-
tierungsprozessen entlang des Strahlweges erzeugt wird. Unter anderem werden in diesen
Reaktionen instabile Nuklide erzeugt, die entsprechend ihrer Halbwertszeit unter Emission
eines Positrons zerfallen. Bei der anschließenden Positron-Elektron-Annihilation werden zwei
511 keV Photonen in entgegengesetzter Richtung emittiert und können mittels eines geeig-
neten PET-Scanners als Koinzidenzereignis detektiert werden. Die im Patienten induzierte
dreidimensionale (3D) β+-Aktivitätsverteilung kann aus den gemessenen Koinzidenzen re-
konstruiert werden. Ein Vergleich der gemessenen mit einer erwarteten, mittels Monte-Carlo
Simulation erzeugten β+-Aktivitätsverteilung erlaubt es, Schlussfolgerungen über die tatsäch-
lich im Patienten deponierte 3D Dosisverteilung zu ziehen. Diese Art der Datenauswertung
wurde erfolgreich für die qualitative Dosisverifikation von über 440 Patienten eingesetzt, de-
ren Tumore (vorwiegend im Kopf- und Halsbereich) an der GSI mit 12C-Ionen bestrahlt
wurden.
Bei der konventionellen 3D IBT-PET-Datenverarbeitung wird eine mögliche intrafrak-
tionelle Bewegung des Zielgebietes nicht berücksichtigt und fehlerhaft rekonstruierte β+-
Aktivitätsverteilungen sind die Folge. Daher werden vierdimensionale, zeitaufgelöste (4D)
Rekonstruktionsalgorithmen benötigt, die für die spezielle Geometrie eines in-beam PET-
v
Scanner adaptiert wurden und eine Kompensation der bewegungsinduzierten Artefakte er-
möglichen. Im Rahmen der vorliegenden Arbeit wurde für den an der GSI installierten
Doppelkopf-PET-Scanner Bastei ein 4D Maximum-Likelihood-Expectation-Maximization
(MLEM) Algorithmus implementiert. Die Funktionsfähigkeit des Algorithmus sowie dessen
verbesserte Reduktion von Bewegungsartefakten im Vergleich zu einem bereits vorhandenen
Koregistrierungsansatz wurde anhand verschiedener Messungen mit bewegten radioaktiven
Quellen und bestrahlten Phantomen sowie einer vergleichenden Simulationsstudie dargelegt.
Für die Experimente wurden entsprechende Phantomgeometrien (zumeist aus Polymethylme-
thacrylat (PMMA)) sowie ein Bewegungstisch für reguläre eindimensionale (1D) Bewegungs-
muster entworfen und gefertigt. Zudem wurde durch die erfolgreiche, quasi-statische und
nahezu artefaktfreie Rekonstruktion einer rotierenden und sich damit zweidimensional bewe-
genden Aktivitätsverteilung die prinzipielle Anwendbarkeit des 4D MLEM Algorithmus für
komplexere Bewegungsmuster gezeigt. Systematische Punktquellenmessungen mit 1D cos2-
und cos4-förmigen Bewegungsmustern haben deutlich gemacht, dass der Bewegungseinfluss
mit der gleichen Anzahl an Bewegungsphasen besser kompensiert werden kann, wenn die
Bewegungsphasen entsprechend der Bewegungsamplitude anstelle der -phase unterteilt sind.
In jedem Fall können aber zufriedenstellende Rekonstruktionsergebnisse erzielt werden, wenn
durch geeignete Parameterwahl eine mittlere Restbewegung pro Bewegungsphase von maxi-
mal etwa der halben Größe eines Detektorkristalls eingestellt wird. Durch weitere Experimen-
te konnte gezeigt werden, dass nach der Rekonstruktion mit dem 4D MLEM Algorithmus die
relevanten Parameter für die qualitative Dosisverifikation (Teilchenreichweite, laterale Feld-
position und -gradienten) zuverlässig erfasst werden können. Dies ist auch dann der Fall,
wenn nur eine verminderte Anzahl an Koinzidenzereignissen, so wie sie unter klinischen Be-
dingungen zu erwarten ist, für die Auswertung verwendet wird.
Um die gemessene β+-Aktivitätsverteilung besser zu beurteilen, sollte sie mit einer simu-
lierten, für die bewegungskompensierte Bestrahlung erwarteten Verteilung verglichen werden
und es bedarf deshalb einer 4D Version der Simulationssoftware. Diese muss die Erzeugung so-
wie den Zerfall der Positronenemitter unter Berücksichtigung der intrafraktionellen Bewegung
simulieren und aus den gültigen Koinzidenzereignissen Listmode-Datensätze erstellen. Eine
derart überarbeitet Version des Simulationsprogramms wurde für den Bastei PET-Scanner
erstellt und wird in dieser Arbeit vorgestellt. Informationen über den exakten Verlauf der be-
wegungskompensierten Bestrahlung werden durch das Therapiekontrollsystem geliefert. Diese
Informationen sowie die intrafraktionelle Bewegung werden in die Simulation realistischer β+-
Aktivitätsverteilungen bzw. der zugehörigen Listmode-Datensätze einbezogen. Anhand einer
präklinischen Phantom-Simulationsstudie wurde die korrekte Funktionsweise des Simulati-
onsprogramms sowie die Notwendigkeit der zusätzlichen Parameter gezeigt.
Im Gegensatz zur Datenauswertung für statische Zielvolumina bedarf es bei intrafraktio-
neller Bewegung gegebenenfalls zusätzlichen Aufwand, um eine Fehlinterpretation aus dem
Vergleich der gemessenen und simulierten β+-Aktivitätsverteilung zu vermeiden. In der vor-
liegenden Arbeit wird beispielhaft gezeigt, dass sich bei fehlerhafter Bewegungskompensation
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die gemessene und simulierte β+-Aktivitätsverteilung einander ähneln können, obwohl die
applizierte Dosisverteilung deutlich von der geplanten abweicht. Im Gegensatz dazu können
auch Abweichungen zwischen Messung und Simulation auftreten, die nicht auf anatomische
Veränderungen, sondern auf eine ungenaue 4D Datenverarbeitung zurückzuführen sind. Es
werden Vorschläge unterbreitet, um den Prozess der 4D IBT-PET Datenauswertung zu op-
timieren und somit Fehlinterpretationen zu vermeiden.
Die vorliegende Dissertationsschrift enthält durch die Bereitstellung der benötigten 4D
Rekonstruktions- und Simulationsprogramme grundlegende Arbeiten für eine mögliche zu-
künftige Anwendung der 4D IBT-PET als qualitatives Dosismonitoring bei intrafraktionell
bewegten Zielvolumina. Für weitere Verbesserungen des Verfahrens sind zusätzliche syste-
matische Betrachtungen mit realistischeren, mehrdimensionalen und unregelmäßigen Bewe-
gungsmustern notwendig. Zukünftige Untersuchungen sollten außerdem echte Bestrahlungs-
pläne, Atemkurven sowie 4D Patienten-CT-Daten einschließen, um den erwartbaren Nutzen
eines 4D IBT-PET Dosismonitorings besser abschätzen zu können.
vii
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1.1 Potential and obstacles of ion beam therapy
Cancer diseases are the leading cause of death worldwide. A total number of 7.6 million
cancer related deaths in 2008 was estimated by the World Health Organization and its can-
cer research agency, the International Agency for Research in Cancer (IARC) (Ferlay et al.
2010a). Besides individual genetic factors and different physical, chemical and biological car-
cinogens, the age is a fundamental risk factor for cancer incidence. Due to population growth
and ageing, a global burden of 22.3 million new cancer incidences in 2030 is predicted com-
pared with 12.7 million incidences in 2008 (Bray et al. 2012). Figure 1.1 displays the absolute
and percentage distribution of the most frequent cancer sites for incidence and mortality in
2008. Lung cancer is the most common cancer and has one of the highest case fatality rates
(ratio of mortality to incidences) of about 86%. Only liver cancer has an even higher fatality
rate of about 93%. Improving the treatment options for these frequently occurring cancers
could prevent many deaths.
Conventional curative treatment strategies include surgery, radiotherapy and systemic ther-
apy or combinations thereof and have to be selected individually. If possible, surgery is the
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Figure 1.1: Estimated cancer incidence and mortality worldwide in 2008 from data provided by the
GLOBOCAN databank of the IARC (Ferlay et al. 2010b). The pie charts show the absolute and per-
centage distribution of the most frequent cancers (exclusive non-melanoma skin cancer) summarized
for both sexes.
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method of choice for primary treatment of early stage localized cancer. For inoperable pa-
tients, radiotherapy may often be an alternative. Continuous improvements in radiotherapy
result in better local tumour control and higher survival rates. Evidence for improved outcome
by the application of e.g. new treatment planning algorithms and beam delivery techniques,
the combination of radiotherapy with chemotherapeutic drugs or revised treatment schedules
and prescribed doses is obtained by the evaluation of clinical trials. For non-small cell lung
cancer (NSCLC) which accounts for the majority (about 80%) of all lung cancers, Partridge
et al. (2011) reviewed 24 published clinical trials and found a clear tumour dose-response
relation. Therefore, dose escalation studies are suggested for treating NSCLC. Also for liver
metastasis, high-dose radiotherapy seems to be effective (Rusthoven et al. 2009).
To deliver higher doses, the treatment field should be limited to the tumour volume and
the surrounding normal tissue, and nearby organs at risk (OARs) must be prevented from
additional dose to avoid severe acute complications and late effects. Today, several external
radiotherapy modalities are available beside the conventional three-dimensional (3D) con-
formal radiotherapy. For instance, in static and rotational intensity modulated radiotherapy
(IMRT) the dose distribution is adjusted to the 3D tumour shape by modulating the beam in-
tensity when irradiating from different directions. Stereotactic radiotherapy and radiosurgery
use high doses delivered in one or only a few fractions for non-invasive tumour ablation and
thus require improved delivery precision. Another approach is the ion beam therapy (IBT)
utilizing proton beams or beams of other light ions like helium, carbon or oxygen. From a
physical point of view, ion beams have the advantage to generate steep dose gradients, in par-
ticular in the beam direction as illustrated for 12C ions in figure 1.2. The inverse depth-dose
Figure 1.2: Comparison of depth-dose curves in water (a) for 6MV and 15MV photons provided
by Hoinkis and Tillner (2013) and for pristine 12C ions beams of 200AMeV and 270AMeV taken
from Schardt et al. (2010), both with courtesy of the authors. The curves are scaled to the same
dose in the entrance channel. The superposition of single Bragg peaks with suitable energies leads
to the formation of a spread-out Bragg peak (SOBP) at a defined depth (b). The intensities of ten
12C beams with energy differences of about 3.5AMeV had been optimized by the treatment planning
program TRiP (Krämer et al. 2000) to generate a deep-seated high dose plateau (the SOBP) of about
27mm width (with courtesy of C. Bert).
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profiles of mono-energetic ions possess a characteristic narrow high-dose region, the Bragg
peak, and a rapid distal fall-off at the end of the ion range. Therefore, ion beam plans allow
for same homogeneous dose coverage of the tumour volume as e.g. IMRT photon plans do,
but they provide a better sparing of healthy tissue and nearby radiosensitive structures by
utilizing only a few treatment fields. From a radiobiological point of view, the potential
benefit from the increased relative biological effectiveness (RBE) is an additional argument
for the application of ions, especially those heavier than protons. Their high linear energy
transfer (LET) causes a more effective radiation damage to the tissue and helps to reduce
radioresistance due to hypoxia or poor reoxygenation in some tumours.
Several studies and clinical trials (Schulz-Ertner and Tsujii 2007; Jensen et al. 2012; Ogino
2012) provide sound evidence that carbon ion and proton radiotherapy yield better outcome
than photon radiotherapy for several tumour entities in terms of reaching higher local control
and overall survival rates as well as inducing less side effects. Uveal melanomas, specific tu-
mours of the skull base and pediatric tumours (Combs et al. 2009) are for instance considered
as clear indications for IBT. Promising outcome has also been reported for early stage lung
cancer (Miyamoto et al. 2003; Nihei et al. 2006) and hepatocellular carcinoma (Kato et al.
2004; Chiba et al. 2005). Although IBT might offer such a high clinical potential, only 37
IBT facilities were operating worldwide at the end of 2011 (PTCOG 2012) but with tendency
to rise. The majority, namely 33 of the 37 facilities offered proton beams and only 6 of them
were capable to treat patients with carbon ion beams.
Besides the clinical aspects, the benefit of IBT has to be validated taking also economical
and safety issues into account. The ongoing discussion about the cost-effectiveness of par-
ticle therapy lacks in a general consensus (Lodge et al. 2007; Pijls-Johannesma et al. 2008).
For lung tumours, Peeters et al. (2010) stated a relatively small cost difference between par-
ticle and photon therapies and predicted reduced costs for hypofractionated schedules for
which excellent results have already been achieved with carbon ions (Miyamoto et al. 2007).
Other obstacles for a better establishment of IBT are technical challenges related to ion
range uncertainties. The depth of the the Bragg peak position in the patient is well tunable
by the initial ion energy but is strongly affected by the composition of the traversed tissue.
Thus, the patient-specific tissue densities must seriously be taken into account when selecting
the required beam energies for creating a treatment plan where the spread-out Bragg peak
(SOBP) position should match exactly with the tumour depth. Uncertainties in the finally
administered dose distribution in the patient may originate systematically or coincidentally
from imaging, dose calculation, patient setup, changed patient constitution and beam de-
livery. For instance, the final treatment plan is in some degree subjected to artefacts in
the planning X-ray computed tomography (CT) image, the calibration between Hounsfield
units (HUs) in the CT image and stopping power (Schaffner and Pedroni 1998; Rietzel et al.
2007), the treatment planning algorithm itself (Endo et al. 1996; Krämer et al. 2000; Pa-
ganetti et al. 2008) and the variability of its required input parameters. Additionally, the
exact verification of treatment plans in water phantoms is limited by the accuracy of the
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dose measurement mostly performed with ionization chambers that quantify doses with an
estimated standard uncertainty of about 2% for protons and about 3% for other ions (IAEA
2000). Commissioning errors as well as limited precision of patient positioning devices and of
beam delivery components like energy degraders, patient-specific compensators or movable
beam nozzles introduce further inaccuracy. Thus, high standards of quality assurance are
exceedingly required in IBT. These include the compilation of robust treatment plans, the
initial commissioning and daily, weekly or otherwise scheduled consistency checks of all hard-
and software components (Jäkel et al. 2000; Karger et al. 2000).
Beside the technical issues, the influence of the patient itself has to be considered. Includ-
ing the effects of non-tissue components like metal implants, prostheses or inserted fiducial
markers for range calculations is quite difficult (Jäkel and Reiss 2007). Basically, variable
tissue geometry between imaging for treatment planning and each fraction of radiotherapy
application might induce density changes within the treatment field and thus lead to a range
shifting in IBT. This inter-fraction variability is e.g. related to patient weight loss, tissue
swelling and secretion formation due to inflammatory processes, different filling of the gas-
trointestinal tract for lesions in the abdominal region as well as tumour shrinkage as a direct
treatment response. For fractionated photon radiotherapy of NSCLC, Fox et al. (2009) re-
ported individual tumour shrinkage between 0.2% and 81.6% of the initially defined volume
after the application of 50Gy within 25 daily fractions.
All these circumstances justify the demand of in situ dose verification systems for IBT since
severe overdosage in healthy tissue and underdosage in the tumour volume might already be
caused by slight density deviations within the beam path. Contrary to photon radiotherapy,
a portal imaging technique that utilizes the therapeutic ion beam is not feasible since the
ions are absorbed in the patient. Ions with higher energy than used for the treatment itself
might be used for radiography imaging if the tissue has a limited thickness and ions will
therefore be transmitted (Rinaldi et al. 2013). At the Paul Scherrer Institute (PSI) in Villigen,
Switzerland a new concept has been brought into experimental operation. A 150 kV X-ray
fluoroscopy system mounted at Gantry 2 takes images in beam’s eye view (BEV) direction,
either prior to the treatment for position verification or synchronized with beam delivery to
control the irradiation (Safai et al. 2012). Other monitoring techniques rely on secondary
radiation emerging from the products of nuclear reactions between a fraction of the incident
ions and tissue nuclei. Within a femto- to picosecond time frame after such reactions took
place, prompt γ-rays are emitted from excited nuclei. Different detector concepts like slit
(Testa et al. 2009; Smeets et al. 2012) or Compton (Kormoll et al. 2011; Roellinghoff et al.
2011; Kurosawa et al. 2012) cameras are still under investigation for the direct assessment
of the ion range. An adequate handling, processing and evaluation of these data is pursued
for a real-time monitoring. Nowadays, positron emission tomography (PET) is the only
dose monitoring technique for IBT that has already been successfully applied under clinical
conditions (Hishikawa et al. 2002; Enghardt et al. 2004b; Parodi et al. 2007c; Hsi et al. 2009;
Nishio et al. 2010). Positron emitters are created by nuclear fragmentation reactions as a
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side effect during the irradiation with stable ion beams (Enghardt et al. 1992). Typically,
the relevant radioactive nuclides decay according to their specific half-lives within seconds to
tens of minutes into stable nuclides under the emission of a positron. Subsequently emitted
annihilation photons can be detected as coincidence events by a dedicated PET scanner and
thus allow for the reproduction of the induced β+-activity in the body. However, the finite
half-lives and the time-consuming reconstruction impede a real-time dose validation. Only
relative changes of tumour and body shape during fractionated therapy can be identified by
a simple comparison of β+-activity distributions from different fractions (Nishio et al. 2010).
A more extensive analysis includes the precalculation of an anticipated β+-activity (Pönisch
et al. 2004; Parodi et al. 2007a) and a comparison with the measurement. Consequently,
conclusions can be drawn about potentially dislocated dose portions in the patient and an
intervention before the next fraction is possible.
Between 1997 and 2008, a pilot project was carried out by the German Cancer Research
Center (DKFZ), the Heidelberg University Hospital (UKL-HD), the GSI Helmholtzzen-
trum für Schwerionenforschung (GSI) and the Forschungszentrum Rossendorf (FZR) (today
Helmholtz-Zentrum Dresden-Rossendorf (HZDR)). About 440 patients mainly suffering from
head and neck cancer have been treated with 12C ions at a medical beamline installed at GSI
in Darmstadt (Eickhoff et al. 2009). The HZDR group monitored for all patients the dose de-
livery of each fraction by means of a double-head PET scanner which was directly integrated
into the treatment site (Enghardt et al. 2004a). Dedicated algorithms for the reconstruction
of β+-activity distributions and the simulation of expected PET data sets had been developed
and were successfully applied.
1.2 Objectives of the thesis
IBT has demonstrated promising clinical results due to its tumour conformal dose distribu-
tion. The treatment precision for tumour entities in the thoracic or upper abdominal region
like lung, liver or pancreatic tumours suffers from intra-fractional motion, mainly related to
respiration. The concept of traditional photon radiotherapy to add safety margins in the
treatment plan to cover a predicted motion amplitude is inappropriate for IBT with actively
scanned ion beams. Thus, four-dimensional, time-resolved (4D) treatment planning and new
motion-mitigated beam delivery techniques involving real-time target localisation and adap-
tation of the irradiation have been developed. The complexity of these techniques and the
large intra-fractional density fluctuations in particular within the thorax region increase the
risk of a potentially inaccurate dose deposition and demands control.
The IBT-PET dose monitoring has shown benefit when it was applied for static and well-
fixated tumour entities. It has not been employed for intra-fractionally moving targets yet,
including the reconstruction and simulation of data sets. If it would be applied in its approved
status for studying activated moving structures, precise conclusions about the delivered dose
would be contradictable due to motion related blurring artefacts in the reconstructed PET
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images from measured data sets. The reason therefor is the transportation of generated
β+-emitters until their decay together with the moving anatomical structures. In general,
although the β+-emitters might be placed all the time at the position where they have been
created within the moving target, they will decay at another coordinate relative to the fixed
PET scanner coordinate system. Annihilation photons will accordingly be registered by other
detector elements and thus distort the information in the measured data set. To compensate
the induced artefacts, motion information has to be involved when reconstructing β+-activity
distributions. Furthermore, the motion and related beam adaptation has to be modelled when
simulating IBT-PET data sets. Only then, simulated and measured data sets may contain
comparable information.
Within this thesis, three main issues are addressed related to the revision of the IBT-PET
dose monitoring for a potential application with moving targets. After some basics about
particle therapy, moving targets and IBT-PET the following topics will be discussed:
• Reconstruction of IBT-PET data under consideration of target motion:
An implemented time-resolved reconstruction algorithm is presented. Its performance
is evaluated by means of a simulation study, systematic off-line experiments and dedi-
cated phantom irradiation. The applicability of the reconstruction method for different
motion mitigated beam deliveries is also demonstrated by phantom experiments.
• Simulation of IBT-PET data sets taking into account the target motion, adaptive beam
delivery and variable decay positions of the β+-emitters:
The revised simulation software for generating expected IBT-PET data sets from mov-
ing target structures is explained in detail. The simulation result is utilized for the
rating of the measured β+-activity distribution and thus is an important part of the
whole IBT-PET monitoring. The functionality of the 4D simulation is exemplified by
means of a selected experiment scenario.
• Drawing conclusions from the comparison between measured and simulated 4D IBT-
PET images in the presence of deficient motion mitigation or data synchronization:
Beside the identification of usual properties like correct particle range, field position
and local deviations, attention has to be turned to the availability of possible treatment
errors related to breakdown or malfunction of the motion compensation. Systematic
experiments are presented which demonstrate the limitation of the dose verification for
moving targets utilizing the hitherto existing workflow. Related recommendations for
a correct interpretation of the 4D IBT-PET data are given.
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Robert Wilson raised the idea of using fast protons or heavier ions for radiotherapy in 1946
(Wilson 1946). The first medical application of proton beams succeeded 1954 at the Lawrence
Berkeley Laboratories and 1957 in Uppsala. Others followed in Havard, Dubna, Moscow,
Loma Linda, Massachusettes, Chiba, Tsukuba and Villigen, just to mention a few. Patient
treatment with heavier ions started 1975 at the Lawrence Berkeley Laboratory using helium
and neon beams. Finally, carbon ions prevailed and are now available for therapy in Chiba,
Hyogo, Gumna (all in Japan), Lanzhou (China), Pavia (Italy) and Heidelberg (Germany)
(PTCOG 2012). At the latter, IBT with oxygen is also planned for the future (Kurz et al.
2012). Moreover, even mixed beam irradiation scenarios had already been considered (Kanai
et al. 1997).
Until today, almost 105 patients in total have been treated with ion beams worldwide, more
than 80% of them with protons and nearly 10% with carbon ions (PTCOG 2012). A limited
number of patients underwent a treatment of lesions in the lung or liver. Clinical studies
at the facilities in Loma Linda (USA), Tsukuba, Kashiwa, Hyogo and Chiba (all in Japan)
have reported promising outcome for these patients (Pijls-Johannesma et al. 2010; Skinner
et al. 2011; Tsujii and Kamada 2012). However, the potential of ion beam therapy might
not have been fully exploited for these patients, due to the passive beam shaping mostly in
combination with limited motion compensation and missing dose monitoring.
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2.1 Physical and biological properties of ion beams
Wilson’s suggestion for applying ion beams in radiotherapy was based on the specific ion-
ization of ion beams within tissue, their reduced straggling compared to electrons and the
previously investigated dependency of biological damage from ionization density. Within this
section, the physical and biological rationale will be presented that made IBT becoming a
serious treatment modality in radiotherapy.
2.1.1 Dose deposition
When high energetic charged particles pass through matter, they are capable to produce
ionization, i.e. to liberate bound electrons of the medium by inelastic collisions and thus to
loose gradually their energy. When the particles have slowed down to an energy below a
certain cutoff energy, ionization becomes impossible and the particles are considered as non-
ionizing radiation. The remaining energy near the end of the particle range is spent to other
processes like excitation and elastic scattering. The elastic collisions between the incident ions
and the atoms of the material are mediated by their Coulomb interaction. A third process
that might lead to energy loss is the emission of bremsstrahlung in the electric field of the
atomic nuclei or electrons. For heavy, charged particles with a mass M > me (heavier than
electrons), this process can be neglected for therapy relevant energies in comparison to the
ionization processes, since the intensity of the bremsstrahlung is in classical approximation
proportional to the square of the acceleration in the electric field and therefore ∼M−2.
Stopping power
The mean energy E that is lost within a distance l is described by the stopping power S.
This quantity depends on the type of the charged particles, their energy and the material
where the stopping takes place. To reduce the dependence on the density of the material the
mass stopping power
S
ρ
= 1
ρ
dE
dl
[
S
ρ
]
= Jm2 kg−1 (2.1)
is considered (ICRU 2011). This total mass stopping power is composed by the different
channels of energy loss between the charges of the projectiles and the target nuclei and can
be expressed as
S
ρ
= 1
ρ
Sel +
1
ρ
Snuc +
1
ρ
Srad, (2.2)
where Sel denotes the electronic stopping power related to inelastic interactions with the
electrons in the material and resulting in ionization or excitation of the atoms, Snuc the nuclear
stopping power related to elastic Coulomb interaction and Srad the radiative stopping power
related to the emission of bremsstrahlung which is negligible in the following considerations.
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Figure 2.1: Total mass stopping power of liquid water in dependence of the kinetic energy per nucleon
for ions already been used or planned to be used in IBT (left) and the electronic Sel/ρ and nuclear
mass stopping ratio Snuc/ρ exemplary shown for protons (1H) an helium ions (4He) (right). Data
for protons and helium ions originate from the online database of the National Institute of Standards
and Technology (NIST) (Berger et al. 2005) with values according to the International Commision on
Radiation Units and Measurements (ICRU 1993a). Data for heavier ions (12C, 16O, 20Ne) are taken
from Paul and Schinner (2003).
Figure 2.1 shows the total mass stopping power of water for ions that had been (4He, 20Ne),
are (1H, 12C) or will soon be (16O) applied in IBT. From the detailed presentation for protons
and helium ions, it is clearly visible that the total mass stopping power is dominated by the
electronic stopping power in a wide energy range relevant for IBT.
Electronic energy loss
The energy loss in single collisions due to the electronic interaction was the first time described
in a classical approximation by Bethe (1930). For moderately relativistic charged particles
(except electrons) with massM , velocity v and charge Zeff ·e, the mean energy loss in material
is given by the Bethe formula (Beringer et al. 2012)
−dEdl = 4piNAr
2
emec
2Z2eff
Zm
Am
1
β2
[
1
2 ln
2mec2γ2Tmax
I2
− β2 − δ(βγ)2 −
C
Zm
]
(2.3)
with variables as explained in table 2.1. Material related influence is considered by the term
Zm/Am which defines the electron density ne of the material and by the mean excitation en-
ergy I which is e.g. given for different materials by the International Commision on Radiation
Units and Measurements (ICRU) (ICRU 1984). Without the correction terms δ and C, (2.3)
holds true in a wide range of particle velocity (β & 0.1). The energy loss in a given material
is mainly a function of the particle charge (∼ Z2eff) and its velocity (β). An important rela-
tion is the increase of energy loss per unit length when the velocity and hence β decreases
continuously as the particle passes through the medium. Only a minor dependence on the
particle mass M is given by Tmax which is the maximum kinetic energy transfer to a free
electron within a single collision. This quantity is calculated and approximated for heavy
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Table 2.1: Overview and definition of variables used in Bethe formula (2.3).
Symbol Definition Unit or Value
mec
2 Electron mass · c2 0.510 998 918(44)MeV
NA Avogadro’s number 6.022 1415(10)× 1023mol−1
re Classical electron radius 2.817 940 325(28) fm
Zeff · e Effective charge of incident particle
Zm Atomic number of stopping medium
Am Atomic mass of stopping medium gmol−1
β v/c
γ Lorentz factor 1/
√
1− β2
I Mean excitation energy of stopping medium eV
Tmax Maximum energy transfer in single collision eV
δ(βγ) Density effect correction to ionization energy loss
C Shell correction for small energies
particles with (M  me) as
Tmax =
2mec2β2γ2
1 + 2γme/M + (me/M)2
≈ 2mec2β2γ2. (2.4)
For very high as well as low energies the correction terms must be considered. At high
energies, the electric field of the particle gets deformed and extended. The density effect
correction δ accounts for a limited field extension due to polarization effects of the medium
which results in a shielding of distant electrons and consequently, a smaller energy loss by
collisions with these electrons. The shielding due to polarization depends strongly on the
density of the medium. δ is normally computed with the parametrization after Sternheimer
and Peierls (1971). The fitting formula and fitted parameters for several media are for
instance compiled by Sternheimer et al. (1984). For energy loss at low energies, the shell
correction C/Zm accounts for the atomic binding of electrons which cannot be considered as
static anymore as it is done for higher energies. A discussion of low-energy corrections can
be found in the ICRU report 49 (ICRU 1993a). With properly included corrections, (2.3) is
accurate within 1% for β & 0.05 or protons with energies about 1MeV (Beringer et al. 2012).
Particle range and straggling
Ion beams possess a well-defined range in material. It is defined as the traversed distance
until the total kinetic energy has been transferred to the medium and the particle is at rest.
The mean particle range R is calculated by the integration of the reciprocal stopping power
over energy (between initial kinetic energy Ekin,0 and 0) or over the velocity (between the
initial velocity v0 and 0)
R =
Ekin,0∫
0
1
dE
dl
dE =
v0∫
0
dl
dE
dE
dv dv. (2.5)
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Considering the stopping power of electronic interactions described in (2.3) and identifying
the energy E proportional to particle mass and thus proportional to the number of nucleons
A in the particle (E = A · f(v)), the following correlation is evident
R(Ekin,0) ∼ A
Z2
. (2.6)
Since the interactions are of statistical nature with a very high number of ion-electron colli-
sions and since large angle scattering is unlikely for ions, only a slight straggling in range is
observable between same particles with same initial kinetic energy Ekin,0. The angular spread
of the Coulomb scattering, relevant near the end of the particle range, depends heavily on
the mass of the projectiles. Consequently, lighter charged particles (protons) are more likely
to undergo large-angle scattering and thus show a more pronounced straggling in lateral di-
mension and also in range than heavier ions like carbon. For particles with mass number A
and charge number Z having a mean range R in water (given in cm), Tobias et al. (1980)
parametrized the uncertainties considered as Gaussians by giving the standard deviation for
range straggling σx and lateral straggling σy as
σx = 0.012
R0.951
A0.5
σy = 0.0294
R0.896
Z0.207A0.396
. (2.7)
To give a number, at a range of 20 cm in water which is in first order an acceptable approxi-
mation for tissue, one obtains σx = 0.6mm and σy = 1.1mm for carbon ions (A = 12, Z = 6)
and σx = 2.1mm and σy = 4.3mm for protons (A = Z = 1), respectively.
Linear energy transfer (LET) and dose
Besides the stopping power and the finite range, the LET of ion beams is an often referred
quantity. It defines for a certain material and a given type and energy of particle the mean
energy loss by electronic stopping within a certain distance. Thus, it is (except the sign)
equivalent to the mean energy loss described by (2.3). For dosimetric considerations the
deposited energy near the particle track is relevant. The released secondary electrons them-
selves may transfer their kinetic energy by further ionisation of surrounding atoms. So-called
∆-electrons with higher kinetic energy may leave the considered volume. Therefore, the
restricted linear energy transfer is defined as
LET∆ = Sel −
dEke,∆
dl , (2.8)
where Eke,∆ expresses the mean sum of kinetic energies greater than ∆ from all released
secondary electrons (ICRU 2011). According to the LET value, one differentiates between
low LET radiation (LET . 3.5 keV/µm) like electrons, γ- or X-rays and high LET radiation
such as neutrons and low-energetic ions. The low LET radiation creates a diffuse and low
dense pattern of ionization, but for high LET radiation a substantial number of ionization
events occur within a short part of a particle track (cp. figure 2.2). The LET value has to
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High LET radiation Low LET radiation
Figure 2.2: Schematic representation of ionization density in a restricted volume (black) for high and
low LET radiation. In both examples the same number of ionization events (purple) are produced
that illustrate the same amount of deposited dose. In contrast to the locally dense ionization along the
particle track (green) of high LET radiation an equally distributed pattern of ionization is generated
by the low LET radiation.
be clearly distinguished from the dose which is the clinically prescribed value that has to be
matched when computing treatment plans in radiotherapy. The same amount of dose can
be delivered with high or low LET radiation. The absorbed dose D is defined as the mean
imparted energy to matter of mass m
D = dEdm [D] = J kg
−1 = Gy. (2.9)
A combination of the information about energy dependent stopping power and dose for
high LET ion beams results in the characteristic depth-dose profiles for homogeneous matter
as already shown for 12C ions impinging on water in figure 1.2. The often called inverse
profiles of ion beams possess a flat plateau region in the entrance channel where only less
dose is deposited due to low LET, if particles are not too heavy. When the projectiles have
slowed down the LET increases and a sharp dose peak, the Bragg peak, is formed at the
end of the finite range. Thus, ion beams are capable to constitute tumour conformal dose
distributions with reduced entrance dose and almost completely missing exit dose.
Nuclear fragmentation
For the exact calculation of dose distributions, the influence of nuclear fragmentation re-
actions has also to be considered in IBT since beam fragmentation tend to deteriorate the
sharp dose contours. A fraction of the incident ions undergoes these processes which are
mainly peripheral collisions occurring primarily at higher energies. A two-step model of
the fragmentation reactions was at first proposed by Serber (1947) and is today known as
abrasion-ablation model (Gaimard and Schmidt 1991). The collision time between the in-
cident particle and the nucleus is quite short (10−23 s) in comparison to the time scale of
interaction between nucleons in the nucleus (10−21 s – 10−16 s). The composition of the reac-
tion partners is modified during the collision step and a certain amount of excitation energy
is transferred to the so-called prefragments. In the second step, the system reorganizes by
thermalisation and deexcitation under evaporation of neutrons, protons and light nuclei as
12
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well as by fission and the emission of gamma rays. A detailed outline on heavy fragment
production by nucleus-nucleus collisions is given by Hüfner (1985).
Consequences of nuclear fragmentations for IBT with ions heavier than protons can be
summarized as follows (Kraft 2000). Since in peripheral collisions only a small amount of
momentum is transferred to the target nuclei, the projectile fragments remain quite large and
propagate with almost unchanged velocity. However, the emission angle of the fragments is
larger than the lateral scattering by electronic interaction. This leads to a broadening of the
beam profile. The projectile fragments can also undergo secondary fragmentation which might
not be neglected. Due to the reduced mass and/or charge number of the projectile fragments,
their lateral and range straggling changes a little according to (2.7), and in particular their
mean range differs from that of the primary projectiles and scales according to (2.6). For
instance for 12C ion beams, the typical projectile fragment 11C will be stopped proximal
and others like 11B in the fragment tail distal to the planned Bragg peak position. Hence,
the Bragg peak becomes broadened which has to be considered for treatment planning. If
treatment plans are created for passive beam delivery (cp. section 2.2.1), one has to keep in
mind that material in the beam path used for beam modulation like range shifters or absorbers
induces an additional amount of fragments which is avoidable when active delivery techniques
(cp. section 2.2.1) are applied. Related to the intolerable amount of generated fragments from
ion beams heavier than neon, these particles are not contemplated for radiotherapy. Cross
sections for certain fragmentation reactions of lighter ion beams (5 ≤ Z ≤ 10) (Schall et al.
1996) reveal that carbon beams produce a quite small amount of low-Z fragments.
2.1.2 Biological effectivity
The absorbed dose is a well defined quantity. However, in several biological systems or under
changed conditions same dose values can evoke varying biological reactions.
Cell death and survival curve
The mechanisms leading to radiation effects in biological systems can be classified in two
groups. If the energy is absorbed in the critical target molecule itself, it is referred to as a
direct effect. If radiation is absorbed by other structures and in a subsequent step trans-
ferred to the target molecule, it is called an indirect effect. A typical example for the latter
one is the radiation induced hydrolysis of water accompanied with the formation of oxygen
radicals which are likely to induce chemical reactions. The most important target molecule
in radiotherapy is the deoxyribonucleic acid (DNA). The aim is to induce modifications in
the double-stranded DNA molecule of the tumour cells. These modifications will result in
mutations and in mitotic or clonogenic cell death1 if repair mechanisms fail. Non-repaired
double-strand breaks or incorrect reparation results are considered to be the main mechanism
1The cell looses its reproductive integrity and its ability to proliferate indefinitely. Such a cell is considered
as dead although it might retain its ability to synthesize proteins and DNA and undergoes a small number
of cell cycles.
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Figure 2.3: Schematic representation of cell survival curves for different LET radiation after Herr-
mann et al. (2006). Low LET radiation requires higher doses for inducing the same amount of cell
death. The dose ratio (RBE) changes with considered value of survival fraction.
for biological effects. Hence, cell survival is an often investigated quantity to rate the effec-
tivity of a particular dose. The cellular survival fraction s/s0 of an initial cell population s0
after the irradiation with a dose D is well described by the widely accepted linear quadratic
(LQ) model (Kellerer and Brenot 1974)
ln
(
s
s0
)
= −αD − βD2 [α] = Gy−1 [β] = Gy−2. (2.10)
α and β are cell and tissue specific constants that determine the initial slope and curvature
of the survival curves. Influencing factors for cell survival are e.g. radioresistance, repair
capacity, current cell cycle phase, fractionation schedule of the radiotherapy, duration of
irradiation, oxygen supply, existence of biological or chemical modifications and the quality
of radiation (Herrmann et al. 2006). Also the difference in ionization density of high and low
LET radiation induce different responses in biological systems. Figure 2.3 shows the typical
progression of cell survival curves for high and low LET radiation.
Relative biological effectiveness (RBE)
To quantify the influence of certain factors onto cell survival, the parameter RBE is used. It
rates the biological response to a dose delivered with a specific type of radiation. In particular,
the RBE for a certain test radiation that delivers a dose DT is related to a dose of a reference
radiation DX (predominantly 60Co γ-rays or 250 keV X-rays) that generates the same effect
in a given biological system under identical conditions and is defined as (Herrmann et al.
2006)
RBE = DX
DT
∣∣∣∣
same endpoint
, (2.11)
where a biological endpoint could e.g. be a certain amount of cell survival as illustrated
in figure 2.3 for the high LET test radiation. Detailed considerations and recommendations
concerning the RBE in IBT are given by the IAEA (2008). The RBE value is rather complex.
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In first approximation it increases with LET and as the LET increases along the path of
slowing down ions the RBE rises in depth. The RBE of ion beams depends additionally
on the particle type, even if they have the same LET (Goodhead et al. 1992). For proton
beams a constant generic RBE value of 1.1 is recommended for clinical practice by the ICRU
(2007), although experimental data give evidence that the RBE rises clearly at the distal
end of the proton Bragg peak (Paganetti et al. 2002). For carbon ions a variety of RBE
values have been reported, even RBE > 6 can be found in the literature. Ando and Kase
(2009) reviewed the published RBE values for high LET radiation for different biological
systems and endpoints. The higher RBE values with nonlinear dose dependence for carbon
ion beams make carbon favourable in comparison to proton beams. However, the increased
RBE values, either constant or variable, have to be taken into account during treatment
planning. Treatment plan optimization is not restricted to the consideration of physical dose,
but rather the isoeffective dose DisoE (Wambersie et al. 2007; IAEA 2008) should form a
homogeneous Bragg peak in the target volume.
2.2 Technical aspects of ion beam delivery
2.2.1 Active and passive beam delivery technique
Currently, there are two ion beam delivery techniques available for the administration of
treatment fields to specific tumour locations. These are commonly referred to as scattered
and scanned or passive and active beam delivery (Kraft 2000), but also as beam widening and
conformal technique (Blattmann 1992), respectively. Both methods fit the treated volume in
two dimensions in BEV to the shape of the target volume.
Passive beam delivery
Highly energetic, narrow ion beams with constant energy are provided by cyclotrons or syn-
chrotrons. To realize a useful beam cross section covering the tumour size in BEV, the narrow
beam is defocused and passively widened by double scattering techniques or semi-actively by
wobbling magnets (Chu et al. 1993). Also a combination of both systems is feasible as it was
installed at the heavy-ion medical accelerator in Chiba (HIMAC) (Kanai et al. 1999). To
form a SOBP, the particle energy is modulated by moving or static ridge filters or rotating
modulator wheels. The material of varying thickness generates a specific SOBP extension
and conformation taking also the RBE dependence into account. The components are pro-
duced for individual tumour thicknesses. Additional homogeneous degraders or range shifters
are brought into the beam path to reduce the remaining maximum energy according to the
maximal required penetration depth for a specific patient. In lateral dimension the treatment
field is confined by an individually fabricated collimator or a commercial multileaf collima-
tor. The distal shape of the high dose volume is adapted to the distal tumour contour by an
individually manufactured range compensator put directly at the skin of the patient. Compo-
nents for passive beam delivery are summarized by Kraft (2000) and presented in more detail
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Figure 2.4: Outline of passive beam shaping with components as explained in the text using double
scatter beam broadening and range modulation by a moving ridge filter. The volume treated by the
SOBP covers the whole tumour volume and its distal shape is adapted to the distal target curvature
by a patient specific range compensator. However, the proximal shape of the high dose region does
obviously not reproduce the proximal target contour. Consequently, overdose regions upstream of the
tumour have to be accepted.
by Chu et al. (1993). Figure 2.4 shows a scheme of the various components and illustrates
the main disadvantage of this beam delivery technique. Since the longitudinal extension of
the SOBP is constant for the whole lateral field cross section, the high dose volume overlaps
unnecessarily with healthy tissue proximal to the target volume.
Active beam delivery
Active beam delivery was at first brought into operation using proton beams at PSI (Pedroni
et al. 1995) and carbon ion beams at GSI (Haberer et al. 1993). The raster scanning with
carbon ions is nowadays also available at the Heidelberg Ion-Beam Therapy Center (HIT)
(Heeg et al. 2004) and at the HIMAC in Japan (Furukawa et al. 2010b). The concept of
active beam delivery is rather simple as illustrated in figure 2.5. The target volume is divided
into a grid of volume elements (voxels), and for each voxel a certain isoeffective dose is
prescribed. Voxels that require same beam energy to match the Bragg peak depth with
the voxel position (depending on proximal tissue density) are grouped together in iso-energy
slices. Within each slice the thin pencil beam with a full width at half maximum (FWHM)
of a few millimetres is scanned by means of dipole magnets in lateral direction (horizontally
and vertically) from voxel to voxel. At each position a predefined amount of ions is deposited
using raster scanning, where the scan velocity is modulated while the beam is sweeping from
voxel to voxel, or spot scanning, where the beam is turned off when changing the magnetic
field for the next position. Changes between energies are either realized by absorbers of
different thickness at cyclotron accelerators, which are normally used in proton therapy, or
by the accelerator itself. Synchrotrons allow for a pulse to pulse variation of the beam energy,
intensity and FWHM. The layers are separated in depth by only a few millimetres to allow
for overlapping of Bragg peaks. To minimize the number of required energies in the treatment
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Figure 2.5: Illustration of active ion beam delivery using vertical and horizontal deflection magnets
to direct a pencil beam to a certain lateral position in the planned treatment volume. The requested
ion beam energy defines the depth of the Bragg peak in the target. In each iso-energy slice, the beam
is scanned along a predefined path. Hence, the whole target volume is covered with an individual dose
without using any patient specific components.
plan, ripple filters are used to broaden the Bragg peak (Weber and Kraft 1999).
In principle, arbitrary depth dose profiles are produced by this technique, but treatment
planning is more complex (Krämer et al. 2000; Krämer and Scholz 2000). The dose deposited
in a certain voxel is composed of the Bragg peak dose at the voxel depth and the dose deposited
by ions of higher energy traversing that voxel to deeper seated voxels. Nevertheless, active
beam delivery with raster scanning magnets is the favourable implementation in upcoming
installations and is predicted to be the standard technique in the future of IBT (Jäkel et al.
2008). Active beam delivery of carbon ions at the GSI facility has been used for investigations
within this thesis.
2.2.2 Beam monitoring for pencil beam scanning
Beam monitors are important components for the active beam delivery, since it demands
the measurement and control of particle fluences and beam position with high precision and
within a few microseconds. For this purpose, parallel-plate ionization chambers (ICs) are
used to measure particle fluxes that range for carbon ions approximately from 2 × 106 to
1 × 109 ions per second (Voss et al. 1998; Furukawa et al. 2010b). Multi-wire proportional
chambers (MWPCs) are employed for the monitoring of beam position and focus size. For
safety reasons, the monitoring units are mounted at the last segment of the beamline, they
might be installed as redundant systems and failures in their read-out electronic as well as
the detection of unexpected beam properties have to cause interlocks (Badura et al. 1997).
At GSI, a front-end therapy control system is responsible for the control of beam position
and scanner magnets. Data of the MWPC are read and analysed during treatment and saved
afterwards for documentation purpose (Brand et al. 1998).
If the required number of particles at a certain beam position has been detected by in-
tegrating the measured IC values, a co-called nextpoint signal initiates a change of beam
direction (Badura et al. 2000). At GSI, these nextpoint signals are recordable and can be
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used in combination with the logged MWPC data for a retrospective analysis of the beam
delivery.
2.2.3 Considerations in treatment planning related to patient CT image
For reaching a certain depth in inhomogeneous tissue, the energy selection of pencil beams
has to be performed very carefully. As known from (2.3) and (2.5), the range of ions depends
directly on the electron density of the penetrated material. Thus, diagnostic imaging for
treatment planning in IBT has to provide information on that quantity. The absorption of
X-ray photons in tissue is related to the tissue electron density, and therefore CT images are
employed for treatment planning. Other imaging techniques like magnetic resonance imaging
(MRI) may provide comparable spatial resolution and higher time contrast without radiation
exposure and can be exploited for target delineation; but as long as the electron density is
not reproducible from these techniques, CT imaging stays mandatory for treatment planning
in IBT. The attenuation of the tissue is converted into the grey values of the Hounsfield scale
and presented in a voxelized image. The Hounsfield unit (HU) of a certain tissue is calculated
by its linear attenuation coefficients µ as
HU = 1000 · µ− µwater
µ
. (2.12)
By this definition, the HU of water is 0 and that of air is -1000. HUs in the voxels along the
beam path are transformed into water equivalent pathlength (WEPL), and a corresponding
energy is selected. Final treatment plans are verified with respect to range by measurements
in water phantoms prior to the treatment. Even if differences between several CT scanners
can be compensated, a lot of effort was necessary to reduce the uncertainty between ion range
and HU by means of different calibration approaches (Schneider et al. 1996; Jäkel et al. 2001;
Kanematsu et al. 2003). Finally, the accuracy of carbon ion range determination in soft tissue
from CT images was reported to be within 1mm for typical depths of head and neck cancer
(Rietzel et al. 2007).
For further reduction of uncertainties, optimal beam angles have to be selected based on
the planning CT image for creating robust treatment plans (Jäkel and Debus 2000; Cao
et al. 2012). Besides the sparing of critical structures and OARs, tissue inhomogeneities
within the irradiation field should be avoided as far as possible. Limited possibilities of
settings at fixed beam nozzles promote the necessity of ion beam gantries when searching
for optimal beam angles. Several gantry concepts are realized for proton beams. The first
gantry for carbon beams went recently into operation in Heidelberg (MedicalPhysicsWeb
2012), and a superconducting rotating gantry is in the design phase at the National Institute
of Radiological Sciences in Japan (Iwata et al. 2012).
If motion has to be considered during treatment planning, a 4D CT scan is required. The
provided data set consists of a stack of 3D CT images, each representing a quasi-static motion
phase of a periodic motion or of one specific motion cycle. If a conventional static CT image
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was acquired from a free-breathing patient, the CT image would result in a time-averaged,
and thus blurred and inaccurate reproduction of anatomical structures within the thorax and
abdomen (Shimizu et al. 2000; Rietzel et al. 2005).
2.3 Organ motion in ion beam therapy
The more precisely a dose distribution can be adapted to the tumour contour, the smaller are
the safety margins, and consequently, the higher is the disturbing influence of target motion.
Besides the dose errors emerging when the target is shifted laterally out of the treatment
field, IBT is additionally prone to misdosage if the WEPL of the penetrated tissue proximal
to the target changes during therapy. Especially the precise and favourable active beam
delivery has a high tendency to fail if the patient is insufficiently immobilized and/or motion
mitigation techniques are omitted.
2.3.1 Types of organ motion
Target motion can arise from several physiological processes and is hardly avoidable. The
most severe influence of target motion is found for those entities located in the thoracic and
abdominal region. Due to its origin, motion becomes relevant on different time scales. Three
types of organ motion can be classified (Langen and Jones 2001).
1. Spontaneous and position-related patient motion
Patient motion is most efficiently suppressed by well established immobilization tech-
niques. Individual devices are mounted as tight as possible and tolerable. Additionally,
the treatment and the imaging for treatment planning should be performed in same
position and with same fixation devices. Since patient motion occurs on a time scale
of several minutes and longer, it can be neglected after the patient has been precisely
positioned, normally based on its bony anatomy.
2. Inter-fractional motion
Slow physiological processes like digestion and peristalsis evoke changes in patient
anatomy within a few minutes to hours and days. Within a fraction the influence
can almost be ignored, and an intervention is only required at the beginning of a frac-
tion. The inter-fractional motion extend of different tumour sites has been investigated
in several studies (Langen and Jones 2001). Typical targets affected by inter-fractional
motion are e.g. prostate, bladder, rectum and uterus, but also liver and pancreas might
be involved. Changes in patient condition like weight loss might also be observable
on a day-to-day level, and often tumour shrinkage starts already during the fraction-
ated therapy as exemplarily shown for NSCLC by Britton et al. (2007) and Fox et al.
(2009). Due to the related increase in contralateral lung dose in some cases an adaptive
replanning is recommended by Hui et al. (2008).
3. Intra-fractional motion
Targets changing their position on a time scale of seconds to minutes will definitely
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affect the delivered dose distribution, although the patient has been positioned correctly.
Intra-fractional motion can originate from slow progressive processes like peristalsis or
muscle relaxation during prolonged treatment times. A more important influence in
the thorax and upper abdomen arises from periodic motion due to heart beat (Mori
et al. 2007) and breathing (Seppenwoolde et al. 2002; Liu et al. 2007). Respiration
related changes in WEPL have been examined for pancreatic (Kumagai et al. 2009),
liver (Minohara et al. 2003) and lung cancer (Mori et al. 2007, 2008), and local changes
in WEPL of even more than 20mm have been reported.
An increased impact of intra-fractional motion on the dose inhomogeneity is found for
active beam delivery with scanned ion beams. In particular, this is the case for intensity
modulated particle therapy (IMPT) where the total dose is optimized by means of
multiple fields (Lomax 1999; Gemmel et al. 2008). An inter-field motion of 5mm for an
IMPT plan was found to generate local underdosage in the target volume of about 20%
(Lomax 2008). A more general problem for active beam delivery is the unpredictable
interference of pencil beam motion and target motion (Phillips et al. 1992). Generated
interplay patterns with regions of over- and underdosage are strongly affected by several
parameters like the scanning direction (Lambert et al. 2005) or the motion amplitude
and start phase (Bert et al. 2008). Motion mitigation methods are required to avoid the
occurrence of interplay patterns (Grözinger et al. 2006) and to exploit the full potential
of IBT for the treatment of moving tumours in the lung or liver.
2.3.2 Detection of intra-fractional motion
A reliable detection of the target motion is a prerequisite for a successful motion compensa-
tion. Real-time information is needed for an instantaneous tuning of beam parameters. The
available systems can be classified into systems for direct measurement of the tumour motion
and those for measuring a motion surrogate signal. Modern radiotherapy facilities are some-
times equipped with kV X-ray imaging systems suitable for taking fluoroscopic sequences. In
combination with fiducial markers implanted near or into the tumour (Shirato et al. 2003),
the most precise measurement of tumour motion is feasible. However, the implantation bares
additional risks and fiducial markers are not well suited for IBT because of their unknown
influence in the CT images that are used for treatment planning and energy selection to meet
certain ion ranges (Jäkel and Reiss 2007). Due to the radiation burden of fluoroscopy, it
cannot be applied throughout the whole treatment delivery. A non-invasive but also direct
imaging modality is ultrasound (US) that can be applied for monitoring abdominal organs
or the diaphragm. 3D tracking accuracy below 2mm has been reported for tracking the liver
in volunteers (Harris et al. 2010). The feasibility of implementing US for target tracking in
IBT is currently under investigation by means of phantom measurements at HIT (Schwaab
et al. 2012).
Respiratory motion is mostly detected by means of surrogates. Spirometry might be used
to detect surrogate signals like temperature, flow and volume (Hoisak et al. 2004) of inhaled
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air. It might also be used to control the breathing during treatment by means of deep-
inspiration breath hold (Mah et al. 2000) or active breathing control (Wong et al. 1999). The
stereoscopic observation of optical markers attached to the patient skin or the optical scanning
of the body surface (Hughes et al. 2009) delivers alternative surrogates. Strain gauges or
pressure belts clasped around the thorax (Li et al. 2006b) measure a one-dimensional (1D)
motion signal allowing to detect defined states of a breathing cycle. However, the correlation
between the motion signal and the internal target motion is always a critical issue of motion
surrogates. For instance, Gierga et al. (2005) report a generally good correlation but also
possible variation in tumour state for a certain external marker position. Hysteresis and
time delay may vary with tumour size, its location and the considered motion direction. For
motion consideration within this thesis, it may be assumed that the correct internal target
motion is accessible.
Internal target trajectories have been investigated in detail e.g. for bronchial carcinoma
by fluoroscopic imaging of implanted fiducial markers (Seppenwoolde et al. 2002) or by CT
imaging (Liu et al. 2007). For anatomical structures that undergo a remarkable motion
during a breathing cycle, a predominant motion amplitude in the cranio-caudal direction has
been observed, for both tumours located in the thorax (Keall et al. 2006) and organs within
the abdomen (Brandner et al. 2006). A simplified 1D approximation for the motion pattern
over time t is given by Lujan et al. (1999) using the parametrization
y(t) = y0 − a · cos2n
(
pi · t
τ
− Φ0
)
, (2.13)
with y0 indicating the elongation at exhalation, a the peak-to-peak amplitude, τ the period
time of a breathing cycle and Φ0 the phase at t = 0. Shirato et al. (2004) used this equation
to fit tumour trajectories received from fluoroscopic marker tracking and revealed that the
value of the parameter n is mostly equal to 1 (43%) or 2 (38%). Although real 3D motion
patterns are more complex in terms of exhibiting irregular modulations of the amplitude and
frequency as well as probable baseline shifts, the described motion pattern (2.13) with n < 3
is often used for systematic experimental investigations. The values of the other motion
parameters show a quite large variability between several patients. For lung tumours, the
value of the peak-to-peak amplitude a depends on the location of the tumour inside the lung
(upper or lower lobe) and its possible attachment to a bronchus or the chest wall. Mean
values are often reported to be below 10mm (Keall et al. 2006). Especially the more seldom
cases with higher values (also above 20mm) require an adequate motion compensation during
treatment because of their increased risk for inducing dose failures.
2.3.3 Motion compensated ion beam therapy
The critical influence of target motion on the homogeneity of the dose distribution in IBT
demands a 4D treatment planning for active pencil beam scanning (Bert and Rietzel 2007;
Knopf et al. 2010) and passive beam delivery (Engelsman et al. 2006) as well. Several so-
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lutions for motion mitigated beam delivery have been proposed. Most of them rely on the
initially extracted motion information from a 4D planning CT image and the acquisition of
motion parameters during treatment. For choosing a certain mitigation technique, patient-
specific parameters like physiological condition, tumour size, location and motion pattern as
well as accelerator parameters like dose rate, availability, restrictions in energy modulation,
maximum scan speed for active beam delivery and the time latency of beam monitoring have
to be considered.
The most relevant motion compensation techniques in IBT for free breathing patients are
identified as follows (Rietzel and Bert 2010; Schardt et al. 2010; Knopf et al. 2010; Bert and
Durante 2011).
1. Margin based approach
Like in photon therapy, the planned target volume is expanded to cover the whole target
at any time (ICRU 1993b, 1999), and the treatment plan is delivered like a static one.
This method has already been successfully applied for lung cancer using passive beam
delivery (Bush et al. 2004; Nihei et al. 2006), but for larger motion amplitudes the
amount of involved normal tissue limits the dose given to the tumour. For scanned ion
beams, a simple adding of safety margins is not sufficient because of interplay effects.
Nevertheless, safety margins are also required for other motion mitigation techniques
to overcome their limited precision.
2. Rescanning (or repainting)
Raster scanning is applied for the multiple irradiation of the target volume with a corre-
spondingly less amount of particles per scan (Phillips et al. 1992). Different repainting
strategies are presented by Zenklusen et al. (2010). For non-synchronized target and
beam motion, the compensation of interplay patterns improves with rising number of
rescans. Uncorrelated target and beam motion can e.g. be established by a random
delay between the rescans or a random order of energy slices (Seco et al. 2009). Res-
canning has not been applied for patients yet, but simulation studies (Knopf et al.
2011) pronounce that the benefit of rescanning will be dependent on the geometry and
number of treatment fields and on several motion and beam parameters. The major
drawbacks of rescanning are the flattening of field gradients, high doses delivered to
surrounding healthy tissue and the prolonged treatment time because of the reduced
beam intensity.
3. Gating
A real-time monitoring of the respiration cycle is used for temporal synchronization
of the beam application within a predefined motion state (Minohara et al. 2000). The
motion amplitude during the beam delivery, normally at end-expiration phase, is signif-
icantly reduced, and safety margins can be decreased. The residual motion within the
gating window may still induce interplay patterns, but they are reducible by an enlarged
pencil beam width (Bert et al. 2009). Gated irradiation with passive beam shaping is
under investigation and in clinical use at several ion beam centres (Nihei et al. 2006;
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Lu et al. 2007; Iwata et al. 2010). Evidently, gating increases irradiation time. This
may become a critical issue at synchrotron-based facilities, since the restricted duty
cycle of the accelerator may miss the gating window. Variable beam extraction phases
can enlarge the synchrotron efficiency and thus reduce the treatment time (Tsunashima
et al. 2008).
4. Tracking
To compensate for target motion in all directions during the whole respiration cycle,
the scanned particle beam has to be adapted in lateral position and energy. A future
implementation of proton beam tracking is intended at Gantry 2 at PSI (Safai et al.
2012). Up to now, the only prototype for beam tracking (Bert et al. 2007; Grözinger
et al. 2008) and promising results from phantom studies (Bert et al. 2010) are avail-
able at GSI. The raster scanning magnets are utilized to follow the detected lateral
target motion in real time (within 1ms with an accuracy below 0.16mm). For energy
adjustment, the therapy control system drives a double-wedge degrader that is placed
proximal to the target (Weber et al. 2000). Bragg peak depth changes of 5mm in water
are achievable within 16ms (Saito et al. 2009). An alternative wedge design integrated
into the beamline has been proposed by Chaudhri et al. (2010). The obvious advantages
of beam tracking are the precise dose distribution, the potentially reduced margins al-
lowing for dose escalation in the tumour and the irradiation without prolongation of
treatment time. However, a detailed investigation of robustness against uncertainties
in motion monitoring and changes in patient geometry or motion patterns during the
beam delivery is required prior to a clinical implementation of beam tracking.
A combined application of these approaches is feasible to overcome the remaining drawbacks
of the individual methods. For instance, an additional rescanning during gated beam delivery
may reduce residual interplay patterns (Furukawa et al. 2010a), or the delivery of a rescanned
treatment plan while tracking the target may reduce the influence of temporarily imprecise
motion signals. At GSI there is a unique availability of a motion mitigated 12C pencil beam
irradiation using rescanning, gating and/or tracking for experimental operation.
2.4 Dose monitoring by means of positron emission
tomography
Quality management in IBT demands high effort during treatment planning, plan verification
and beam delivery as it had e.g. been reported for the former German heavy ion therapy
project at GSI (Karger et al. 2000). Furthermore, an in vivo verification of the actually
delivered dose distribution is highly desired. Changes in tissue density within the treatment
field can arise from
- anatomical changes due to tissue swelling, shrinkage or deformation,
- inaccurate positioning of the patient and
- patient motion,
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and may cause serious deviations between planned and delivered dose distribution. The
dose monitoring should discover these deviations. This requires a reliable verification and/or
detection of
- lateral field position,
- ion beam range and
- local deviations proximal to the Bragg peak.
Currently, several approaches are under investigation concerning an in vivo and in situ
dose verification. The delayed effect of fatty replacement in the vertebral bone marrow after
proton therapy can be visualized by means of MRI but only post-treatment (Gensheimer
et al. 2010). Retrospective, contrast-enhanced MRI seems to be feasible to verify the proton
range in liver cancer patients (Yuan et al. 2013). The detection of emitted prompt γ-rays
during the beam delivery promise a high count rate and valuable information about particle
range, but detector design, data handling and reconstruction have to be improved further to
reach clinical feasibility.
The only method of an in vivo dose monitoring that has already been successfully proven
under clinical conditions in IBT is positron emission tomography (PET). Pioneering work
started 1979 in Berkeley, USA (Llacer et al. 1979), where later a few patients had been
irradiated with radioactive probing beams. Similar concepts were investigated at the HIMAC
facility for delivering radioactive (11C) beams with therapeutic (Urakabe et al. 2001) or
probing (Iseki et al. 2004) purpose. The position where the beam has been stopped in the
tissue can directly be visualized. Due to the high costs for the production of radioactive
beams and safety concerns related to shielding of the beam, this method did not prevail.
During the last two decades, promising experiences have been obtained with PET imaging
in combination with IBT using stable carbon and proton beams. So far, several patients
have been monitored after passive beam delivery in the USA (Parodi et al. 2007c; Hsi et al.
2009) and in Japan (Hishikawa et al. 2002; Nishio et al. 2007, 2010) and about 440 patients
during scanned carbon ion treatment at GSI (Enghardt et al. 2004a). At the HIT facility, a
PET/CT scanner went into clinical operation (Bauer et al. 2012), and a patient study with
a planned number of 240 patients to be monitored by means of this device after scanned IBT
(Combs et al. 2012) commenced recently.
Performing the PET measurement at least shortly after the irradiation is mandatory in all
cases, since the relevant β+-emitters decay rapidly. The measurements can be accomplished
by several approaches (Shakirin et al. 2011). The method of choice is a measurement during
the pauses between beam extraction cycles of a pulsed irradiation and some seconds immedi-
ately afterwards (Enghardt et al. 2004b). This approach is called in-beam PET. The clinical
workflow remains almost undisturbed, and highest signal strength might be detectable. How-
ever, expensive, dedicated scanner systems are necessary for a direct implementation into the
treatment sites. In contrary to the in-beam PET method, it is feasible to performed the
measurements after the irradiation at all. These methods are denoted as off-beam PET and
can be distinguished into two concepts. A measurement that is performed inside the treat-
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ment room with an individual scanner at the treatment site (Nishio et al. 2010) or with a
conventional diagnostic scanner nearby (Zhu et al. 2011), is named in-room PET. The treat-
ment room remains blocked for a certain time, and the patient throughput is reduced. If the
patient has to walk or to be transported to a scanner placed in close vicinity to the treatment
room, the PET monitoring will be called off-line PET (Hishikawa et al. 2002; Parodi et al.
2007c). The diagnostic full-ring scanners offer better solid angle coverage and thus reduced
reconstruction artefacts, but due to the delayed start of measurement, only a reduced number
of β+-emitters is available to contribute to the signal. Range verification by means of off-line
PET requires angular field directions, since for opposing fields the distal β+-activity fall-off
will overlap with the activity plateau in the entrance channel of the other field.
2.4.1 Principle of PET imaging in ion beam therapy
Generation of positron emitters
Nuclear fragmentations between the primary particles and atomic nuclei of the target material
had been identified in section 2.1.1 as an obstacle for the delivery of sharp dose contours.
However, among the generated fragments there are β+-emitting nuclides (Tobias et al. 1971;
Enghardt et al. 1992) which offer the possibility for an indirect, qualitative dose monitoring
using PET imaging devises. One of the main advantages is that radioactive nuclides are
generated as a by-product during treatment. Thus, no additional ionizing radiation needs
to be supplied to the patient and the effect is referred to as autoactivation. Nuclei of β+-
emitters bare an excess of protons in comparison to their stable isotopes. Hence, they are
mostly created within fragmentation reaction where neutrons are released. The β+-emitters
are created from the nuclei of the tissue (target) as well as from the nuclei of the impinging
ions (projectiles) as long as their mass number Z is at least equal to 5 (for the generation
of the lightest β+-emitter 8B) (Firestone and Shirley 1996). Within peripheral interactions,
only a small part of the projectile momentum is transferred to the target atoms. Therefore,
the target fragments stay at rest while fragmented projectiles move on with almost the same
velocity and only marginal changes in direction. Due to the range scaling (2.6), the projectile
fragments will be stopped slightly before or behind the Bragg peak position of the initial
projectiles, but they may also undergo secondary fragmentation reactions along their track.
If the ion beam consists of light (Z < 5) particles like protons or helium ions, no β+-emitting
projectile fragments will be produced, and the induced β+-activity in the tissue is only formed
by the target fragments. These occur along the whole track of the incident ions except for
the last section where the projectiles have slowed down and the remaining kinetic energy is
below the threshold energy for nuclear reactions. However, it is feasible to exploit only the
created plateau of β+-activity of the target fragments for range verification after IBT with
protons as it was firstly demonstrated by Parodi et al. (2007b) with phantoms and in a small
patient study (Parodi et al. 2007c).
From a biochemical point of view, the tissue in the human body constists of water, fat,
proteins and carbohydrates. The elemental content of a reference man is dominated by oxygen
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Table 2.2: Typical β+-emitters generated within PMMA during the irradiation with 12C ions of
295AMeV. The given half-lives T1/2 are taken from Firestone and Shirley (1996), the mass and charge
numbers (A and Z) define according to (2.6) the relative range in comparison to the initial 12C
projectiles (R/R12C). Values printed in grey are hypothetical values, since these β+-emitters occur as
target fragments only while the others are found to be target and projectile fragments as well. The
percentage contributions of the nuclides to the projectil and target fragments and the to total number
of β+-mitters are stated as it was simulated with POSGEN (Pönisch et al. 2004; Hasch 1996).
Percentage contribution to
Nuclide T1/2 A Z R/R12C1 Target fragm. Projectile fragm. All β+-emitters
15O 122.24 s 15 8 0.70 25.69 0.00 23.16
14O 70.606 s 14 8 0.66 0.78 0.00 0.70
13O 8.58 ms 13 8 0.61 0.02 0.00 0.02
13N 9.965 min 13 7 0.80 2.26 0.00 2.04
12N 11 ms 12 7 0.73 6.57 9.67 6.87
11C 20.39 min 11 6 0.92 59.19 77.45 60.99
10C 19.255 s 10 6 0.83 3.96 8.26 4.39
9C 126.5 ms 9 6 0.75 0.38 2.38 0.57
8B 770 ms 8 5 0.96 1.16 2.24 1.26
(61wt%), carbon (23wt%) and hydrogen (10wt%), followed by nitrogen (2.6wt%), calcium
(1.4wt%) and phosphorus (1.1wt%) and other minerals (ICRP 1975). The relevant β+-
emitters originate from the most frequent elements in the body. Due to its low price, good
machinability and in particular its composition of carbon, hydrogen and oxygen, PMMA
(C5H8O2)n is in first approximation considered as tissue equivalent material for IBT and it
is therefore often used for experimental investigations. Typical β+-emitting nuclides created
during the irradiation of PMMA with 12C ions are summarized in table 2.2. The amount
of induced nuclides per incident ion depends on the cross sections for the reaction channels
generating these β+-emitters and on the exact composition of the tissue. The different half-
lives of the β+-emitters indicate clearly that the relative amount of a certain nuclide will vary
strongly with time, even during the irradiation which normally takes up to a few minutes. In
biological systems, the additional effect of washout disturbs the original distribution of β+-
emitters (Mizuno et al. 2003; Fiedler et al. 2008), i.e. the β+-emitters are transported away
from their point of origin by means of blood flow, lymphatic circulation and other metabolic
processes, or they diffuse in a random direction. With elapsing time after the irradiation, the
number of β+-emitters decreases considerably and the influence of washout increases (Parodi
et al. 2008; Knopf et al. 2009).
Decay of positron emitters
Except the described mechanism for generating a mixture of β+-emitters within the irradiated
volume, the following processes are the same as in diagnostic PET imaging. The unstable
1Theoretical values of extremal range deviation relative to the primary, incident 12C ions. These values can
only be achieved if β+emitters are created immediately at the target surface.
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β+-emitters with charge number Z and mass number A change into a more stable state.
They decay according to their half-life by converting a proton into a neutron and emitting a
positron e+ and an electron neutrino νe
A
ZX −→ AZ−1Y + e+ + νe. (2.14)
Typically, the neutrino leaves the body without any interaction. The conservation of energy
for a three-body decay does not define fixed energies for the particles. Hence, there is an
energy spectrum of the emitted positron with a maximum energy of a few MeV or below
depending on the Q-value of the β+-emitter. The positron is slowed down in the body within
a distance of some micro- to a few millimetres by releasing its kinetic energy when undergoing
several interactions with the surrounding matter, similar as it is known for electrons (Beringer
et al. 2012). The total stopping power of the positron consist mainly of two parts:
- The radiative stopping power is related to the radiation loss by means of the emission
of bremsstrahlung within the Coulomb field of the nuclei or the atomic shell. It is the
dominant interaction for high energetic (several tens of MeV) positrons.
- The collision stopping power is the relevant part at the low energy range of the emitted
positrons. The theory of Bethe can be applied with well defined mean excitation energy,
density effect and shell correction. The transferred energy of the positrons leads to
excitation and ionization of the atoms.
Stopping powers of positrons are further discussed and tabulated by the ICRU (1984), and
their collision stopping power was e.g. investigated and described in detail by Seltzer and
Berger (1982, 1984). Recently, Tufan et al. (2013) published an analytical description for the
calculation of stopping powers of positrons in human tissue and provided also the data for
PMMA shown in figure 2.6.
The slowed down positron forms with a nearby electron a positronium configuration of
short life time and annihilates almost instantaneously with the electron. Normally, two
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Figure 2.6: Stopping power and range in continuous slowing down approximation of positrons in
PMMA calculated by M. Ç. Tufan according to Tufan et al. (2013) and with properties of PMMA as
specified by Berger et al. (2005) (with courtesy of M. Ç. Tufan).
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annihilation photons of 511 keV are emitted in opposite direction as determined by the con-
servation of energy and momentum. Deviations in emittance angle and photon energy will be
found for annihilation events that occur when the positron has still a residual kinetic energy.
Annihilation events with the emission of 3 photons occurs rarely and shall be neglected here.
The annihilation photons may interact with the surrounding matter along their path when
propagating through the patient body and thus will be attenuated. Mainly the incoherent
(Compton) scattering contributes to the energy loss and changes in the direction of the
photon. The cross section for the photoeffect scales strongly with the effective charge of the
material (∼ Z3.8) and is of minor importance but also relevant in biological systems. Pair
production is not feasible with a photon energy of 511 keV.
Detection of annihilation photons
The detection of both annihilation photons originating from one decay event allows to draw
some conclusions about the coordinates where the annihilation and approximately the decay
of the β+-emitter took place. The coincident registration of two photons in different detector
segments defines a line of response (LOR) (or more accurately: a volume of response) that
connects the two front surfaces of the segments and at which the annihilation must have
occurred under ideal circumstances. For a valid LOR, the two detector segments are located
within a valid acceptance angle in a full-ring scanner or at different detector heads in a
double-head PET scanner. A timing window of typically some nanoseconds specifies whether
two detected events are considered as a coincidence. If more than two photons are registered
within this timing window and defining a multiple coincidence, the event will be refused. As
illustrated in figure 2.7, three possible scenarios can fulfill the timing requirement of a prompt
coincidence.
- A true coincidence occurs when both photons of an annihilation event are detected
within a valid LOR and none of them is scattered before reaching the detector.
- A scattered coincidence occurs when at least one of the annihilation photons is scattered
Figure 2.7: Schematic illustration of the three different types of prompt coincidences with indicated
detector segments (grey) defining the LORs (dashed) in a full-ring scanner. The annihilation photons
of a true coincidence (left) are created (blue spot) within the same LOR as they are detected. The
point of annihilation of a scattered coincidence is outside of the defined LOR (middle). Two photons
belonging to different annihilation events specify the LOR of a random coincidence (right).
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and both photons are detected in a valid LOR. This LOR does not include the point
of annihilation. The misplaced LOR will reduce the spatial resolution and the contrast
of the reconstructed β+-activity image.
- A random coincidence is detected when two positrons annihilate and one photon of
each annihilation hits the detector while the others are absorbed or emitted in an solid
angle that is not covered by the PET scanner.
To reduce the influence of scattered coincidences, an energy window is applied and photons
with energy below a certain threshold are rejected. Several methods for further scatter and
attenuation correction are available (Zaidi 2001). Random coincidences occurring outside
the beam extraction cycles are distributed uniformly in time, and just a fraction of them
is counted as prompt coincidence, i.e. is included in the prompt timing window. Thus, the
number of prompt random events can e.g. be estimated by sampling the random events for
each LOR within a delayed timing window (delayed coincidence) and subtracting them from
the measured prompt events prior the reconstruction.
Besides the timing and energy resolution, a suitable PET detector needs a high spatial res-
olution in terms of identifying a small partial volume where the photon interaction occurred.
The conventional and widely used detector type is based on scintillation crystals coupled to
photomultiplier tubes (PMTs). The scintillator material has a high linear attenuation coef-
ficient due to its high density and high effective charge number and thus is suited to absorb
photons. However, the crystal thickness of several millimetres or few centimetres enhance the
risk of parallax errors for non-perpendicular impinging annihilation photons. To compensate
for parallax errors, the depth of interaction (DOI) in the crystal needs to be determined. Sev-
eral approaches for DOI measurement and other developments in PET detector technology
enabling e.g. time-of-flight (TOF)-PET measurements are presented by Lewellen (2008).
Challenges in image reconstruction and rating the result
Ideally, the reconstruction of the β+-activity should generate an artefact- and noise-free β+-
activity distribution with a high contrast ratio. This is hardly achievable, because IBT-PET
data processing has to get along with additional challenges compared to the diagnostic PET
imaging. A major problem is the deficiency in counting statistics. It is limited by the dose
given to the patient and the cross sections for nuclear fragmentation reactions generating the
β+-emitters in the body. Furthermore, it is diminished by the limited solid angle coverage
if a double-head PET scanner is used. LORs in certain directions are not available, i.e. an
important piece of information about the location and dimension of the irradiated volume is
lost and reconstruction artefacts are inevitable (Crespo et al. 2006).
The reconstructed β+-activity changes strongly with time and location in the body. A
mixture of β+-emitting nuclides is created during the course of beam delivery giving rise to
a characteristic activity build-up. Concurrently, the decay of the nuclides starts immediately
after their generation and takes place according to the different half-lives. Due to the time
dependence of the activity and because different physical processes generate the dose or the
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β+-activity, it is obvious that the activity can only be a qualitative measure for the applied
dose distribution. Anyway, since the β+-activity is solely created within the irradiated vol-
ume, at least the distal fall-off of the β+-activity is, depending on the applied ions, somehow
correlated to the ion beam range, which is the most important property to be verified. A
workflow for a qualitative dose monitoring by means of IBT-PET is described in the next
section.
2.4.2 In-beam PET at GSI
About 440 patients have been treated with 12C ions at GSI within a pilot project carried
out by DKFZ, UKL-HD, GSI and FZR (now HZDR) between 1997 and 2008. Well fixated
tumour entities mainly located in the head and neck region (Schulz-Ertner et al. 2007) but
also in the pelvis were irradiated typically within 20 fractions (1 fraction per day). Radiation
induced β+-activities were acquired for each fraction by a dedicated PET scanner (Bastei)
and were normally evaluated for the first treatment field per fraction.
Double-head PET scanner BASTEI
Figure 2.8 shows the the installed PET scanner Bastei (Pawelke et al. 1996; Enghardt et al.
2004a) at GSI. It consists of two detector heads to allow for variable angular positioning of
the patient couch relative to the fixed horizontal beam line. In total, 64 conventional bismuth
germanate (BGO) scintillator block detectors as used in the ECAT EXACT PET scanner
(CTI PET Systems Inc., Knoxville, TN) are arranged at two spheroid segments of 4×8 blocks
and cover a solid angel of about 9%. The BGO scintillation crystals (54mm×54mm×20mm)
of the detector blocks are notched to create an 8× 8 matrix of crystal elements with a front
surface area of 6.75mm × 6.75mm. Four PMTs are attached to each BGO crystal block.
Figure 2.8: Former medical treatment site at GSI with integrated double-head PET scanner Bastei.
The scanner geometry allows for a variable positioning of the patient table relative to the fixed beam
window.
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Amplitude analyses of the PMT signals define one of the 2048 crystal elements per detector
head. Two photons have to be detected at different detector heads to be considered as
coincidence. Furthermore, an energy window of 250-850 keV is applied and the prompt as
well as the 128 ns delayed timing window have a width of 12 ns. The electronic read-out
hardware subdivides each of the two detector heads into 4 buckets consisting of 2 × 4 BGO
block detectors. The buckets, their 8 blocks and the crystal elements are numbered internally
in a well-defined order.
Listmode data format
The data acquisition of the in-beam PET scanner BASTEI at GSI is performed in listmode
format. That means, registered coincidences are stored in their chronological order as single
datawords. As depicted in figure 2.9, each of the 32-bit data words includes the information
about the fired crystals and contains among others one bit that indicates the beam status at
the time when the event was detected, i.e. whether it took place during the beam extraction
phase (called spill) or in-between the spills. Time stamps written approximately every 10 ms
into the data stream enable the reconstruction of all events measured during an arbitrary
time interval. Although some of the bits in the data words don’t contain any information, the
existing hardware prohibits a direct implementation of additional information from other data
acquisition tools into the data words. A retrospective temporal correlation of the listmode
data with e.g. a motion acquisition system is only feasible if the system tapes the spill signals
which can be assigned to the beam status information given in the PET data.
Bucket number
Upper / lower detector
/
Block number within bucket/
Column number in the 8×8 crystal matrix/
Row number in the 8×8 crystal matrix/
Beam status (spill on/o)
Prompt or delayed coincidence
Multiple photon detection
Coincidence data or time
No information
Figure 2.9: Structure of a 32-bit listmode data word of the Bastei PET scanner. Each square
stands for one bit with the possible status 0 or 1. The first bit (grey) defines the data type. If this
bit is set (equal to 1), the data word will be a time stamp encoding within the following 31 bits
the time elapsed since the start of the measurement. Otherwise the illustrated pattern applies. The
bucket, block, row and column numbers (blue and red) define exactly the two crystals that belong
to the measured coincidence. Information given by the bits for beam status, delayed and multiple
coincidences might be used during the image reconstruction to correct for random coincidences and
those coincidences related to prompt γ-rays during the beam extraction.
Workflow of dose monitoring
As stated previously, the β+-activity is correlated to the applied dose distribution, but the
exact dose is not accessible by a β+-activity measurement. A simple comparison of acquired
β+-activity distributions from different fractions is performed at the National Cancer Center
in Kashiwa (Nishio et al. 2010) to identify relevant changes in tumour and body shape
during fractionated therapy. A more complex monitoring workflow that allows for an early
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Planned dose distribution
Predicted β+-activity distributionMeasured β+-activity distribution
Simulation
Beam delivery
Measurement
Reconstruction
Comparison
Figure 2.10: Illustration of the workflow performed for each fraction for patients treated within the
pilot project at GSI, exemplarily shown for a patient suffering from a tumour at the skull base. A
PET listmode data stream (count rate shown in black and beam status in grey) is measured during
the delivery of the planned dose and reconstructed afterwards. The information about the exact time
structure of the irradiation progress and the relation between dose and activity are taken into account
during the simulation of an equivalent listmode data set. The reconstructed predictive β+-activity
distribution is compared to the result from the measurement and deviations are reported to the
physicians. Dose and the β+-activity distributions are shown as coloured contour lines superimposed
to the planning CT image.
intervention (already after the first fraction) has been established for the pilot project at GSI
and is outlined in figure 2.10. It is based on a comparison of the acquired β+-activity with
an expected one that needs to be simulated for each fraction.
A planned treatment field is delivered to the patient, and an instantaneous acquisition of
the annihilation photons is performed by means of Bastei. To avoid a prolongation of the
total treatment time and to sustain an acceptable patient throughput, the PET measurement
was only prolonged for 40 s after the beam delivery. Typically less than 105 true coincidences
had been acquired during the measurement time and where used for reconstruction. An
implemented maximum likelihood expectation maximization (MLEM) algorithm (Lauckner
1999; Hinz 2000; Pönisch et al. 2003) was applied for the β+-activity reconstruction. Co-
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incidences acquired during the beam extraction were ignored, since a huge fraction of them
are random coincidences related to the prompt γ-ray emission. The iterative reconstruction
algorithm is capable to include corrections for photon attenuation and scattering in the tissue
on the basis of the planning CT image, for random coincidences as well as for the limited
solid angle coverage of the PET scanner and its detection efficiency specified by means of
calibration scans. More details about the reconstruction are given in section 3.1.1.
An in-house development of a Monte-Carlo simulation program (Hasch 1996; Pönisch 2003;
Pönisch et al. 2004) is used for the generation of an expected listmode data set. The time-
dependent production and decay of the β+-emitters within the tissue as well as the emission
and detection of the annihilation photons are considered . Since the time structure of the
ion beam delivery depends on the daily accelerator parameters and is influenced by possi-
bly occurring interlocks, the predicted listmode data need to be calculated for each applied
fraction.
The dose monitoring is completed by a comparison between the measured and the precal-
culated β+-activity. Within the pilot project at the GSI the conformity between both β+-
activity distributions was rated and documented by experienced observers. First approaches
for an automatisation has recently been obtained (Helmbrecht et al. 2012; Kuess et al. 2012).
If predicted and measured β+-activity distributions match each other, it can be concluded
that the administered dose distribution also matches the planned dose distribution. If not,
the reason for the mismatch can be investigated by modifying the planning CT image and
recalculating the predicted β+-activity distribution until it corresponds to the measured one
(Enghardt et al. 2004b). Relevant deviations indicating changes in the patient’s anatomy
or its positioning are reported to the physicians who decide about an intervention during
the therapy. Although no instantaneous reaction is possible during the beam application by
means of IBT-PET, corrective interventions are feasible before the next fraction is applied.
IBT-PET for moving targets
Tumours subject to physiological motion pose an even more urgent demand for in vivo treat-
ment verification than static ones. The inherent challenges for a conformal dose application
in intra-fractionally moving tumours, especially by the state-of-the-art active beam delivery,
increase the risk for an insufficient dose homogeneity and location. To apply the described
workflow for IBT-PET, additional information has to be included and handled correctly.
These are e.g. the 4D planning CT images, the motion surrogate signal and detailed infor-
mation about the motion mitigated beam delivery. The simulation of listmode data and the
reconstruction of β+-activity distributions need to be upgraded to dedicated 4D algorithms
to account for the motion dependent displacement of the induced β+-emitters. Moreover, the
simulation program has to be adapted by an additional consideration of the time-dependent
relative movement between target volume and scanned beam to simulate the accurate β+-
emitter distribution generated during the irradiation. The topic of 4D reconstruction is
covered by chapter 3 and the implemented 4D simulation is presented in chapter 4.
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Reconstruction of IBT-PET data sets acquired from moving objects would result in blurred
β+-activity distributions if no motion information was integrated in the reconstruction pro-
cess. A time-resolved reconstruction algorithm has been selected and implemented for the
double-head PET scanner Bastei. An in-house motion table had been developed and was
brought into operation at the former medical beamline at GSI for dedicated phantom studies.
Oﬄine measurements revealed a reasonable functionality of the reconstruction algorithm in
terms of reliably reducing motion artefacts. In-beam PET data have been acquired from
moving targets irradiated with 12C ion pencil beams and using several motion mitigation
techniques. The aim was to demonstrate that characteristic properties are also reliably ac-
cessible from the 4D reconstructed β+-activity distribution, similar as it is known from static
target measurements. Further improvements towards clinical application are discussed af-
ter the presentation of the experimental results. Some parts of the work presented within
this chapter have been published in different manuscripts (Laube et al. 2010b, 2011, 2012b;
Stützer et al. 2013) and were presented at several conferences (Laube et al. 2009a, 2010a,
2012d,a,c).
3.1 Reconstruction algorithm
It has been shown in the pilot study at GSI that the in-beam PET listmode data taken
during patient treatment can be well evaluated with the maximum likelihood expectation
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maximization (MLEM) algorithm, at least for static tumour entities. The aim of a PET data
reconstruction in general is to find the β+-activity distribution within the image space from
which it is most likely to obtain the measured coincidence data. These projection data, in
the following called histogram, contain for each LOR the number of detected coincidences
during the whole measurement time. Each number is obviously affected by the amount of
β+-activity within the volume of the LOR but also by the individual detection efficiency of
both crystals and the material within the field of view (FOV) leading to photon attenuation
and scattering. The latter influences can be effectively corrected by means of a calibration
scan of the PET scanner (Lauckner 1999) and the patient CT image used for treatment
planning (Pönisch 2003), respectively. Starting with the corrected histogram, each voxel
in the selected image space is assigned with a discrete β+-activity during the reconstruction
process. Several 4D reconstruction algorithms exist for diagnostic PET imaging (Nehmeh and
Erdi 2008) with commercial full-ring scanner systems. For the unique double-head scanner
Bastei, an individual 4D reconstruction had to be implemented.
3.1.1 3D MLEM reconstruction applied at GSI
The investigation of noise-robust 4D tomographic reconstruction algorithms for moving tar-
gets is based on the existing 3D MLEM algorithm, which shall briefly be introduced in this
section. In a pre-reconstruction step the measured listmode data of the considered time in-
terval (typically from the beginning of the first beam pulse until 40 seconds after the end of
the irradiation) are sorted into a histogram consisting of 20482 bins. Thereby, coincidences
detected during the spills are neglected because most of these events are coincidental hits of
prompt γ-rays. A correction for random coincidences is done in each LOR by subtracting
the number of delayed events from the number of the prompt coincidences. The remaining
events are corrected for the corresponding individual detector efficiencies of both crystals
that were gained from a calibration scan with a quasi-two-dimensional (2D) homogeneous
β+-activity distribution in the midplane of the FOV (Lauckner 1999). Furthermore, the his-
togram is modified according to the individual attenuation probability of the different LORs.
If the annihilation photons cross a larger amount or a denser medium, they will have a lower
probability to reach the detectors, and consequently a smaller number of coincidences will be
measured in those LORs. The integral attenuation coefficients along the LORs for 511 keV
photons are deduced from the planning CT scan, and the histogram is weighted by their
inverse values. The new histogram represents the projection data that would have been mea-
sured with an ideal detector if the same and still unknown β+-activity distribution had been
placed into vacuum. The final step of the pre-reconstructional analysis is the weighting of
each LOR by its length in terms of intersected voxels in the image space which is determined
on-the-flight by means of a Monte-Carlo method.
The subsequent reconstruction process seeks the β+-activity distribution in the FOV that
would most likely lead to the modified projection data. The applied MLEM algorithm is an
iterative reconstruction method. The β+-activity distribution of the kth iteration step X(k)
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Forward projection
Back projection
Multiplication/Normalization
PET image of iteration (k-1)
Projection ratio
Measured projection
Correction image
PET image of iteration k
Figure 3.1: Illustration of the calculation rules for one iteration cycle of the 3D MLEM algorithm as
given by the iteration formula (3.1). Coloured processes and input parameters in the flowchart (right)
correspond to the terms highlighted in the equation (left).
consisting of M voxels is calculated from the image of the (k − 1)th iteration X(k−1) by the
formula
X(k) = X
(k−1)
s3D
AT
Y
AX(k−1)
, (3.1)
where Y is the measured histogram modified according to detector efficiency, attenuation and
scatter influence, s3D a normalization and A the system matrix. The elements aij (i = 0 . . . L,
j = 0 . . .M) of the system matrix denote the probability for measuring a coincidence in a
certain LOR i when an annihilation event takes place at a specific voxel j. And the transposed
system matrix AT denotes the probability that an annihilation event took place at a specific
voxel when a coincidence is measured in a certain LOR. Elements of the (transposed) system
matrix will be zero if the LOR does not intersect the corresponding voxel. A is also called
projection operator, because the application of A to a β+-activity distribution X, (AX),
generates a histogram, i.e. the activity in the FOV is projected onto the LORs by a forward
projection. And vice versa, if the transposed matrix is applied to a histogram, the information
in the LORs will be transformed back into the image space. This operation is called back
projection. Without TOF information it is assumed that all voxels within the volume of a
LOR have the same probability to contain the point of annihilation for an event measured in
this LOR.
In the first iteration cycle, when there is no result from a former iteration, it is commonly
accepted to use a homogeneous β+-activity distribution in the image space as a start solution
X(0). As shown in figure 3.1, the first step in each iteration cycle is the calculation of a
forward projection from the result of the previous cycle. This generates a histogram that
would have been measured most likely if X(k−1) had been the real distribution. The result of
the forward projection is compared to the modified measured histogram Y by calculating the
quotient Y/(AX(k−1)) for each LOR. Ideally, the histogram of projection ratios will converge
to 1 in each LORs with increasing number of iteration cycles. This would indicate that
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the reconstructed β+-activity distribution approximates the wanted β+-activity distribution
quite well. For further improvement, a correction image for the result of the last iteration
cycle is generated by means of a back projection of the projection ratio histogram. The
correction image is multiplied voxel by voxel with the β+-activity distribution X(k−1). The
finally applied normalization s3D includes a scaling, to ensure that the total amount of β+-
activity in the whole image space is kept constant, and a correction for the position dependent
solid angle coverage by the PET scanner. The new distribution X(k) serves as input for the
next iteration cycle. For reaching acceptable results, only a few (10 to 20) iteration cycles
are necessary. Depending on the computational power, the size of the field of view and
the number of measured coincidences, the whole calculation lasts less than 10 minutes for a
typical clinical data set.
3.1.2 4D in-beam PET reconstruction methods
The most often occurring, radiation induced β+-emitters in tissue, like 11C, 15O, 10C and 13N
(cp. table 2.2), have relatively large half-lives in comparison to the few seconds long duration
of a respiration cycle. Consequently, the nuclides generated at specific locations in the body
are transported with the moving anatomical structures relative to the fixed coordinate system
of the PET scanner. The statistical process of radioactivity, i.e. the unpredictable time span
between the generation and decay of a certain β+-emitter, in combination with the intra-
fractional motion allows a wide range of possible decay locations. Even for a gated irradiation,
when the beam is applied at one specific motion phase, the decay of a nuclide will take
place at an arbitrary, unpredictable motion phase and a correspondingly shifted location.
A retrospective, time-resolved evaluation of the IBT-PET data is necessary to consider the
different motion states. For commercial full-ring PET scanners, dedicated 4D reconstruction
algorithms might be supplied by the vendors. For the unique geometry of Bastei, there is no
pre-assembled 4D reconstruction available. Several algorithms known from diagnostic PET
imaging have been examined in more or less detail and rated for its applicability.
Transformation of LORs prior to 3D reconstruction
Gained time-resolved information on the translation and rotation of the examined body in
the FOV of the PET scanner might be used to transform the LOR for each coincidence prior
to the reconstruction of the listmode PET data set (Menke et al. 1996). The advantage
is to retain maximal statistics, and thus a low-noise image from the information content
of all coincidences could be calculated. The actual 3D reconstruction algorithm remains
unchanged; only the input histogram is modified. Each coincidence is weighted according to
the attenuation and detection efficiency in the corresponding LOR and then rebinned to the
LORs that would have probably been hit if there was no motion. An additional out-of-FOV
correction might be applied (Bühler et al. 2004). The LOR transformation can be carried
out in the image space or directly at the sinogram (Woo et al. 2004). However, due to the
geometric arrangement of the BGO block detectors in the Bastei scanner (cp. section 2.4.2)
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LOR
Exhalation phase Inhalation phase
Considerably moving Almost static
Figure 3.2: Illustration of the impracticability of LOR transformation for lung lesions with the help
of a coronal plane from a 4D CT scan at exhalation (left) and inhalation phase (right). A fictitious
LOR (not to scale) intersecting the tumour volume in the right lung is marked in both images (black
detectors). The coloured areas indicate for this exemplary CT scan sections of almost static structures
and considerably moving tissue within the LOR volume, respectively. Without the information at
which position along the LOR the annihilation occurred the transformation rule from the inhalation
to the exhalation phase is unknown, i.e. whether the LOR has to be transformed (to the upper grey
LOR) according to the tumour motion or whether it should remain non-shifted like the ribs.
there are no sinogram data accessible.
The method of LOR transformation works quite well for rigidly moving anatomical struc-
tures. Head movement is e.g. easily detected by tracking an attached marker target via an
infra-red camera. There is no relative motion between the skeletal parts and the soft tissue
inside the skull. As illustrated in figure 3.2, for the thorax and abdomen there may be regions
of major or minor pronounced motion impact within a single LOR. Without TOF-PET it is
not feasible to locate the actual position of the positron annihilation within the LOR. There-
fore, when correcting for the detected motion it is unclear how to transform the coordinates
of the LOR. A future application of TOF-PET detectors with a timing resolution better than
200 ps might solve that problem or will at least narrow the region of probable annihilation
point coordinates (Crespo et al. 2007). Since TOF information has not been available yet,
this reconstruction approach for 4D in-beam PET data was not pursued in detail.
Retrospective co-registration of gated reconstructions
For the gated reconstruction algorithm, the listmode PET data are divided into N different
subsets according to the registered motion cycle. The poor statistics of IBT-PET data are
reduced further for each subset by this gating process. For a sufficiently high number N ,
the subsets represent events acquired during quasi-static motion phases, and therefore the
3D MLEM algorithm can be applied for each of them. The number of subsets (commonly
8 to 10) as well as the sorting rules should be the same as in the 4D planning CT image
to have an appropriate attenuation correction for each motion phase. Traditionally, 4D CT
binning is done into isochronous phases between trigger points at exhalation state. This phase
sorting will generate subsets of PET data with almost equivalent counting statistics in each
phase leading to a similar signal-to-noise ratio (SNR) but with different magnitude of residual
motion. First commercially available, retrospective amplitude-binning demonstrated superior
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Transformation to reference state and summation
Final PET image at reference state
Figure 3.3: Illustration of the calculation rules for the gated reconstruction as given in (3.2). Coloured
boxes in the flowchart (right) correspond to the terms highlighted in the equation (left). Small, non-
labelled boxes are those shown with same colour in figure 3.1.
performance in terms of reduced CT image artefacts (Li et al. 2012) due to comparable motion
influence in each subset.
To utilize the full signal acquired during the entire respiration cycles and to improve the
inherent low SNR in the individually reconstructed β+-activity distributionsX(k)t , t = 1 . . . N ,
the images are co-registered as illustrated in figure 3.3 according to
X
(k)
0 =
N∑
t=1
Dt→0X
(k)
t =
N∑
t=1
Dt→0
(
X
(k−1)
t
s3D
AT
Yt
AX
(k−1)
t
)
. (3.2)
The index 0 indicates the reference state to which all images are registered after k iteration
cycles using the individual transformation matrices Dt→0. X(k)t defines the β+-activity dis-
tribution of a data subset calculated by the 3D MLEM algorithm (3.1) with k iterations from
the pre-corrected histogram of the tth motion phase. The transformation matrices have a
dimension of M ×M , where M stands for the number of voxels in the image space. The
elements dij specify the fraction of voxel j in the distribution of motion phase t that is shifted
into voxel i of the reference image. This concept allows to transform rigid or non-rigid objects
easily in an arbitrary direction, to rotate them around different axes or to include deforma-
tion. For patient treatment, the transformation information has to be deduced for instance
from the 4D planning CT image.
Promising results have been demonstrated by the retrospective co-registration in diagnostic
PET imaging in terms of contrast improvement and better lesion localisation (Thorndyke
et al. 2006). For in-beam PET data from phantom experiments, where the β+-activity
distribution was limited to the detector midplane ofBastei, an equal reconstruction approach
has been tested using a fast-performing back projection algorithm instead of the 3D MLEM
reconstruction (Parodi et al. 2009).
4D MLEM reconstruction
The 4D MLEM reconstruction algorithm (Li et al. 2006a; Qiao et al. 2006) also assigns each
coincidence to a motion phase and corresponding histogram Yt as explained for the gated
reconstruction but processes all coincidences within each iteration cycle to ensure a maximum
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Correction image
Multiplication/Normalization
PET image of iteration k
PET image of iteration (k-1)
. . .. . . Image in phase NImage in phase tImage in phase 1
Transformation into N phases
Transformation to reference state and summation
Figure 3.4: Illustration of the 4D MLEM reconstruction algorithm as defined by (3.3). Coloured
boxes in the flowchart (right) correspond to the highlighted terms in the equation (left). Small,
non-labelled boxes are those shown with same colour in figure 3.1.
of statistics. The β+-activity distribution after the kth iteration cycle at the reference position
X
(k)
0 is calculated by the iteration formula
X
(k)
0 =
X
(k−1)
0
s4D
N∑
t=1
Dt→0AT
Yt
AD0→tX
(k−1)
0
. (3.3)
As illustrated in figure 3.4, the imageX(k−1)0 at reference state is transformed into the different
phases by applying the matrices D0→t (and scaled according to the number of measured
coincidences per phase). As in the 3D MLEM, a forward and back projection is calculated
in each phase. The resulting correction images are summed up in the reference state under
consideration of the limited solid angle coverage of the scanner prior the transformation by
the matrices Dt→0. Thus, only the image X(k−1)0 needs to be updated (voxelwise multiplied
with the correction image) and normalized by s4D in each iteration cycle.
3.1.3 Comparison of gated co-registration and 4D MLEM
The reconstruction methods of gated co-registration and 4D MLEM have been implemented
for the in-beam PET scanner Bastei. A comparison of their performance is done by means
of a simulation study.
Annihilation point distribution
An annihilation point distribution within a virtual phantom reflecting a geometry similar
to a small cylindrical version (Shakirin 2009) of the standard IEC body phantom setTMof
the National Electrical Manufacturers Association (NEMA) (cf. figure 3.5) has been created
by means of a Monte-Carlo code. Input parameters for this code are the phantom geome-
try, the total number of annihilation points in the whole phantom, the ratio of annihilation
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Figure 3.5: Geometry of the NEMA-like phantom. The blue cylinder contains a background an-
nihilation point density. A cylindrical insert is centred in the middle and six spherical inserts are
placed with their midpoints at center height at a distance of 28.5mm from the phantom axis. The
four smallest of the six spherical inserts are chosen as hot structures (red), and the cylindrical insert
as well as the two biggest spheres are determined as cold inserts (grey).
point densities in cold, background and hot structures and the determination for each in-
sert as hot or cold structure, i.e. to contain a high or low annihilation point density. A
cold : background : hot ratio of 0 : 1 : 4 and the filling of the four smallest spheres according
to the highest/hot and of all other inserts according to the lowest/cold annihilation point
density have been chosen. The resulting numbers of annihilation points in each structure
and the annihilation point densities are summarized in table 3.1 for a filling of the phantom
with 1.35×106 annihilation points. The positions of the randomly chosen annihilation points
have been sorted for visualization into a grid of cubic voxels with 1.6875mm side length.
Figure 3.6 shows two cross sections of the generated annihilation point distribution.
Table 3.1: Number and density of simulated annihilation points within the different structures
of the NEMA-like phantom for a filling with 1.35 × 106 annihilation points in total and using a
cold : background : hot ratio of 0 : 1 : 4.
Structure Volume / cm3 Annihilation points Density / cm−3
Whole phantom 318.09 1 350 000 4244.08
Not insert (background) 275.56 1 256 488 4 559.73
Inner cylinder (cold) 22.62 0 0.00
Sphere 6 mm (hot) 0.11 2 063 18 238.90
Sphere 10 mm (hot) 0.52 9 550 18 238.90
Sphere 14 mm (hot) 1.44 26 205 18 238.90
Sphere 18 mm (hot) 3.05 55 695 18 238.90
Sphere 22 mm (cold) 5.58 0 0.00
Sphere 26 mm (cold) 9.20 0 0.00
Cold 37.40 0 0.00
Background 275.56 1 256 488 4 559.73
Hot 5.13 93 513 18 238.90
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Figure 3.6: Cross sections through the simulated annihilation point distribution for the phantom
midplane at z = 0mm (left) and for the plane at x = −14.3mm (right) intersecting the 2 spherical
inserts with diameter of 22mm (y ≈ −25mm) and 14mm (y ≈ 25mm). The shape of the phantom
and inserts are outlined by dashed contours.
Simulation of listmode data
The annihilation point distribution has been placed into the field of view of the Bastei
scanner with the phantom midpoint at the isocentre and the axis of the cylindrical phantom
parallel to the z-axis, which connects the two detector heads. A simulation program has been
developed that generates listmode files based on the given annihilation point distribution and
a motion of the phantom parallel to the y-axis and according (2.13). A first simulation with
an amplitude of 0mm, i.e. a static phantom, was performed as reference to be reconstructed
by the approved 3D MLEM algorithm. A cos2 motion pattern with a peak-to-peak amplitude
of 20mm and a period of 5 s has been chosen for testing the 4D reconstruction algorithms.
The decay times td for the different annihilation points are uniformly distributed within the
time interval [0 s, 100 s) to ensure a symmetric population of the 9 amplitude-sorted motion
phases according to the symmetric motion pattern. For each annihilation point the decay
position ~rd in the PET-coordinate system of the scanner has been determined by the formula
~rd = ~rstat + 20mm
(
cos2
(
pi · td
5 s
)
− 0.5
)
·

0
1
0
 , (3.4)
where ~rstat defines the simulated annihilation point coordinate in the static phantom. At
positions ~rd two annihilation photons are emitted isotropically but in opposite direction. No
scattering or attenuation of the photons inside the phantom is considered for that simulation.
About 6% of the 1.35 × 106 photon pairs (80 942 for the moving and 81851 for the static
phantom) hit the detector crystals of Bastei and are stopped within the crystal depth
of 20mm concerning a linear attenuation coefficient of 0.095mm−1 for 511 keV photons in
BGO. The correlated listmode words (cp. page 31) are saved into the listmode files for the
corresponding motion phase.
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Reconstruction
Transformation matrices were generated for 9 amplitude-sorted motion phases of the cos2
phantom motion. All voxels with midpoint coordinate belonging to the cylindrical phantom
are considered to be shifted parallel to the y-axis by applying the matrices. Voxels outside
the phantom are not transformed by the matrices, neither the voxels next to the phantom in
radial direction (distance from phantom axis > 45mm) nor those above or below the phantom
(|z| > 25mm).
The simulated listmode data were reconstructed on an image space comprising 70×70×40
(x×y×z) cubic voxels of 1.6875mm side length. 10 iterations were used for all reconstruction
algorithms, the 3D MLEM for the static phantom and the gated co-registration and the 4D
MLEM for the moving phantom. Two sections through the resulting β+-activity distributions
are presented in figure 3.7. Similar patterns of activity inside the phantom can be found for all
three distributions. This indicates that the 4D algorithms do not perform significantly worse
than the 3D MLEM does for the static target. The β+-activity distribution generated by the
gated co-registration discloses slight artefacts in those parts of the image space not belonging
to the phantom. Shady patterns are generated next to the phantom in motion direction, and
artificially sharp edges are created at the upper and lower phantom layer. A better design
of transformation matrices might probably reduce these artefacts. However, with the same
transformation matrices, the 4D MLEM seems to have a better performance and to be less
-40 -20 0 20 40
y / mm y / mm
-40 -20 0 20 40
4D MLEM
-40 -20 0 20 40
x / mm
Gated co−registration
-40 -20 0 20 40
x / mm
Static target
-40 -20 0 20 40
x / mm
-40
-20
0
20
40
y 
/ m
m
-30
-15
15
30
z 
/ m
m
-40 -20 0 20 40
y / mm
0
1.0
0.75
0.5
0.25
A
ct
iv
ity
 / 
a.
u.
0.0
Figure 3.7: Sections through the reconstructed β+-activity distributions for the static NEMA-like
phantom (left) and for the moving one calculated by the gated co-registration (middle) and the 4D
MLEM (right). The upper row displays the midplane at z = 0mm and the lower row the plane at
x = −14.3mm. The phantom geometry corresponding to the shown sections is outlined by dashed
contours. The β+-activity distributions are scaled to contain the same total amount of activity in the
whole image space.
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prone to those artefacts. Due to the limited solid angle coverage and the correspondingly
missing projections, prolongation artefacts in z-direction are clearly visible in all β+-activity
distributions and the cold and hot spherical inserts are not entirely recovered.
The known phantom geometry allows to quantify the local contrast recovery (LCR) of the
reconstruction algorithms, i.e. how clearly the inserts can be resolved within the background
activity. For the chosen cold : background : hot ratio of 0 : 1 : 4 the local contrast recovery for
the hot inserts (LCRH) and for the cold inserts (LCRC) have been calculated as defined by
Shakirin (2009)
LCRHi =
H˜i − B˜i
3 · B˜i
· 100% LCRCi = B˜i − C˜i
B˜i
· 100%. (3.5)
H˜i, B˜i and C˜i denote for the corresponding insert i the median values of the β+-activity
in the locally considered areas which should contain hot, background and cold activity val-
ues, respectively. H˜i and C˜i are determined from all voxels whose midpoint belongs to the
corresponding insert. Voxels with a midpoint coordinate that has a maximum distance of
3mm from the insert (for the cylinder in radial direction only) are taken into account for
the B˜i calculation. A LCRC value has also been determined for the phantom boundary for
which the voxels with a maximum distance of 3mm from the boundary have been considered.
Those of them located inside the phantom have been used for the calculation of B˜ and those
outside the phantom for the C˜ calculation, respectively. Results from all three β+-activity
distributions are displayed in figure 3.8. Except for the spherical insert of 22mm diameter,
the LCR values from the 4D MLEM are of same magnitude or exceed those values from
the 3D MLEM of the static phantom. LCR of the gated co-registration is inferior for most
inserts.
The reconstruction codes have not been optimized for fast performance, yet. The 4DMLEM
seems to be a little faster in the current version than the gated co-registration. However, the
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Figure 3.8: Local contrast recovery values for the inserts and the boundary (definition given in the
text) of the NEMA-like phantom calculated from the reconstruction results of the static target (white),
the gated co-registration (dark grey) and the 4D MLEM (light grey) using (3.5).
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better LCR and the avoidance of artefacts related to the image transformation are the main
criteria that count in favour to the 4D MLEM. Thus, for following investigations the 4D
MLEM algorithm is applied.
3.2 Experiments with moving radioactive sources
The performance of the 4D MLEM has been systematically tested by radioactive source mea-
surements. Therefore, two types of experiments were performed. The first proof-of-principle
experiment for testing the correct implementation of the reconstruction workflow with mea-
sured data uses a relatively complex 2D motion pattern. In a second experiment campaign,
the influence of the motion onto the reconstructed PET images has been investigated system-
atically for different parameters of the 1D motion pattern and of the reconstruction process.
3.2.1 Rotation of radioactive sources
Experimental setup
As depicted in figure 3.9, the rotating motion table (cf. appendix C.1) from the GSI facility
has been positioned in between the two detector heads onto the patient couch. The height
was adjusted by the patient couch so that the upper surface of the rotating platform was
1.5mm below the isocentre height. The horizontal platform is rotated between −14◦ and
10◦ around the vertical rotation axis which proceeds parallel to the z-axis but shifted by
50mm in x-direction. The motion period was tuned to a value of about 3.8 s. The motion is
monitored indirectly by utilizing a displacement laser sensor (Model OD100-35P840, SICK
Vertriebs-GmbH, Düsseldorf, Germany) which is attached to the static part of the motion
table and records continuously the distance to the edge of the moving platform.
Figure 3.9: Setup for an experiment with the rotating motion table (grey) positioned at the patient
couch (transparent) between the two detector heads of the in-beam PET scanner and oriented in the
left-handed coordinate system (left). The blue laser sensor mounted at the static part of the motion
table measures continuously the distance to the edge (white tape) of the rotating platform. A 68Ge
line source and two elevated 22Na point sources are placed off-centred onto the top of the platform
(right).
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Table 3.2: Isotope, geometry, activity and position of the radioactive β+-emitting sources.
Source ID Isotope Geometry Activity z-position Distance to rotation axis
D8–187 68Ge line (19 cm) 6.15MBq 0mm ≈ 60mm (min)
MR–137 22Na point 0.84MBq 16mm ≈ 50mm
MR–138 22Na point 0.85MBq 16mm ≈ 95mm
Three radioactive β+-emitting sources with properties as summarized in table 3.2 have
been placed onto the rotating platform at different positions. The line source was placed at
isocentre height (z = 0mm) parallel to the x-axis and shifted by about −60mm in the y-
direction. The point sources have been placed 50mm and 95mm apart from the rotation axis
and elevated 16mm in height by means of two PMMA blocks (cp. figure 3.9). Coincidence
data were acquired under rotation and with static motion table as reference.
Data processing
The analogue voltage output signal of the displacement sensor is proportional to the distance
to the moving platform but not to the rotation angle. A calibration between the relative
amplitude of the laser signal and the rotation angle was done by R. Lüchtenborg from the
GSI Biophysics department. The 25 sampling points (equidistant voltage signals) of this
calibration and a linear interpolation for steps of 1◦ is plotted in figure 3.10. The analogue
signal of the displacement sensor contains a high frequency noise. To get rid of this noise, a
low pass filter has been applied to the signal after a fast Fourier transformation (FFT) (cp.
appendix B).
A time correlation between the listmode PET data and the acquired signals from the
displacement sensor is feasible by spill-like timing signals logged in both data streams. The
coincidences acquired from 16 motion periods were divided into 9 phases spaced by 3◦ (-14◦,
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Figure 3.10: Relation between the rotation angle and the relative amplitude of the displacement
laser sensor signal. The sampling points of the calibration (black squares) have been interpolated
linearly for steps of 1◦ (red circles). The obtained relation differs obviously from a linear one (dashed
line).
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-11◦, ... 7◦, 10◦). Corresponding transformation matrices were generated by using a polygon
clipping algorithm for the calculation of the intersecting volumes of each rotated voxel with
each voxel of the fixed grid in the image space (cp. appendix A.3).
The attenuation correction for the 511 keV annihilation photons is created for each motion
phase by approximating the geometry of the motion table with attenuation coefficients µ for
the corresponding materials. The internal dimensions of the ball bearing and drive mechanism
is unknown. Thus, the attenuation correction considers in z-direction simply
- the 10mm PMMA (µ ≈ 0.110 cm−1) of the patient couch,
- 15mm trovidur (µ ≈ 0.127 cm−1) for the static part of the motion table,
- a 2mm air gap to the rotating platform,
- the 38mm thick rotating platform made of trovidur and including a 135mm×269mm×
8mm slit at the corner were the coupling from the motor drive enters the platform,
- a screw at the rotation center (µ ≈ 0.656 cm−1) and
- the 2 PMMA blocks below the point sources, each with a dimension of 50mm×50mm×
16mm.
Activity reconstruction
The correct sorting of listmode data into motion phases is verified by reconstructing the 9 data
subsets separately by the 3D MLEM algorithm. The residual motion of 3◦ per motion phase
is neglected during the reconstruction. The number of coincidences per subset varied between
1.58 × 105 and 4.13 × 105, mainly depending on the residence time of the platform in the
corresponding angular interval. The resulting β+activities in the image space of 140×120×50
voxels are shown in figure 3.11 for the height of the sources. The line source and the two
point sources are well detectable, however with a considerably lower activity density in the
68Ge line source compared to the 22Na sources.
No remarkable blurring within the single images and a clear angular shift between the
different phases demonstrate the correct sorting of coincidences into the motion phases. The
activity of the point sources in the 2D images of figure 3.11 was fit to a 2D, elliptical Gaussian
function
F (x, y) = c0 + c1 · e−U/2, U = (x′/g)2 + (y′/h)2, (3.6)
where c0 and c1 are two constant coefficients and 2g and 2h are the axes lengths of an ellipse
which has its centre at (xc, yc) and is oriented under an angle φ relative to the coordinate axes
x and y. Thus, the coordinates of the rotated ellipse x′ and y′ given in (3.6) are calculated
as
x′ = (x− xc) cosφ− (y − yc) sinφ y′ = (x− xc) sinφ+ (y − yc) cosφ. (3.7)
The upper part of table 3.3 summarizes the results for all 9 phases. The center coordinates
of both sources move as expected. The residual motion per phase of source MR–137 with
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Figure 3.11: 3D MLEM reconstruction results of the phase separated listmode data with rotation
angles between 10◦ (upper left) and −14◦ (lower right). The upper part of the images (y > 0) shows
the β+-activity distribution at a height of z ≈ 16mm and the lower part that for isocentre height with
z = 0mm. The star marks the position of the rotation axis. All images are scaled to their maximum
activity.
a distance of about 50mm to the rotation axis is defined by the arclength of circa 2.6mm.
However, the approximated semi-axes have almost the same size indicating a circular shape
of β+-activity and only inferior motion-related blurring. For source MR–138, there is a larger
residual motion per phase defined by the arclength of about 5mm. Thus, for the majority
of the motion phases, there is a slight blurring artefact detectable quantified by the different
lengths of the semi-axes g and h.
Figure 3.12 shows the reconstructed β+-activities from the static reference measurement
and from that with rotating platform. The 4D MLEM algorithm with correctly sorted list-
mode data and dedicated transformation matrices for the 2D motion pattern reproduces
the results from the static reference very well. As listed in the lower part of table 3.3, the
determined point source positions at (xc, yc) and their size is almost identical to those in
the static measurement. Only the major-axis for source MR–138 is slightly increased, but
stays within the range as for the single motion phases. In contrast to that, a 3D MLEM
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Table 3.3: Fit results of point source activities according to (3.6) and (3.7) for images in figure 3.11
and figure 3.12, respectively. For both 22Na point sources the determined center positions at (xc, yc)
and the two semi-axes g and h are tabulated. The angle φ is omitted since it is not very meaningful
for the almost circular shapes.
MR–137 MR–138
xc/mm yc/mm g/mm h/mm xc/mm yc/mm g/mm h/mm
Phase 0 42.4 49.6 2.1 2.2 −22.8 60.2 2.1 2.2
Phase 1 40.0 49.2 2.1 2.0 −25.6 56.8 2.0 2.4
Phase 2 37.4 48.5 2.1 2.0 −28.6 52.7 2.1 2.4
Phase 3 34.8 47.9 2.1 2.2 −31.3 48.6 2.1 2.3
Phase 4 32.5 47.1 2.0 2.0 −33.7 44.6 2.0 2.3
Phase 5 29.9 46.2 2.0 2.2 −35.9 40.3 2.0 2.2
Phase 6 27.6 44.9 2.2 2.1 −38.0 35.5 2.1 2.4
Phase 7 25.0 43.8 2.1 2.1 −39.8 30.6 2.1 2.3
Phase 8 23.1 42.6 2.0 2.1 −41.1 27.0 2.0 2.0
Static 34.2 47.7 2.1 2.0 −32.0 47.6 2.0 2.0
4D MLEM 34.1 47.7 2.1 2.0 −32.0 47.4 2.1 2.3
3D MLEM 31.0 46.0 9.9 2.1 −33.7 42.8 2.1 17.8
reconstruction without any consideration of the motion shows severe motion artefacts. The
size of the β+-activity spreading is correlated to the distance of the sources to the rotation
axis, i.e. to the motion magnitude at the corresponding position in the FOV. Although an
approximation of the smeared point source activities by (3.6) and (3.7) is not expedient, the
results are included in table 3.3 and confirm at least the clear smearing in one direction.
The examination of the β+-activities at several z-positions (not shown) reveals that resolv-
ing the source positions is at least feasible for the considered spatial region near the midplane
between the two detector heads. Prolongation artefacts related to the double-head geometry
are still inevitable as already known from static target measurements (Crespo et al. 2006).
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Figure 3.12: Reconstructed β+-activity distributions from radioactive sources. Images are scaled
to their individual maximum. Results are shown for a static reference measurement (left) and for
the measurement with platform motion reconstructed with the 4D (middle) and 3D (right) MLEM
algorithm. The upper parts of the images (y > 0) show the activity at z ≈ 16mm and the lower part
that at isocentre height (z = 0mm). The stars mark the position of the rotation axis, which proceeds
perpendicular to the x-y plane.
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3.2.2 One-dimensional point source motion
After demonstrating the general functionality of the 4D reconstruction algorithm with a
complex motion pattern and correct processing of the listmode data, a more systematic
measurement campaign with regular 1D motion patterns has been realised. The aim was to
evaluate the reconstruction result as a function of motion parameters and of the listmode
data sorting and to find an acceptable setting for the evaluation of subsequent experiments.
Experimental setup
A stack of two 22Na point sources with a total activity of 1.37MBq was placed at the tar-
get holder of the in-house developed motion table (cf. appendix C.2) and positioned in the
midplane between the two detector heads (z = 0). Motion patterns according to (2.13) have
been driven with symmetric maximum elongation in ±y-direction. Different peak-to-peak
amplitudes a have been selected: 1mm, 2mm, 4mm, 8mm, 10mm, 15mm, 20mm, 24mm,
30mm, 40mm, 54mm and 70mm. For each value a cos2- and cos4-shaped motion was per-
formed, i.e. the exponent 2n of the cosine function was adjusted with n = 1 and n = 2. PET
data were acquired during 20 motion periods with a period time τ = 6 s.
Data processing
For the PET data reconstruction the listmode data have been divided into 1 to 15 motion
phases related to the time-correlated motion signal recorded by the motion table. Both
sorting the raw data into motion phases according to the motion amplitude (equal range of
residual motion) and sorting the raw data into motion phases according to the phase of the
periodic motion (equal length in time) have been tested. The mean residence probability of
the point sources inside each motion phase (cp.appendix E) is considered for generating the
corresponding transformation matrices.
Final β+-activity distributions are analysed in the x-y-plane (z = 0). β+-activity profiles
parallel (y) and perpendicular (x) to the motion direction have been extracted from the con-
sidered 2D images by summing up the pixel values in the corresponding direction. The ratio
of the full width at tenth maximum (FWTM) values from both profiles (FWTMy/FWTMx)
is calculated as figure of merit for each image. These ratios are studied as a function of the
number of considered motion phases N and the mean residual motion in all phases ∆y. The
mean residual motion for a periodic motion function y(t) is calculated within one cycle as
∆y = 1
N
N−1∑
i=0
[max y(t)−min y(t)]ti≤t<ti+1 , (3.8)
where ti denotes the times when the target enters a new motion phase. These times can be
expressed as ti = i · τ/N for time-sorted motion phases. For amlitude sorting, (3.8) can even
be reduced to ∆y = (max y(t)−min y(t)) /N .
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Reconstructed β+activities
The β+-activity distributions of the moving point sources were reconstructed on an image
space of 100× 100× 20 cubic voxels with a side length of 1.6875mm, which is one-fourth of
the BGO crystal segment width of 6.75mm. 10 iteration steps were used for the 3D MLEM
(1 motion phase) and the 4D MLEM (2 to 15 motion phases) reconstructions. The calculated
β+-activity distributions in the midplane using the 3D MLEM algorithm (and neglecting the
motion at all) is shown in figure 3.13 for the cos4-shaped motion (n = 2) and the different
investigated peak-to-peak amplitudes a. Regions with pronounced activity indicate positions
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Figure 3.13: Colour-coded β+-activity distributions reconstructed with the 3D MLEM algorithm
from cos4-shaped (n = 2) point source motion with peak-to-peak amplitudes between 1mm and
70mm. Each image depicts the activity in the detector midplane and is scaled to its maximum value.
Included contour lines are equally spaced. The determined ratio of the FWTM values is written in
the lower right corner of each plot. The exemplary profile (black) parallel to the motion direction for
70mm peak-to-peak amplitude clarifies the necessity to examine the FWTM values (red) instead of
the more common FWHM values (blue).
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of longer residence times. With increasing amplitude, these positions emerge clearly at the
reversal points. Unequal intensities between positive and negative y-coordinates are related
to the asymmetric motion pattern of the cos4 motion. Motion artefacts (prolongation in
y-direction) appear already for relatively small motion ranges of approximately 4mm. This
is reflected by the increased values of the FWTM ratio. Instead of the commonly accepted
FWHM evaluation, the FWTM values have to be examined to consider the whole range of the
activity smearing. By visual investigation, a maximum FWTM ratio of 1.1 and a minimum
ratio of 0.9 were defined as the limits for regarding a distribution as undisturbed. This means
that the deviation between the two FWTM values is less than 10% and the distribution has
almost the circular shape as it is expected from a static point source.
The listmode data have also been reconstructed using the 4D MLEM algorithm with several
motion phases which have been determined according to the amplitude or time. For the cos2
and cos4 motion with a peak-to-peak amplitude of 30mm, figure 3.14 shows exemplarily the
resulting β+-activity distributions that have been reconstructed with 1 to 8 motion phases.
The FWTM ratio decreases rapidly with rising number of motion phases. However, sorting
the listmode data according to the amplitude requires only 5 phases for both motion patterns
to reach a FWTM ratio below 1.1. The FWTM ratios for time sorting will fall below that value
only if at least 10 (cos2) or 13 (cos4) motion phases are considered, which is approximately
twice the number as for sorting by amplitude. Additionally, for a small number of motion
phases in the time sorting regime (and especially for the asymmetric cos4 motion) some
weird β+-activity patterns are formed, since there is a considerably large residual motion
range within each or some of the motion phases.
FWTM ratios have been determined for both types of motion patterns (cos2 and cos4)
with various amplitude values, both sorting techniques (by amplitude and time) and for up
to 15 motion phases. Results are given in figure 3.15 as a function of the number of motion
phases N and the mean residual motion ∆y as defined in (3.8). As already demonstrated
for the 30mm peak-to-peak amplitude in figure 3.14 the remaining motion influence onto the
reconstructed β+-activity distribution is increased for a lower number of motion phases. For
the same (small) number of motion phases the FWTM ratio increases with increasing peak-
to-peak amplitude. If possible, sorting by amplitude should obviously be preferred, since in
comparison to sorting by time, less motion artefacts are produced for the same number of
motion phases and the same motion amplitude. It seems that a larger number of phases is
required for compensating the artefacts arising from the asymmetric cos4 motion if listmode
data are sorted by time. If FWTM ratios are plotted as a function of the mean residual
motion (right column in figure 3.15), then there is no longer a dependence on the peak-to-
peak amplitude. Also the dependence on the listmode sorting regime decreases. Results from
the asymmetric cos4 motion are quite similar but show a steeper slope for sorting by time.
From both motion patterns and motion phase sorting regimes, it can be concluded that
the spatial resolution of the motion acquisition system should be about half the size of a
PET crystal element (0.5 · 6.75mm) to keep the corresponding uncertainty below the mean
residual motion where the FWTM ratios are definitely below 1.1. Furthermore, it is indicated
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Figure 3.14: Reconstructed β+-activity distributions and FWTM ratios (in the lower right corner)
with increasing number of utilized motion phases defined for (a) cos2 and (b) cos4 motion, each with
a peak-to-peak amplitude of 30mm. The upper rows show the results for motion phase sorting by
amplitude and the lower ones those for sorting by time.
by the systematic investigation that intra-fractional motion artefacts are reliably diminished
by means of the 4D MLEM algorithm, at least for the clinically relevant peak-to-peak am-
plitudes of maximal 20mm to 30mm and utilizing motion phase sorting as specified by the
corresponding 4D planning CT image, which consists typically of 8 to 10 motion phases. For
further investigations with peak-to-peak amplitudes of 20mm, a reasonable agreement is to
perform listmode data reconstruction with 9 amplitude-sorted motion phases.
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Figure 3.15: Ratio of the FWTM values of the β+-activity profiles parallel and perpendicular to
the motion direction as a function of the used number of motion phases (left) and the mean residual
motion amplitude within the motion phases (right) for twelve investigated peak-to-peak amplitudes
of a moving point source. Using one motion phase corresponds to a 3D reconstruction. The range of
10% deviation between both FWTM values is highlighted in grey. The first two rows are the results
for cos2-shaped motion (n = 1) and the last two rows for cos4-shaped motion (n = 2), both for sorting
by amplitude (first and third row) and sorting by time (second and fourth row).
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3.3 In-beam PET measurements with moving targets
To test the 4D MLEM algorithm under more realistic conditions, dedicated phantom irra-
diations combined with in-beam PET measurements have been performed. Two types of
experiments had been designed to verify the two major issues that have to be monitored by
an in vivo dosimetry system in particle therapy: the range of the incident particles within
the target material and the lateral field position. Both properties can be well assessed by
in-beam PET measurements for static target volumes. It should be demonstrated here that
under intra-fractional target motion the β+-activity distribution ican be well represented in
the static reference frame of the target by the 4D MLEM reconstruction algorithm. This
would allow for a similar analysis as for static β+-activity distributions as introduced on
page 31. Therefore, static measurements serve as reference for a comparison with the 4D
MLEM results.
3.3.1 Verification of lateral field position and gradients
Experiment design
Homogeneous 100mm× 100mm× 30mm (x× y× z) PMMA blocks have been manufactured
to serve as targets for investigating the conservation of lateral field position and gradients un-
der target motion and different motion mitigated beam deliveries. By means of the stepping
motor driven motion table (cf. appendix C.2) a target has been positioned symmetrically
between the double-head PET scanner and performed a periodic cos2- or cos4-shaped mo-
tion according to (2.13) with a peak-to-peak amplitude of 20mm. The motion proceeded
perpendicular to the beam direction. A quasi-mono-energetic 12C ion beam impinged almost
parallel to the x-axis on the target front surface and was stopped at a depth of about 60mm
in the target. The maximum of the induced β+-activity distribution, which is correlated to
the Bragg peak region, appears approximately at isocentre depth (x = 0).
Due to the selection of two energies with a small difference of 1.1AMeV (forming a tiny
SOBP) and the usage of a 3mm ripple filter (Weber and Kraft 1999), the region of the β+-
activity maximum is slightly broadened in depth and shifted in upbeam direction. The lateral
target displacement was compensated by instantaneous target tracking, gated irradiation with
a 30% or a 50% exhalation gating window1 or by a simple rescanning plan. In the lateral
direction, the pencil beam was scanned along a horizontal line encompassing 51 raster point
coordinates on a grid with 1mm spacing. The length of 50mm was enlarged by adding some
rasterpoints as margins for gated and rescanned beam delivery. A total margin length of
6mm has been added for a gating window of 30%, 10mm for a gating window of 50% and
20mm for rescanning. For each planned beam direction, a total number (distributed over the
two energies) of 7.6 × 107 12C ions has been requested to induce a high number of positron
1Within this thesis the gating window definition is related to the amplitude as follows: The given percentage
defines the valid fraction of the peak-to-peak amplitude of the motion (∆a). An exhalation gating window
comprises all target positions in the interval [ymin, ymin + ∆a] and an inhalation gating window those posi-
tions included by the interval [ymax−∆a, ymax], where ymin and ymax denote the minimum and maximum
target elongation.
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emitters for these basic experiments. To ensure a homogeneous β+-activity distribution along
the whole field width, all plans consisted of 60 rescans which had been delivered within 2–3
minutes. This is approximately the same time span needed for the delivery of a treatment
field under therapeutic conditions. A motion period of τ = 6 s was selected to avoid a beat
frequency with the accelerator cycle time which was about 4.5 s (2.3 s beam on, 2.2 s beam
off) for target tracking and rescanning and about 8 s (5.8 s beam on - if target inside gating
window, 2.2 s beam off) for gated irradiation, respectively.
In-beam PETmeasurements of the induced β+-activity distributions were performed during
the irradiation and additional 40 s afterwards with ongoing target motion. Thereafter, the
motion was stopped and the target positioned at mid elongation. The remaining β+-activity
was assessed in a static follow-up measurement which started 355 s after the irradiation had
been finished and lasted 380 s.
Data processing
For the in-beam PET measurements with moving targets, a 4D MLEM reconstruction with 9
amplitude-sorted motion phases and a conventional 3D MLEM reconstruction with neglected
target motion have been performed, each within an image space of 90× 100× 30 (x× y× z)
voxels. For each motion phase, an attenuation correction has been generated by means of an
artificial CT image with the target and motion table platform at mean residence elongation
inside the motion phase. For the 3D MLEM reconstruction of the moving and static target,
the attenuation correction considers the target at mid elongation position.
All following evaluations are presented for the listmode data with the total number of
measured coincidences as well as for a thinned data set which emulates more therapy relevant
counting statistics. Therefore, approximately 87.5% of the measured coincidences have been
rejected randomly from the in-beam PET data in each motion phase. Events considered for
the 3D MLEM reconstruction in the static follow-up measurement have been decreased by
limiting the considered time interval for reconstruction to 30 s. Table 3.4 summarizes the
approximate number of coincidences gained from the different experiments before and after
thinning. The larger the planned target volume (increased margins) the higher is the induced
β+-activity in the target, and this is roughly reflected by the number of detected coincidences.
The main focus of attention was on the lateral β+-activity fall-off regions. These are inves-
tigated by means of (lateral) activity profiles parallel to the motion direction and intersecting
the high-activity region correlated to the Bragg peak. Deviations between the 4D MLEM
profile and those from the the 3D MLEM or static follow-up are globally quantified by the
normalized root mean square error (NRMSE):
NRMSE = 1maxA4D −minA4D
√√√√ 1
m
m∑
i=1
(
Ai −A4Di
)2
, (3.9)
where m specifies the number of data points in the profiles, Ai specifies the activity values
in the profile to be compared and A4Di represents those in the profile from the 4D MLEM
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Table 3.4: Approximate number of coincidences contributing to the reconstruction results of the
different experiments for the examination of lateral field properties.
Entire data sets Thinned data sets
Experiment In-beam Follow-up In-beam Follow-up
Tracking – cos2 5.9× 105 7.5× 105 7.4× 104 7.0× 104
Tracking – cos4 5.7× 105 7.3× 105 7.1× 104 6.8× 104
Gating 30% – cos2 7.0× 105 7.9× 105 8.7× 104 7.3× 104
Gating 30% – cos4 6.3× 105 7.7× 105 7.8× 104 7.2× 104
Gating 50% – cos2 6.7× 105 8.0× 105 8.4× 104 7.4× 104
Gating 50% – cos4 5.9× 105 8.0× 105 7.4× 104 7.5× 104
Rescanning – cos2 8.1× 105 9.2× 105 1.0× 105 8.5× 104
Rescanning – cos4 8.0× 105 9.1× 105 1.0× 105 8.5× 104
reconstruction. More detailed analysis of the motion influence onto the lateral activity gradi-
ents and their conservation by means of the 4D MLEM is done by calculating the penumbra
widths (between 20% and 80% of the maximum value) at the BEV left (pen−y) and right
(pen+y) slopes of the profiles. Furthermore, the centres of mass of the activity profiles yCOM
are examined by
yCOM =
m∑
i=1
yi ·Ai
m∑
i=1
Ai
(3.10)
to quantify additional differences between 3D and 4D MLEM reconstruction results.
Evaluation of reconstructed β+-activity distributions
The reconstructed β+-activity distributions from high and low counting statistics for the
cos2-shaped motion pattern combined with tracking, gating and rescanned beam delivery are
shown in figure 3.16. Images from the reduced counting statistics have a clearly enhanced
noise level but still reflect the major properties. All images show activity only inside the
marked target volume with a characteristic maximum (laterally extended peak) and a sharp
distal edge at isocentre depth. In lateral direction, the activity broadens with increasing treat-
ment field size and distributions from the 3D MLEM reconstructions are laterally smeared
according to the uncorrected target motion. For all cases the target size was big enough to
cover the full width of the β+-activity distribution. In comparison to the in-beam PET, the
static follow-up measurements exhibit a decreased activity in the proximal plateau region rel-
ative to the peak activity. This is related to the nuclides mainly contributing to the different
parts (cf. table 2.2). The peak activity is predominantly generated by projectile fragments,
primarily consisting of 11C with a half-life of 20.39min. Most target fragments in the plateau
region have shorter half-lives like e.g. 122.24 s for 15O, and these are already mostly decayed
when starting the follow-up measurement. Therefore, a comparison between the different
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Figure 3.16: Reconstructed β+-activity distributions summed up over the target height of 3 cm from
total (a) and reduced (b) counting statistics. The beam impinged from the left on the target (dashed
line). The cos2-shaped motion in y-direction was compensated by one of the four motion mitigation
techniques. Results from in-beam PET data are shown for 4D (1st row) and 3D MLEM (2nd row)
reconstruction in comparison to those from the static follow-up measurement (3rd row). Vertical lines
indicate the position of evaluated profils.
59
3 Reconstruction of in-beam PET data taken from moving targets
   
   
       
         







	    

         
   
         
          
   
   
       







	
     
          
   
     
          
   
     
   
 
       	  
          
   
      
   
   
       
       







	    
          
   
  
        
            
         
          
   
   
       







	
     
          
     
   
          
   
     
   
        	  
          
     
   
Figure 3.17: Profiles parallel to the motion direction and intersecting the high activity region (as
indicated for the cos2 motion in figure 3.16) calculated from all detected coincidences (a) and from
the thinned data sets (b). For each investigated motion-compensated beam delivery (tracking, gating,
rescanning) profiles are shown for cos2-shaped (upper row) and cos4-shaped (lower row) motion pattern
and different reconstruction methods. Solid lines stand for in-beam PET measurements with the
moving target reconstructed without (grey) and with (black) consideration of the motion. The dotted
line is related to the static follow-up measurement. All profiles are normalized to enclose the same
area under the curve. The light grey areas indicate the widths of the treatment plans for the different
motion compensation techniques.
distributions is only done in the peak region by extracting activity profiles parallel to the
motion direction.
Figure 3.17 presents an overview of the profiles from the different experiments for recon-
struction with high statistics (figure 3.17a) as well as for the thinned data sets (figure 3.17b).
According to the better SNR in the images gained from high statistics, these profiles show
a very smooth curve progression. Although profiles from the thinned data sets contain a
higher noise level, the broadening according to the applied motion-compensated beam deliv-
ery technique and the related size of the added safety margins is quite well visible. In all
diagrams (independent from the motion pattern, the beam delivery and counting statistics)
the results from 4D MLEM reconstruction match quite well to those from the static follow-up
measurement. This means that the implemented 4D MLEM reconstruction has the potential
to disclose deviations from an expected β+-activity distribution, similar as it is known from
the 3D MLEM reconstruction applied for static target analysis.
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Results from 3DMLEM reconstructions reach the same maximum values but have shallower
lateral slopes. This blurring results in missing activity in the centred target region and
additional activity in the more lateral parts. By calculating the centre of mass yCOM according
to (3.10), it is found that for cos4 motion the 3D MLEM profiles are shifted to the right side
due to the longer residence time of the target at positive elongation. From table 3.5 it
Table 3.5: Statistics of profiles shown in figure 3.17. For each profile the centre of mass yCOM, the
NRMSE relative to the profile from the 4D MLEM reconstruction and the penumbra values for the
left (pen−y) and right (pen+y) slope of the profile between 20% and 80% of the maximum value are
tabulated.
Profiles of figure 3.17a (all data) Profiles of figure 3.17b (thinned data)
yCOM NRMSE pen−y pen+y yCOM NRMSE pen−y pen+y
Tracking – cos2
3D MLEM −1.8mm 7.1% 17.8mm 18.0mm −1.9mm 7.1% 19.2mm 17.5mm
4D MLEM −1.7mm — 10.7mm 10.0mm −1.8mm — 10.0mm 11.5mm
Static follow-up −1.7mm 2.1% 12.0mm 11.1mm −1.7mm 4.1% 13.4mm 14.1mm
Tracking – cos4
3D MLEM 0.7mm 10.1% 17.5mm 17.5mm 0.6mm 10.8% 18.0mm 17.8mm
4D MLEM −1.8mm — 9.9mm 9.7mm −2.1mm — 9.8mm 9.5mm
Static follow-up −1.8mm 2.2% 11.1mm 10.5mm −1.8mm 3.3% 11.6mm 12.0mm
Gating 30% – cos2
3D MLEM −1.6mm 7.9% 17.8mm 19.1mm −1.6mm 8.8% 18.2mm 19.2mm
4D MLEM 0.1mm 10.9mm 11.2mm 0.2mm — 9.4mm 10.8mm
Static follow-up 0.1mm 1.7% 11.7mm 11.9mm 0.3mm 3.2% 11.5mm 12.2mm
Gating 30% – cos4
3D MLEM −0.1mm 7.3% 19.4mm 18.7mm 0.2mm 9.0% 20.4mm 20.3mm
4D MLEM −0.7mm — 11.0mm 11.5mm −0.5mm — 10.2mm 10.3mm
Static follow-up −0.6mm 2.2% 11.6mm 11.2mm −0.4mm 4.1% 13.2mm 11.3mm
Gating 50% – cos2
3D MLEM −2.0mm 7.5% 18.1mm 18.1mm −2.2mm 7.8% 17.1mm 19.6mm
4D MLEM −0.3mm — 12.6mm 12.2mm −0.5mm — 14.1mm 13.3mm
Static follow-up −0.2mm 1.9% 12.9mm 12.3mm −0.6mm 4.5% 15.8mm 11.9mm
Gating 50% – cos4
3D MLEM −0.8mm 7.4% 19.8mm 21.0mm −0.6mm 9.3% 23.0mm 21.7mm
4D MLEM −1.4mm — 11.2mm 13.0mm −1.5mm — 11.1mm 13.2mm
Static follow-up −1.2mm 2.1% 12.8mm 13.2mm −1.1mm 4.2% 12.9mm 14.1mm
Rescanning – cos2
3D MLEM −1.3mm 4.9% 20.3mm 21.9mm −1.5mm 5.8% 22.6mm 25.5mm
4D MLEM −1.4mm — 16.7mm 17.0mm −1.5mm — 17.8mm 16.9mm
Static follow-up −1.4mm 2.5% 17.5mm 19.1mm −1.5mm 3.4% 17.0mm 17.8mm
Rescanning – cos4
3D MLEM −1.2mm 7.0% 22.5mm 23.3mm −0.9mm 7.8% 22.0mm 23.6mm
4D MLEM −3.5mm — 16.4mm 19.1mm −3.5mm — 15.9mm 19.9mm
Static follow-up −3.7mm 1.8% 18.3mm 19.0mm −4.0mm 3.9% 17.9mm 20.7mm
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can be extracted that the center of mass is shifted by about 2.5mm if the target tracking
or rescanning approach is applied. For gated irradiation, the shift is diminished to circa
0.6mm, because the gating window has been chosen at exhalation phase. Therefore, the
longer residence at exhalation often overlaps with beam-on periods when all coincidences
are rejected for reconstruction due to the high number of random coincidences originating
from the prompt γ-ray emission. On the contrary, for gated irradiation with symmetric cos2
motion the center of mass is shifted by about −1.8mm due to the same practice of coincidence
rejection during beam delivery. Thus, irrespective of the smeared slopes, if target motion
is disregarded during the in-beam PET data reconstruction, a wrong lateral field position
within the target might be identified depending on the interdependency of the beam delivery
technique and motion pattern.
Furthermore, table 3.5 summarizes the results of calculated NRMSE and penumbra values
for all experiments with high as well as thinned statistics. A general consistency between
values from high and thinned statistics is found. However, NRMSE values from thinned data
tend to be slightly increased and the penumbra values show a larger variability. The quite
good matching between all 4D MLEM and static follow-up measurements is represented by a
small NRMSE of (2.1± 0.3)% for high statistics and (3.8± 0.5)% for thinned data. Also the
penumbra values of 4D MLEM and static profiles are in the same range for all measurements.
For rescanning (which is no active motion compensation), the penumbras are considerably
increased to values above 15mm. Even this high value is clearly exceeded for all experiments
by the penumbras of 3D MLEM profiles. The distinct difference between 3D and 4D MLEM
profiles is quantified by a mean NRMSE and its standard deviation of (7.4± 1.4)% for high
statistics and (8.3 ± 1.5)% for thinned data. The quite large standard deviation is related
to the different behaviour in several experiments: Profiles differ a lot (NRMSE > 10%) if
gradients are large in the 4D profiles (tracking) and the centre of mass is additionally shifted
in the 3D profiles (cos4 motion). If gradients are small in 4D profiles (rescanning) and the 3D
centre of mass remains unshifted (cos2 motion), a relatively high conformity (NRMSE < 6%)
can be found between 3D and 4D reconstructed images.
3.3.2 Verification of particle range
Experiment design
To test the reconstruction algorithm with respect to correct range reproduction, a defined
modulation of the particle range in the moving target is necessary. Ideally, this requires
different particle energies if delivered to homogeneous targets and the exact motion mitigation
for each energy. An alternative are targets consisting of different materials, but the density
to range calibration and exact positioning might be error-prone. A third, fail-safe possibility
has been conceived for testing the range verification under motion by means of in-beam PET.
A defined range modulation of the incident 12C ions has been ensured by a special target
geometry which is shown in figure 3.18. PMMA blocks of 135mm×200mm×90mm (x×y×z)
are furnished at the proximal face surface with three cuboid structures of 10mm width (y)
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Figure 3.18: PMMA targets for the generation of defined under-ranges of 17.5mm, 7.5mm and
12.5mm (left) and over-ranges of 15mm, 5mm and 10mm (right) and their orientation in the coor-
dinate system of the PET scanner (beam parallel to x, motion parallel to y and detector heads above
and below in z-direction). Dimensions are given in mm. The maximum elongation of ±10mm in
y-direction is indicated for the target mid (black line) by the green lines.
and different depths (x). These cuboids are separated by 30mm and thus form a fence-
shaped structure. Cuboid thicknesses of 17.5mm, 12.5mm and 7.5mm have been chosen
for realizing defined under-ranges of the ions in the target. For generating over-ranges, the
pattern is inversely carved into the PMMA block with depths of 15mm, 10mm and 5mm.
Irrespective of the exact motion pattern and motion mitigated beam delivery technique, the
distal edge of a treatment field composed of quasi-mono-energetic pencil beams retraces the
fence structure at an energy-dependent depth in the target.
The treatment plan and measurement regimes were similar to those for the experiments in
section 3.3.1. The treatment plan consisted of 2 energies with a difference of 1.1AMeV and
contained for both energies 141 raster scan coordinates (on a virtual grid with 1mm spacing)
arranged at a horizontal line. The plan with a total number of 10.8×109 12C ions is delivered
by means of 60 rescans between the minimum (-70mm, BEV left) and maximum (70mm,
BEV right) coordinate within approximately 5.3min. The PET listmode data have been
acquired during this time plus additional 40 s and within a static reference measurements
taken from the same targets 355 s past irradiation and lasting for 380 s. For two selected
measurements, the target motion was compensated by means of lateral tracking. Using the
stepping motor driven motion table (cf. appendix C.2), the target with under-range geometry
performed a cos2 motion and the over-range target a cos4 motion, both according to (2.13),
with a peak-to-peak amplitude a of 20mm and a period τ of 6 s.
Data processing
The data from in-beam PET and static follow-up measurements have been reconstructed on
an image space of 100×130×60 (x×y×z) voxels and under consideration of the corresponding
attenuation corrections. In-beam PET data have been reconstructed by the 4D MLEM with
9 amplitude-sorted motion phases and by the 3D MLEM algorithm, both using the high
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Table 3.6: Approximate number of coincidences contributing to the reconstruction results from the
entire and thinned data sets for both fence-shaped target geometries.
Entire data sets Thinned data sets
Experiment In-beam Follow-up In-beam Follow-up
Under-range – cos2 12.8× 105 10.2× 105 7.7× 104 7.9× 104
Over-range – cos4 12.9× 105 10.2× 105 7.7× 104 7.9× 104
statistics of the entire data sets or a more clinically relevant counting statistics gained by a
random rejection of 94% of the initial data in each motion phase. To meet similar statistics
in the static follow-up data, the time interval considered for reconstruction was shortened to
25 s. The approximate number of the examined coincidences are summarized in table 3.6 for
the original and thinned data sets and both targets. The number of coincidences is similar
for the under- and over-range target, since the treatment plan and the motion mitigation
technique were the same for both experiments.
Reconstructed β+-activity distributions are evaluated with respect to a correct reproduc-
tion of the distal edge position relative to the static reference by means of an automated
range comparison (Helmbrecht et al. 2012). Since 12C ion beams have been used, the distal
β+-activity peak is dominated by the projectile fragment 11C which has a reasonably long
half-life of 20.39min. This allows for a good identification of the distal edge position even
in the static follow-up measurements. The comparison algorithm operates on 1D profiles in
the longitudinal direction (parallel to the beam) and compares for each pixel of the BEV the
distal fall-off between a reference profile and a profile from the β+-activity distribution to be
evaluated. Reference profiles are normally obtained from the reconstruction of a simulated
data set, but for these experiments, they are extracted from the static follow-up measure-
ment. Profiles to be compared are scaled to their own maximum value. Only the distal
interval where the β+-activity profile decreases from 0.8 to 0.2 is considered for examination.
This part is shifted against the reference profile until the area which is enclosed between
both profile segments has reached its minimum. The required shift is considered as the range
deviation between both distributions at the corresponding position.
Evaluation of reconstructed β+-activity distributions
Reconstructed β+-activity distributions in the midplane between both detector heads are
represented for the initially high statistics in the upper part of figure 3.19a. From a visual
investigation, it is found that the high-activity region inside the target retraces the pattern
of the proximal target surface after the 4D MLEM reconstruction and in the static follow-
up measurement. This means that the straight line of highest activity proceeds parallel to
the y-direction and is disrupted due to the segments corresponding to the convex or concave
structures at the target surface which protrude into proximal and distal direction, respectively.
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Figure 3.19: Reconstructed β+-activity distributions in the targets with under-range (left) and over-
range (right) geometry for the entire data sets (a) and thinned data sets (b) and the corresponding
results from automated range comparison. The respective target is indicated by its dotted boundary
in the β+-activity distributions and as grey scale CT image superimposed to the range differences.
β+-activity images are scaled to their maximum value. Range deviations are indicated in red for
detected over-ranges and in blue for detected under-ranges. Same ranges are represented in green.
Contrary to that, the reconstructed β+-activity distribution using the conventional 3DMLEM
algorithm illustrates clearly the malfunctioning of the reconstruction if the target motion is
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neglected. Besides the broadening of the activity distribution in lateral direction as already
shown by the experiments in section 3.3.1, a distinctly and visibly disturbed shape of the
distal edge is found. Due to the target motion, β+-emitters can decay several millimetres
apart from the location where they have been created. And since the peak-to-peak motion
amplitude is larger than the 10mm wide target structures, the distal edge seems to form
an almost continuous vertical line in the images. This means that approximately the same
range would be approved for each 1D profile extracted parallel to the beam direction. Solely,
the slight prolongations of the high-activity region into the proximal direction for the under-
range target and into the distal direction for the over-range target give an idea of the actually
induced shape of the β+-activity distribution formed by the target geometry. The positions
of these prolongations in lateral direction depend directly on the motion pattern. For the
symmetric cos2 motion, a symmetric blurring is formed around the target structures at mid
elongation. If the target undergoes the cos4 motion, the prolongations emphasize the mean
residence position in the motion cycle. Thus, the prolongations are shifted to larger y-
coordinates relative to the positions of the target structures at mid elongation.
The results of the automated range verification for reconstructions with all measured data
are shown in the lower part of figure 3.19a. Range deviations for the 4D and 3D MLEM
reconstruction results relative to those for the static measurement are represented as colour-
coded bars superimposed to the CT image with the target at mid elongation. The length of
a bar illustrates the reference range (where the activity of the static target decreases to the
value 0.2) at the corresponding lateral position and its colour the detected deviation. For the
over-range as well as the under-range target, the algorithm identifies at all lateral positions
the same range for the 4D MLEM reconstruction as that in the static reference. For the
3D MLEM reconstruction, serious range deviations have been found at the positions of the
planned range modulations. In the under-range target, these deviations correspond to the
disappeared gaps in the pattern of the distal edge, and the detected over-range values coincide
with the depth of the convex target structures. A concave structure in the over-range target
generates in comparison to the static reference a regions of over-range and a regions of under-
range as well. This has to be rated under the consideration of the asymmetric cos4 motion
with a longer residence time at larger y-coordinates. Due to that main residence position,
the planned over-ranges are found next to the real target structures which is indicated by
the warm colour spectrum (yellow, orange and red). In return, at the actual positions of
the planned over-ranges, the distal edge is found at more proximal positions than expected.
These deviations are interpreted as under-ranges and are shown in different shades of blue
which correspond approximately to the depth of the three target structures.
The upper part of figure 3.19b shows the equivalent reconstruction results for the thinned
data sets as for the high statistics in figure 3.19a. The SNR is obviously decreased, but
the characteristic patterns of the distal edges are quite well reproduced by the 4D MLEM
reconstruction and in the static follow-up measurements. Consequently, the related images
for range deviation in the lower part of figure 3.19b consist mainly of bars in different shades of
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green representing the similar range in both distributions. Only at two profiles in the under-
range target, the algorithm was not able to find the correct range which is indicated by one
red and one blue bar. Irrespective of these two bars, the maximal absolute range deviation
was below 3.5mm. In the β+-activity distributions of the 3D MLEM reconstruction, the
specific pattern of the distal edge disappears in the same way as seen in figure 3.19a. Images
representing the detected range deviations for 3D MLEM reconstructions are quite similar
to those extracted for the data sets with high statistics. This includes on the one hand the
detected over-ranges in the profiles which intersect the convex structures in the under-range
target. On the other hand, in the over-range target the characteristic regions are found with
a similar intensity of over- and under-range, except for the smallest structure depth in the
middle of the target. No over-range is detected there due to the reduced image quality.
From the experiments with fence-shaped target geometry, it can be concluded that the
4D MLEM algorithm is able to reproduce the exact shape of the distal fall-off region in the
reference frame of the target, also for the known low counting statistics in clinical in-beam
PET measurements. Thus, irrespective of the applied motion pattern, the information about
the correct dose deposition in longitudinal direction can be extracted and over- as well as
under-ranges are detectable in a reliable way. This would not be possible if target motion is
neglected during the reconstruction process.
3.4 Summary and discussion
Reconstructed β+-activity distributions from IBT-PET measurements of static and well fix-
ated tumour entities are suitable for monitoring the accurate localization of the dose distri-
bution and particle ranges in the patient. For intra-fractionally moving targets, the image
quality suffers from blurring artefacts independent of the applied measurement regime, either
in-beam, in-room or off-line. Dedicated time-resolved reconstruction algorithms have to be
applied to obtain realistic β+-activity distributions. Normally, these algorithms are commer-
cially provided for diagnostic imaging with conventional full-ring scanners and can be directly
applied for the in-room and off-line PET data reconstruction. In-house developments of IBT-
PET scanners which are implemented into the treatment site for in-beam PET measurements
have unique detector arrangements (Enghardt et al. 2004a; Yamaya et al. 2008; Nishio et al.
2010) and thus require adapted 4D reconstruction algorithms. In this context, a 4D MLEM
algorithm was implemented for the unique in-beam PET scanner Bastei at GSI and was
verified by dedicated experiments. Although this scanner is not used for patient monitoring
anymore, meaningful information can be acquired for similar future installations.
In comparison to the approved 3D MLEM reconstruction for static targets, a 4D MLEM
calculation requires additional operating expense. Several input data have to be handled
correctly for a successful image reconstruction:
- Instead of a single 3D CT volumetric image, a whole set is necessary for a time-
dependent attenuation and scatter correction.
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- Transformation matrices between the different 4D CT image phases have to be created.
This is quite simple for the presented phantom experiments with well-defined rigid
motion patterns. For real 4D patient CT images, dedicated software has to be utilized
to extract the motion information including non-rigid tissue deformation. However, by
means of the transformation matrices, any motion can be considered in the 4D MLEM
algorithm as it was demonstrated for 1D motion and for the rotating radioactive sources.
- The surrogate motion signal has to be recorded during the whole measurement time
and it has to be correlated to the CT phases as well as synchronized with the listmode
PET data stream.
- On the basis of the detected motion signal, the listmode PET data have to be divided
into the different motion phases, ideally in the same way as given by the 4D CT im-
age. For commercial systems, the user might have no influence on CT and PET data
sorting. Traditionally, 4D CT binning is done by phase but first commercially avail-
able retrospective amplitude-binning demonstrated superior performance in terms of
reduced image artefacts (Li et al. 2012). By means of the comprehensive off-beam PET
measurements with moving point sources (cp. section 3.2.2), the same finding were ob-
tained for the PET data sorting. Therefore, the evaluation of in-beam PET phantom
measurements in section 3.3 was done by amplitude-sorted motion phases, although
similar results would be achievable by time sorting using a larger number of motion
phases.
Although an instantaneous intervention during the beam application is not possible by
means of IBT-PET, a fast evaluation of the a fractionated dose distribution is desired before
delivering the next fraction. Therefore, as many as possible steps in the PET reconstruction
workflow should be automatized. For instance, in clinical application it is necessary to au-
tomatize at least the synchronization of the listmode PET data stream with the motion signal
to speed up the data preparation. With the 4 byte long listmode datawords (cp. figure 2.9) of
the in-beam PET scanner Bastei and the existing hardware, it is not feasible to implement
the motion information directly into the PET data stream. Thus, the time consuming syn-
chronization was done manually by means of logged accelerator signals in both data streams
(cf. appendix D).
Anatomical changes, mispositioning or even treatment errors are mainly reflected by blurred
lateral β+-activity gradients and shifted distal edge positions. The phantom experiments
verified that the 4D MLEM algorithm allows for an exact reproduction of both quantities
in comparison to static reference measurements. Since the double-head PET scanner has a
limited solid angle coverage and the number of induced β+-emitters in patients is compara-
bly small relative to diagnostic PET imaging, attention was also paid to clinically relevant
counting statistics when examining the information content of the images. A reduced SNR
decreases the image quality for lowered counting statistics, but the considerable difference
between a 4D and a 3D MLEM reconstruction of the same data set remains clearly accessible.
The correct reproduction of the distal edge progression has been approved for range modi-
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fications ≥ 5mm. One might claim that these modifications are quite large and that smaller
range variations should also be detectable under the target motion. However, compact lung
tumours are often totally embedded in the less dense lung tissue as shown in the CT image in
figure 3.2. Changes of the soft tissue geometry (e.g. due to tumour shrinkage during therapy)
and/or the dense rib tissue (e.g. due to patient mispositioning) might cause larger range de-
viations of up to some centimetres in the lung tissue because of the large density differences
of the penetrated tissues. These deviations are well detectable at the correct positions after
a 4D MLEM reconstruction.
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The reconstruction of the induced β+-activity distribution without motion artefacts in the
quasi-static reference frame of a moving target (chapter 3) is only one of the major pre-
requisites for a successful in vivo dose monitoring by means of IBT-PET. Since the dose
distribution cannot be extracted directly, the validation of the deposited dose distribution is
done by means of a comparison between the β+-activity distributions reconstructed from the
measured and from simulated data, as it is illustrated in figure 2.10. Thus, the simulation
software for generating predicted PET data is also an essential part of the whole dose veri-
fication routine and needed to be upgraded for intra-fractionally moving target volumes. A
first 4D simulation program for listmode data expected to be taken from irradiated moving
targets was elaborated together with Dr. Stefan Menkel within the framework of his master’s
thesis (Menkel 2011). A revised version of the program was published in Physics in Medicine
and Biology (Laube et al. 2013) and presented at the 4th 4D treatment planning workshop
(Laube et al. 2012e).
4.1 Upgrading the IBT-PET simulation from 3D to 4D
The new 4D simulation program is widely based on the 3D program which had been developed
at FZR and was proven by its application within the cancer treatment pilot project at GSI
for the in-beam PET data simulation of about 440 patients with static tumour entities.
Details about the 3D simulation code can be found in the literature (Hasch 1996; Pönisch
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2003; Pönisch et al. 2004). The most relevant parts are briefly outlined together with the
description of the new 4D simulation program.
4.1.1 General and motion-related simulation demands
In general, for each incident ion of the therapeutic beam the program has to
- simulate the generation of certain nuclides at distinct positions inside the tissue and at
defined time points,
- simulate the decay of the nuclides at a certain time after their generation including all
subsequent interaction processes of slowing down the positron until its annihilation,
- simulate the propagation and the interactions of the annihilation photons in the patient
specific tissue,
- determine whether the annihilation photons are registered in the PET detectors for
creating a true coincidence,
- save these valid events as a listmode data stream which can be processed by the recon-
struction program like a measured one.
For the intra-fractional motion the existing 3D IBT-PET data simulation had to be up-
graded by using time-resolved (4D) algorithms to consider the relative movement between
the target volume and the ion beam. The time-dependent anatomical changes in the pa-
tient are relevant to simulate the accurate positron emitter distribution generated during
the irradiation. Moreover, the simulation has to account correctly for the motion-dependent
displacement of the generated β+-emitters which are transported together with the moving
structures until they decay. The decay positions depend on the random decay times and they
usually differ from the positions where the nuclides had been created.
The complexity of the simulation does not only depend on the target motion, but also on
the selected motion mitigation technique used during beam delivery. Table 4.1 summarizes for
Table 4.1: Required changes relative to the planned treatment which are instantaneously performed
during the different motion mitigated beam deliveries for active pencil beam scanning. The 4D
simulation has to consider the actually applied raster scan coordinates and the delivered number of
ions with their energy.
Motion mitigated beam delivery Changes in treatment plan during irradiation
Rescanning None
Gating None, only timing of beam delivery is adapted
Lateral tracking Changed raster point coordinates
Depth-compensated tracking Energy of ions passively changed before entering the patient (done
instantaneously during lateral tracking)
Dose compensation1 Number of ions per raster point instantaneously recalculated during
depth-compensated tracking
1Dose compensation defines a sophisticated technique that tries to homogenize the dose distribution in the
proximal energy layers taking into account the previous dose allocation from already irradiated more distal
energy layers (Lüchtenborg et al. 2011).
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Figure 4.1: Comparison of the required input parameters and information (blue boxes) for the
simulation of a IBT-PET listmode data streams that are expected to be measured during the treatment
of a static (left) and of an intra-fractionally moving target volume (right). Additional parameters for
the 4D simulation program are highlighted.
the different motion mitigation techniques the changes relative to the scheduled treatment
plan which are required during irradiation. These changes are not predictable prior the
treatment, since they depend on the individual progress of the dose deposition and motion
states. To gain simulated listmode data which are comparable to the measured ones, the
actual beam directions as well as the real energy and number of ions delivered to these raster
coordinates have to be taken into account by the 4D simulation software. Therefore, several
input parameters and additional information are required as shown in figure 4.1. These are
shortly explained in the following section.
4.1.2 Input parameters for the 4D simulation program
POSGEN database The simulation of the induced positron emitter distributions by 12C
ion pencil beams utilizes a database created by the Monte Carlo simulation program POS-
GEN (Hasch 1996; Pönisch et al. 2004). This program is based on the energy-dependent
cross sections for nuclear interactions occurring during the irradiation of PMMA with 12C
ions (Sihver et al. 1996; Sihver and Mancusi 2009). For each of the 252 available 12C ion
energies between 80AMeV and 430AMeV that can be delivered for therapeutic application
by the heavy ion synchrotron at GSI, there exists one database file. These files contain
the coordinates of the different β+-emitting nuclides that are most likely generated inside a
PMMA phantom which has been hit by a pencil beam of 105 ions with the corresponding
energy. A short section of one of the database files is illustrated in figure 4.2. For each
possible β+-emitting nuclide, the half-life and the maximal positron energy can be extracted
from an additional look-up table (LUT).
4D planning CT image The simulation of the β+-emitter distribution in the patient is
based on the planning CT. Coordinates of the induced β+-emitters taken from the POSGEN
database are transferred into the CT images under consideration of the breathing cycle and
the related CT phases and using a calibration between the HUs that are extracted from the
corresponding phase of the 4D planning CT image and the WEPL (Rietzel et al. 2007). Fur-
73
4 Simulation of phase-sorted in-beam PET data for moving targets
F_Posi_out v04-295.65.db
NprimPro   100000
A          12.000000
Z          6.000000
E          295.650000
...        ...
Med        pmma
  ...         ...          ...          ...
 292001     0.545635     0.357274    15.683728
 101211     0.887956    -0.155661    13.370442
 162002     0.150114    -0.546603    11.783765
 101011    -0.141006    -0.146831     6.738027
 101211     0.299176     0.249050    14.001625
-276011     0.053655    -0.732353    14.534318
-276011    -0.010622    -0.856129    16.367173
-325011    -0.657923     0.318481    21.066753
-286001    -0.791882     0.380880    26.172061
 101001     0.121368     0.376266     3.520317
 321007     0.355645     0.118979    20.637564
  ...         ...          ...          ...
Number of incident projectiles
Denition of projectiles
Target material
Database header  ID X / cm Y / cm Z / cm
Figure 4.2: Exemplary short section of a POSGEN database file (right) with its header (left) for 105
12
6C projectiles impinging on PMMA with an energy of 295.65AMeV. The ID of each generated β+-
emitter allows to identify the specific isotope with its corresponding half-life. The given coordinates of
the β+-emitters in the PMMA target refer to the propagating beam along the Z-axis and the target
front surface positioned at Z = 0.
thermore, the different CT images are used to simulate the interaction processes of emerging
positrons and annihilation photons within the patient tissue
Transformation between CT phases The transportation of the positron emitters with
the moving target structures from their position of creation to the decay point is obtained from
the transformation between the corresponding motion phases. By means of dedicated software
the transformation matrices between the several CT phases can be extracted automatically
from the 4D planning CT image. The matrices contain for each voxel in the CT image of the
start phase an average 3D vector for its translation to the destination phase. To reduce the
number of the required memory-consuming transformation matrices two sets of matrices are
used. The first set describes the transformation from each phase to a defined reference phase
and the second one the transformation from that reference phase into the different motion
phases. In summary the number of required matrices is only twice the number of motion
phases in the 4D CT image.
Motion surrogate signal Each point in time during the beam application and thePET
measurement can ideally be correlated to one of the 4D CT phases by means of the a dedicated
motion surrogate signal. This ensures to position a β+-emitter from the POSGEN database
into the correct CT phase and to determine the CT phase related to its decay time.
(Retrospective) treatment plan The treatment plan for active pencil beam scanning
(cp. section 2.2.1) consists of two parts. A so-called plan file defines the target point2, the
couch angle and the gantry angle. Thereby, the beam incidence and the beam direction in the
4D CT image can be calculated. The raster-scan file contains for each required energy slice the
beam parameters energy, focus size and intensity as well as the single raster point coordinates
2The target point is the coordinate in the planning CT image that matches with the fixed isocentre in the
treatment room after the patient has been positioned on the treatment couch
74
4.1 Upgrading the IBT-PET simulation from 3D to 4D
...
submachine# 148 294.57 1 3.3
#particles 518013 518013 8.08101E+08
stepsize 1 1
#points 1560
0 0 518013
-1 0 518013
-2 0 518013
-3 0 518013
-4 0 518013
-5 0 518013
-6 0 518013
-7 0 518013
-8 0 518013
...
Scheduled raster-scan le
...
submachine# 148 294.57 1 3.3
#particles 508434 528441 8.08094E+08
stepsize 1 1
#points 1560
6.40869 0 518152
4.16003 0 518064
2.69839 0 517860
1.23676 0 517987
0 0 518179
-1.23676 0 517915
-2.47353 0 518108
-3.93516 0 518267
-5.17192 0 517662
...
Retrospectively created raster-scan le
Figure 4.3: Exemplary, short section of a retrospectively created treatment plan (right) using the
information from the multi-wire and ionisation chamber recorded during the irradiation of a moving
phantom using the lateral tracking technique. The initially scheduled plan (left) intended a horizontal
scanning of the pencil beam from 0mm to −8mm with an equal number of ions delivered at each
raster point. Since the beam has followed the target motion, actual raster scan coordinates from
6.4mm to −5.2mm were detected.
in BEV with the optimized number of ions to be delivered to each point (Krämer et al. 2000;
Krämer and Scholz 2000). As shown in table 4.1, the planned number of ions is delivered
to the planned direction during gated or rescanned beam delivery and the initially scheduled
treatment plan can be used for simulation. For more sophisticated motion mitigation by
means of tracking or dose compensation, the beam direction and potentially also the number
of particles are adjusted during the irradiation according to the current target position. The
actual beam direction and the number of delivered ions are monitored during the beam
application by MWPCs and ICs mounted at the beam nozzle (cp. section 2.2.2). Thus,
a retrospective treatment plan is created that contains for each scheduled raster point the
actual beam direction and delivered number of ions with their initial energy. A short example
for a retrospective raster-scan file in comparison to the scheduled one is given in figure 4.3.
Exact time structure of the beam delivery and motion mitigation In the 3D sim-
ulation program, the irradiation time of the raster points was roughly estimated from the
recorded begin and duration of the beam extraction periods of the synchrotron. Within each
energy slice, the raster points with their planned number of particles were proportionally di-
vided within the spills of the related energy and the irradiation time of the raster points was
simply set to the begin of the corresponding spill. In contrast to that, for the 4D simulation
the exact delivery time for each raster point has to be known due to the changing CT image
states. The time structure of the beam delivery is documented by the recorded nextpoint
signals which are generated when the prescribed amount of ions has been delivered to a raster
point (cp. section 2.2.2).
Before the ions enter the target material, their energy might have to be adapted if depth
compensated tracking is performed. Due to a possibly relative movement between the target
volume and the surrounding tissue the ions could pass other anatomical structures than
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planned. A wedge system for ion range modification is available for experiments at GSI
(Weber et al. 2000; Grözinger et al. 2006). It increases or reduces the amount of absorbing
PMMA material between beam exit window and phantom surface in an extremely fast way
(shift of 5mm WEPL within 16ms (Saito et al 2009)). The related additional WEPL has
to be considered for the ion range determination of the corresponding raster point when
positioning the β+-emitters into the CT images.
Finally, by combining the information from the nextpoint signals, the changing wedge
thickness as well as the surrogate motion signal, a LUT is created. In combination with
the retrospective treatment plan, the following data are provided for each raster point: the
number of delivered ions, the raster scan coordinates, the initial beam energy and its related
WEPL, the additional WEPL of the range-compensating wedge system and the CT image
phase (extracted from the next point signal in combination with the motion surrogate signal).
Geometry of the PET scanner The final detection of valid coincidences depends directly
on the detector geometry. A simulation for a full-ring PET scanner will result in a higher
count rate than for a double-head scanner due to the different solid angle coverage. Currently,
only the Bastei scanner geometry (cp. section 2.4.2) with the coordinates of all 4096 BGO
crystal elements is implemented. The detection efficiency is simulated using the mean free
pathlength of the detector material. Additionally, the format of the listmode data output is
related to the considered PET scanner with its valid LORs.
4.1.3 Workflow of the 4D simulation program
A flowchart of the 4D IBT-PET simulation program is shown in figure 4.4. The simulation
program processes sequentially the single raster points given by the treatment plan. For each
of them the simulation can be divided into the parts of the β+-emitter generation and the
β+-emitter decay with the subsequent detection of annihilation photons.
Generation of β+-emitters
For the planned number of ions delivered to one raster point, a related number of β+-emitters
with their coordinates in PMMA is sampled from the POSGEN database. The mixture of
β+-emitters created in a patient differs from that given in the database due to the specific
tissue composition in comparison to PMMA. This is basically corrected for by introducing
an oxygen enhancement factor that induces an isotope-specific sampling from the POSGEN
database. The occurrence of β+-emitting oxygen isotopes is enhanced relative to other β+-
emitters. The coordinates of the sampled β+-emitters in PMMA are transformed into WEPL.
The information provided by the nextpoint and the motion surrogate signal determines the
current CT image phase to be considered. The transversal coordinates are related to the
CT image under the consideration of the couch angle and the point of beam incidence. The
real depth of the β+-emitters in the patient measured along the beam direction (given by
the retrospective treatment plan) is calculated from the CT image using a HU to WEPL
76
4.1 Upgrading the IBT-PET simulation from 3D to 4D
Reading entries in treatment plan and LUT for current raster point
(number of particles, raster-scan coordinates, time tc, motion phase, WEPL of wedge)
Import of retrospectively generated treatment plan, LUT and 4D CT
Reading POSGEN database for current ion energy
Sampling of a β+-emitter from database + mapping onto CT of current motion phase
Drawing of isotope specic decay time and calculation of td
Residual photon energy > 250 keV?
td ≤ tmax?
Emission of annihilation photons of 511 keV in opposite direction
Determine motion phase of decay related to td
Yes
Transformation of β+-emitter coordinates
from creation phase at tc to decay phase at td
Positron propagation within CT image of decay phase
Photon–tissue interaction based on CT image of decay phase
Yes
True coincidence?
i.e. both photons hit scanner (one at
each head) with DOI < 20 mm
Yes
Writing data set into le for decay phase
(tc, td, crystal IDs, annihilation point coordinates, ...)
Last β+-emitter for raster point?
Last raster point for energy slice?
Yes
Yes
Last energy slice?
Yes
Reordering of data set entries by td and encoding of hit crystal pairs as listmode data
Output of le with listmode data stream for each motion phase
No No No
No
No
No
Figure 4.4: Flowchart of the 4D IBT-PET simulation program for generating motion phase sorted
listmode files for the geometry of the Bastei PET scanner on the basis of the temporal structure and
progress of a real irradiation. Boxes highlighted in grey indicate the new or changed algorithms or
sections where e.g. attention has to be paid to the correct handling of the 4D CT image phases.
calibration and the current water-equivalent thickness of the wedge system. All β+-emitters
from one raster point are assigned to one creation time tc which is equal to the time of the
corresponding nextpoint signal.
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Decay of β+emitters
After positioning the β+-emitters related to the irradiation of one raster point into the CT
image the decay is simulated individually for each single β+-emitter. This includes the
positron propagation and positron-electron annihilation as well as the photon propagation,
interaction and detection.
A decay time td of a nuclide is determined by drawing a random time t from the exponential
distribution with the corresponding decay constant and adding it to the creation time tc of
the nuclide (td = tc + t). Further simulations are only done for β+-emitters if their decay
time td is less than the last time point tmax that has been recorded in the data set of the
measurement. For β+-emitters fulfilling this criterion, the CT image phase associated with
the time point td is extracted. The coordinate of the β+-emitter is changed from the CT
phase of its creation to the CT phase where the decay takes place according to the tissue
deformation between the two phases by applying the transformation matrices.
The following simulation steps are done in the same way as in the 3D simulation but with
the new coordinates in the CT image phase of the decay. A positron is emitted in an arbitrary
direction with an energy randomly chosen from the nuclide-specific β+spectrum. The ranges
of the positrons are taken from the stopping power and range table for electrons (ESTAR)
of the National Institute of Standards and Technology (Berger et al. 1999). These are
converted into the range in tissue by means of the CT image. The resulting final destination
of the positron is considered as the point of annihilation. There, two photons of 511 keV are
emitted in arbitrary but opposite directions. Interactions of the photons within the tissue are
implemented as a probable incoherent scattering and photon absorption. Photon detection
is simulated for the geometry and material of the Bastei PET scanner.
Creation of listmode data streams
Information about the valid coincidences in each decay phase (like creation time tc, decay
time td and coordinates of the positron-electron annihilation as well as the crystal IDs of
the LOR) is collected during the simulation progress. Due to the program structure, the
data set entries are gathered with ascending creation time tc of the nuclides related to the
currently considered raster point. Therefore, after the simulation of the β+-emitter decay
has been completed for all raster points in all energy slices, the data set entries for the
detected coincidences are reordered in each motion phase according to the decay times td.
Generated listmode data words encode the crystal IDs and the beam status (cp. figure 2.9).
The data words of each motion phase are stored as a listmode data stream including time
stamps every 10ms. This allows the same processing by the reconstruction program as for
measured listmode files. Different to measured listmode files, random coincidences during the
beam extraction periods are omitted, since the physical processes leading to the emission of
prompt γ-rays are not included in the simulation software, and neither delayed nor multiple
coincidences are simulated.
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4.2 Verification of the 4D simulation code by means of a
preclinical phantom study
The developed 4D simulation program has been verified by means of a series of test simulations
for a 2D moving β+-emitting source, for artificially simplified and for the real irradiation of
moving phantoms (Menkel 2011). An exemplary experiment with one-dimensional sinusoidal
target motion has been selected to demonstrate the full potential of the 4D simulation code,
namely the simulation of a performed experiment with motion compensated beam delivery
by means of depth-compensated target tracking (Saito et al. 2009; Bert et al. 2010).
4.2.1 Experiment design
Phantom geometry A 100mm×100mm×30mm (x×y×z) PMMA block was positioned
relative to the isocentre and centre in the FOV of the double-head PET scanner. In the beam
direction (x-axis) the isocentre was located 60mm behind the proximal target surface, and in
the y-z plane it was centred in the target. The phantom performed a 1D sinusoidal motion
in y-direction with an amplitude of ±10mm and a period of about 3.5 s. A fixed PMMA
bolus of 7mm depth was placed proximal to the moving phantom at y > 0mm. This means
that in BEV one half of the phantom was covered by the bolus and ions passing the bolus
require a higher energy to deposit their dose at the same depth in the phantom. This geometry
illustrates a simplified model for irradiating a target volume behind tissue of different density,
like treating a compact moving lung tumour behind the almost static ribcage with its bony
ribs and the less dense intercostal spaces. A sketch of the target setup is shown in figure 4.5.
xy
z
Wedge system Bolus Moving target
x
y
Wedge system Bolus Moving target
⊙
z
Figure 4.5: Sketch (not to scale) of the experimental setup in oblique projection (left) and bird’s eye
view (right) with range compensating wedge system, static bolus and the target moving perpendicular
to the beam (red) direction. The blue region indicates the position of the planned target volume.
Dashed lines mark the coordinate system with the isocentre at the origin. By means of an artificial
4D CT image only the bolus and the target are placed in the FOV of the PET scanner.
Scheduled treatment plan To achieve a constant ion range in the phantom, two levels
of 12C ion energies have been used in the treatment plan. The lower level with 294.6AMeV
and 295.7AMeV was used for raster points with negative y-coordinates and the higher level
with 303.1AMeV and 304.2AMeV for those with positive y-coordinates. The Bragg peaks
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are additionally slightly broadened by the 3mm ripple filter in the beamline (Weber and
Kraft 1999). For simplicity and demonstrating basic features, the treatment field created
for the static target consists of only 51 different raster scan coordinates located at isocentre
height (z = 0) on a line segment which proceeds parallel to the y-axis and motion direction
(−25mm ≤ y ≤ 25mm). During 60 rescans in each half (y ≤ 0mm and y > 0mm) a total
number of about 3.96 × 109 particles is delivered to the phantom leading to the creation of
a high number of β+-emitters. Thus, the detection of the emerging annihilation photons
during the spill pauses results in a clear PET signal which is convenient for such fundamental
experiments. For orientation, an estimated mean dose of about 35Gy is deposited within a
total target and bolus volume of about 34 cm3.
Beam delivery and motion mitigation The whole treatment plan is delivered within
24 spills of a nominal duration of 2 s within a 5 s long synchrotron cycle time. To guaranty an
accurate dose deposition in the moving target, the depth-compensating tracking system at
GSI has been used. The lateral target tracking is done by the magnets of the raster scanner
and the required range compensation due to the static bolus geometry by means of the wedge
system. Without range adaptation, the wedges provide a medium water-equivalent thickness
of 92.5mm. If raster points have been planned with the lower energy level but the beam
passes the bolus due to the lateral tracking, the wedges will be opened to provide a reduced
WEPL of about 84mm. On the contrary, if raster points have been planned with the higher
energy level but the beam misses the bolus during the irradiation, the wedges will be closed
to provide an increased WEPL of about 101mm.
4.2.2 4D in-beam PET data simulation
Preparation of input parameters
An artificial 4D CT image has been created with 9 amplitude-sorted motion phases, and
the corresponding transformation information for each voxel was calculated directly from the
well-known geometry and rigid phantom motion. A LUT with entries for all 6120 scheduled
raster scan points has been generated from the recorded motion and nextpoint signals, the
actual beam directions and the changed wedge thickness. A segment of the assembled LUT
is shown in figure 4.6. The information about the current motion phase over time is given
for the 106 s of the motion compensated beam delivery and for additional 5min afterwards
to allow for a simulation of an in-beam and a subsequent decay measurement.
Simulation of 4D listmode data
The described irradiation with depth-compensated target tracking has been simulated. A
section of the resulting count rates of coincidences within the 9 amplitude-sorted listmode
PET data files is shown in figure 4.7. It verifies the correct sorting of coincidences into the 9
motion phase sorted data streams. Only if the target resides in a certain motion phase, a count
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Figure 4.6: Section of the assembled LUT related to the motion surrogate signal for the sinu-
soidal motion (a). The 9 CT image phases (b) are assigned to time throughout the whole measure-
ment according to the detected target amplitude. The acquired beam directions (c) for the shown
718 raster points irradiated with 294.57AMeV during two spills differ from the planned coordinates
(0mm ≤ y ≤ −25mm) due to the lateral tracking of the target motion (dashed line). Almost 28 re-
scans of the line-shaped treatment plan are represented by the zigzag pattern. To perform a range
compensation, the water-equivalent thickness of the wedges (d) is reduced if the beam (partly) passes
the bolus (y > 0mm).
rate larger than 0 will be found in the corresponding listmode file. During the irradiation time
the count rate rises up to an average value of about 120 coincidences per 10ms (which is the
same order of magnitude as for the measured data) and decreases, as expected, continuously
until the end of the simulated measurement time due to the exponential decay of the created
positron emitters.
Regardless of the spill signal, a total amount of 2.9 × 106 valid coincidences occurred
during the simulated time span. However, coincidences detected during the spills have to
be rejected during the reconstruction process for a better comparability between measured
and simulated β+-activity distributions. The reason for that is that measured listmode data
contain a huge number of random coincidences due to the prompt γ-ray emission during the
beam extraction. These random events do not contain valid PET information but exceed the
number of true events by several times. Therefore they are ignored during the reconstruction.
Since processes leading to the emission of prompt γ-rays are not included in the simulation
program, mainly the coincidences emerging from the short living β+-emitters 13O, 12N, 9C
and 8B are affected by the omission of the coincidences detected during spills. The remaining
number of coincidences per motion phase is primarily related to the residence time of the
target within this phase, but it might happen that a motion phase overlaps more often with
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Figure 4.7: Simulated count rates of coincidences in the 9 listmode PET data files (3rd-11th row)
detected by the double-head PET scanner during the irradiation and shortly afterwards. The motion
signal (1st row, red) was used for the identification of the related amplitude-sorted (grey dashed lines)
CT image phase at decay time. The summation of coincidences from all motion phases (2nd row)
shows the target activation during the irradiation with 24 spills (grey). Increased count rates during
the spills correspond to the fast decay of β+-emitters with short half-lives (< 1 s), namely 13O, 12N,
9C and 8B (cp. table 2.2).
spill signals than other phases, and thus a larger fraction of coincidences will be rejected.
Additionally, the amount of coincidences per phase is affected by the interdependency between
the position of the β+-activity within the FOV and the spatially variable solid angle coverage
by the PET scanner. The partitioning of simulated coincidences to the motion phases is
summarized in table 4.2.
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Table 4.2: Amplitude intervals of motion phases, number of simulated coincidences per phase (4th
column), number of coincidences considered for reconstruction (5th column) and the relative amount
of rejected coincidences which occurred during the spill signals (6th column).
Amplitude /mm All Coincidences Rejection rate
Phase min max coincidences out of spill of coincidences
0 −11.25 −8.75 511 065 383 172 25.2%
1 −8.75 −6.25 322 773 244 326 24.3%
2 −6.25 −3.75 256 776 193 255 24.7%
3 −3.75 −1.25 229 039 170 377 25.6%
4 −1.25 1.25 225 709 168 736 25.2%
5 1.25 3.75 238 758 178 461 25.3%
6 3.75 6.25 261 463 194 388 25.7%
7 6.25 8.75 349 707 259 960 25.7%
8 8.75 11.25 487 520 359 769 26.2%
All −11.25 11.25 2 882 810 2 151 444 25.4%
Reconstruction of phase-sorted listmode data and rating the results
It has to be verified that the coincidences are correctly assigned to the 9 motion phases
and that from each phase-sorted listmode data stream an equivalent information about the
induced β+-activity in the target can be deduced. Therefore, the listmode data streams have
been simply reconstructed phase by phase with the 3D MLEM algorithm (cp. section 3.1.1).
For each of the 9 reconstructions an image space of 110 × 80 × 40 cubic voxels with a side
length of 1.6875mm was used. Figure 4.8 depicts the central plane (located symmetrically
between the two detector heads at z = 0) of the β+-activity distributions. It is clearly visible
that the activity appears only in the phantom and the static bolus but not in air-filled space
in between them. The average phantom position is shifted in the y-direction (perpendicular
to the beam direction) from phase to phase as given by the 4D planning CT image. The
generated β+-activity distribution in the middle of the phantom is displaced in the same
way and the steep lateral activity gradients in motion direction are preserved in all phases.
This proves that the lateral target tracking is processed correctly by the simulation code.
Furthermore, the β+-activity maximum in the beam direction (x) is located at the same
depth (x ≈ 0) for all y-coordinates, and thus forms a vertical line in all phases. Since the
range is not affected by the 7mm thick bolus under target motion, the program processes the
information from the wedge system for the range compensation of ions with heterogeneous
energy levels correctly as well.
Profiles parallel to the motion direction (y) and intersecting the high activity region (x = 0,
z = 0) have been extracted from each phase for a more detailed evaluation. The profiles are
shown in figure 4.9. Despite the homogeneous dose deposition, the β+-activity is higher for
smaller y-coordinates than at the side with the static bolus in front of the target. This is
simply caused by the fact that the irradiation was started with the beam delivery to the
negative y-coordinates (no bolus) during the first 12 spills. Thus, the measuring time for
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Figure 4.8: Coloured contour plots of the phase by phase reconstructed β+-activity distributions
for the central plane in the image space (summation over 2 voxel slices near z = 0). The 12C ion
beam impinged on the moving phantom (dashed square changing position in y-direction from phase
to phase) from the left side after it had eventually passed the 7mm thick bolus (dotted rectangle
at y > 0), and it was stopped in the target at isocentre depth (x = 0). While the 5 contour lines
are equally spaced between the minimum and maximum value in each phase, the colour coding is
normalized to the global maximum value of all phases.
annihilation photons emerging from this side of the target is longer than for the other side
where the β+-emitters were generated during the second half of the irradiation. Besides their
asymmetric progression, the profiles show clearly a similar shape for all phases and they are
shifted according to the motion by about 2 − 3mm from phase to phase. A mean FWHM
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Figure 4.9: β+-activity profiles extracted parallel to the motion direction in the phantom at Bragg
peak depth (x = 0) from images in figure 4.8. All profiles are normalized to their own maximum
value. According to the target motion from phase to phase the profiles are shifted in BEV from left
(phase 0) to right (phase 8). For orientation, the position of the static bolus is indicated by the grey
box.
value of 48.7mm with a rather small standard deviation of 0.5mm has been determined
from the 9 profiles. Additionally, the conservation of the lateral activity gradients becomes
manifested when considering the penumbra values and their standard deviations. Due to the
skewness of the profiles, these values have been calculated between 20% and 80% for the left
(y < 0) and between 60% and 10% of the profile maximum at the right slopes (y > 0). Mean
penumbra values with small standard deviation of (6.9± 0.6)mm (y < 0) and (6.2± 0.6)mm
(y > 0) were found, respectively.
4.2.3 Comparison with 3D simulation
Beam delivery by means of correct depth-compensated target tracking generates the same
dose distribution in the target as it can be expected from a static target irradiation. Related
β+-activity distribution are assumed to be almost similar in both cases. To draw final con-
clusions about the correct operation of the 4D simulation program, it needs to be verified
that the obtained results are of similar quality as the results from the 3D simulation program
for static targets and that the high computational effort of using 4D CT images, LUT and
transformation rules is mandatory.
Look-up tables for comparative simulations
Since it has been proven for the 4D simulation in section 4.2.2 that the reconstructed β+-
activity distributions from different motion phases contain similar information, only one (the
4th) of the 9 phases has been selected for the comparison study. For a better comparability,
the 4D simulation has been repeated with the same LUT as in section 4.2.2 but higher
statistics to obtain a similar number of coincidences in the 4th motion phase as in the data to
which it is compared to. This is on the one hand an exact β+-activity distribution which was
calculated by applying the static treatment plan to a fixed and non-elongated target with a
wedge system providing the medium WEPL of 92.5mm. On the other hand, a simulation
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Correct 4D simulation Static irradiation “Uncompensated“ motion
Figure 4.10: Sections of the assembled LUTs for comparative simulations. During correct 4D sim-
ulation (left) the target motion is correctly addressed to the different CT image phases, the raster
scanner follows the lateral target motion and the wedge system performs the correspondingly required
depth compensation. For a static irradiation (middle) the phantom resides in the non-elongated CT
image phase and the scheduled raster point coordinates are delivered without required depth compen-
sation. For an uncompensated-like simulation (right) the relative motion between pencil beam and
target is introduced by considering the recorded raster points of lateral beam tracking to be applied
to a static target. Thus, a relative motion between pencil beam and static bolus is simulated, and
without changes in the wedge thickness, no depth compensation is performed.
is performed which shows that neglecting the relative motion between the pencil beam and
the target as well as ignoring the necessary range compensation causes a clear deterioration
of image quality. To induce the relative motion between the phantom and the beam, the
retrospectively generated treatment file with the measured raster point coordinates from
target tracking has been applied to a fixed and non-elongated target. The LUT contains only
that single CT phase, i.e. no 4D CT image has been considered. Therefore, no transformation
of the β+-emitter coordinates needs to be done. Additionally, the logged changes in the
wedge status have been ignored in the LUT to demonstrate the impact of a missing range
compensation on the resulting β+-activity distribution. Sections of the 3 assembled LUTs
are shown in figure 4.10.
Comparison of simulation results
The reconstruction results from the simulated listmode data for the mid elongation phase
of the correct 4D simulation, for the 3D static reference simulation and for the simulation
without compensation of the ion range and of the relative motion between beam and phantom
are shown in figure 4.11. From a visual survey, it is found that the 4D simulation generates a
distribution of equal shape as the static reference. The width of the distribution in the motion
direction (y) and the width of the high-activity region (x) are conserved. Slight deviations of
absolute values are only visible in the plateau region and in the middle of the high-activity
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Figure 4.11: Reconstructed β+-activity distributions in the midplane of the image space and target.
Results have been obtained from the correct depth-compensated target tracking by the 4D simulation
program in the non-elongated 4th phase similar to that in figure 4.8 but with 2.27× 106 coincidences
(left), from the simulation of a static target irradiation with 2.30×106 obtained coincidences (middle)
and an irradiation without range and motion compensation containing 2.27×106 coincidences (right).
Images are normalized to their own maximum value. The grey lines indicate the position of the
extracted profiles shown in figure 4.12.
region. The result of the uncompensated simulation depicts a clear lateral broadening of the
β+-activity distribution, since there was a relative motion between the pencil beam and the
phantom. The β+-activity at Bragg peak depth (x = 0) in the middle of the target (y ≈ 0)
protrudes slightly to the distal (for y < 0) as well as proximal (for y > 0) direction due to
the missing range compensation.
These findings are also well illustrated by profiles which intersect the target volume longitu-
dinally, parallel to the beam direction and those proceeding parallel to the motion direction
at Bragg peak depth. Figure 4.12 shows the profiles from each of the three distributions.
Longitudinal profiles for voxels with coordinates of y ≈ −4.2mm and y ≈ 4.2mm match
quite well for intervals proximal and distal to the region of the β+-activity peak. Profiles
from uncompensated motion bare a considerably reduced height of the activity peak. An
obvious loss of the steep gradients at the proximal or distal edge of the peak appears with-
out depth compensation, since the beam of higher energy partially misses the bolus and the
beam with the lower energy level might pass the bolus before entering the target. The lateral
profiles for the three simulations do not bare large differences in FWHM values of 49.2mm,
49.3mm and 47.2mm (static reference, 4D simulation and uncompensated motion). How-
ever, the blurring of the lateral activity fall-off for the uncompensated motion simulation is
well reflected by the penumbra values which are increased by more than a factor of two. For
the left slope the penumbra between 20% and 80% of the maximum is raised from 7.1mm
and 6.8mm (4D simulation and static reference) to 15.0mm. Similarly, the penumbra value
for the right slope between 60% and 10% rises from 6.2mm and 6.9mm (4D simulation and
static reference) to 15.9mm.
The comparably larger drop in the middle of the lateral profile from the uncompensated mo-
tion can only be rated under the consideration of the β+-activity smearing in the longitudinal
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Figure 4.12: β+-activity profiles extracted from figure 4.11 which intersect the phantom parallel to
the beam direction for voxels with y-coordinates equal to −4.2mm and 4.2mm (left) and parallel to
the motion direction at the Bragg peak depth (right). Profiles from the 4D simulation show only slight
deviations from the static reference simulation. For the uncompensated motion simulation distinct
deviations are found at the distal (upper left) and proximal (lower left) edges of the peak region as
well as in the middle and the fall-off regions of the lateral profile (right).
direction. Therefore, activity difference images have been calculated. Both the 4D simulated
β+-activity distribution and that from the uncompensated motion simulation are compared
to the static reference distribution by calculating the differences pixel by pixel. Resulting
images are presented in figure 4.13. Difference values for the 4D simulation range between
-0.08 and 0.11, but the image does not show a pronounced pattern. In contrast to that, the
difference image for the uncompensated motion simulation contains values between -0.22 and
0.29 and bares an obvious structure. The dark blue area in the middle (x = 0, y = 0) which
corresponds to the drop in the lateral profile in figure 4.12 as well as the proximal and distal
red spots illustrate the dislocation of the high-activity region due to the influence of missing
range compensation for the bolus when doing lateral tracking. Red and blue stripes at the
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Figure 4.13: Difference images between the β+-activity distributions depicted in figure 4.11. The
images show the absolute deviation for each voxel in the midplane of the 4D simulation result (left)
and the uncompensated motion simulation (right) from the static reference simulation.
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lateral regions are related to the blurred gradients due to the relative motion between pencil
beam and target. The remaining deviations between the reference and 4D simulation might
be ascribed to different origins. First of all, only limited time sections of the whole measure-
ment time are assigned to the 4th phase. These cannot represent the exact development of
the count rate and the β+-activity distribution in time and space, respectively. Secondly,
there are also analogue influences as for the uncompensated simulation, since there is a small
residual motion within the 4D CT image phase. These 2.5mm (cf. table 4.2) are below the
spatial resolution in the midplane of the PET scanner system which is about 5mm due to the
large detector crystals and the double-head geometry (Lauckner 1999). Anyway, the residual
motion might slightly influence the 4D PET images. And thirdly, the observed differences
between the presented β+-activity distributions appear primarily in the target region which is
affected by the rapid transition between bolus and air. This could indicate that the response
time of the wedge system is too long for that density gradient. Fortunately, such sharp edges
occur rarely in patient tissue.
4.3 Summary and discussion
Similar as for IBT-PET dose monitoring in static target volumes, a measured and recon-
structed β+-activity distribution from an intra-fractionally moving target can only be in-
terpreted correctly by the comparison to an expected, simulated distribution. The first
simulation program for the generation of predicted IBT-PET listmode data under the exact
consideration of intra-fractional motion and motion-compensated dose delivery by scanned
ion beams has been developed. Among others, its performance was also validated within the
presented preclinical phantom study including one of the most complex motion mitigated
beam delivery techniques that allows to test the total functionality. Depth-compensated
tracking requires the most complex simulation input. Since the verification can only be done
by analysing the afterwards reconstructed β+-activity distribution high counting statistics
were emulated to reduce additional reconstruction artefacts. To limit the inevitable influ-
ence of the limited solid angle coverage in the reconstructed images, the target volume was
positioned in the midplane of the detector heads. Although the line-shaped geometry of the
target volume is clinically irrelevant, it allowed together with the clear 1D sinusoidal motion
for an explicit assessment of both lateral and distal discrepancies in the β+-activity.
It was clearly demonstrated that the 4D simulation program satisfies the demands of con-
sidering the target motion and motion mitigation. Therefore, in comparison to the clinically
approved 3D IBT-PET simulation program, the presented 4D upgrade requires an additional
set of input data and the handling of the given information. On the one hand, it has been
validated by the comparison to a static reference simulation that this management offers
sufficient accuracy. On the other hand, it was shown by a comparison to a simulation for
uncompensated motion that the additional effort is mandatory. Otherwise a correct dose
monitoring would not be feasible. Besides the 4D planning CT image and the corresponding
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transformation specifications between the single phases, the centrepiece of the input parame-
ters is an individually generated LUT. Its content depends on the applied motion mitigation
technique. In any case the nextpoint signal from each raster point is mandatory and needs
to be synchronized with the motion signal and the CT image phase. For simple rescanning
or for gated irradiation, the treatment plan is delivered without changing the raster scan
coordinates and no further data are required in the LUT. For lateral target tracking, a ret-
rospectively generated treatment plan provides the actually applied raster scan coordinates.
Potentially changed numbers of ions delivered to these raster points are also given in this
retrospective plan and can be used for simulating real-time dose compensation. If range
compensated tracking is performed by means of a fast moving absorber, the LUT will be
extended by the water-equivalent absorber thickness in the beam path.
The 4D IBT-PET simulation program in its current version is feasible or can easily be up-
graded to simulate motion phase sorted listmode data streams from intra-fractionally moving
targets including arbitrary motion patterns, motion-compensated beam delivery with ac-
tively scanned pencil beams of a certain ion species provided by synchrotron or cyclotron
accelerators and considering different PET scanners and IBT-PET modalities:
- It is expected that deformations related to the complex 3D motion patterns found in pa-
tients and including transversal, longitudinal, rotational and deformable motion should
in principle be manageable by means of the transformation matrices (cp. appendix A).
- The POSGEN database for the spatial β+-emitter distribution is currently available for
12C ion beams only. Databases are required for each ion species used for IBT to apply
the 4D simulation program with its current workflow. Since most of the existing ion
beam therapy facilities make use of proton beams (PTCOG 2012), there is an urgent
need for the creation of a proton beam database. Furthermore, databases for larger
pencil-beam widths should be available for gated irradiation to produce simulation
results equivalent to the measured distributions. An artificial beam broadening has
been suggested for that motion mitigation method to generate a larger overlap between
adjacent raster spots and thus to minimize the interplay patterns due to the residual
target motion in the gating window and the beam scanning motion (Bert et al. 2009).
- The implemented usage of the nextpoint signals for the definition of the irradiation
time of each raster point, instead of the spill signals from the synchrotron, makes the
simulation program also applicable for the continuous wave beam delivery by cyclotrons.
These accelerators are much more often in therapeutic use, especially for proton beam
therapy, because of their reliability, relative simplicity, the lower investment costs and
operational expenses.
- According to the used PET scanner, the detector material and the crystal coordinates
defining the valid LORs have to be modified, and the output format of the listmode
data needs to be changed. Up to now, only the double-head in-beam PET scanner
geometry from Bastei at GSI has been considered by the 4D simulation program, but
the implementation of other, mainly full-ring, geometries might be easily possible.
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- The simulation of the different IBT-PET modalities (in-beam, in-room, off-line) is pos-
sible by setting an appropriate maximum value of allowed decay time tmax and selecting
the correct time interval for the data reconstruction. If the patient needs to be moved
prior to an off-line or in-room PET measurement and therefore the motion acquisition
system might be disconnected, it has to be ensured to assemble the total LUT with
an exact temporal relation between the last next point signal, the begin of the motion
acquisition in the PET measurement position and the PET data stream.
A future testing of the simulation program with real patient data is desired. Unfortunately,
until now there are no data available from which a complete LUT could have been created.
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An increased risk for spatial dose misses is expected for the treatment of intra-fractionally
moving tumour volumes because of the continuous density changes in the irradiated tissue
affecting the ion range and because of the more complex beam delivery due to sophisticated
motion mitigation techniques. For static target volumes, the IBT-PET imaging has been
used to detect a potential misdosage by a more or less objective comparison between the
simulated and measured β+-activity distributions (cp. figure 2.10). If deviations are found,
they can normally be addressed to unexpected changes in the anatomical patient geometry or
to positioning uncertainties. In the rare case of serious treatment errors not being excluded
by the therapy control system, IBT-PET for static target volumes will detect an inaccurate
induced β+-activity distribution. Although high standards of quality assurance are available
in clinical environment when applying gated or tracked ion beams to patients, some special
focus was put on the detectability of an imaginable failure of the motion mitigated beam
delivery (Laube et al. 2009a,b). As explained in section 5.1, the interpretation of resulting
β+-activity distributions might become difficult with the conventional comparison of the
results from simulation and measurement. Additionally, a correct correlation between the
motion detection and the listmode PET data stream has to be assured. The impact of a
mismatch between both data streams is shown in section 5.2.
5.1 Detectability of failed motion mitigation
For a safe beam delivery, failures during dose application need to be detected reliably in
real time, especially for the active beam delivery by means of pencil beam scanning. The
beam monitoring with MWPCs has the potential to generate an immediate interrupt of the
treatment if a planned raster point position was missed by the pencil beam. However, for
lateral target tracking another and potentially more complex interlock system is desired,
since the scheduled raster point positions are adapted in real time due to the target motion.
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Consequently, the beam will miss the positions given in the treatment plan if tracking is
performed exactly. Currently, the actually applied beam directions (and the number of
delivered ions) can be monitored but only evaluated retrospectively. For gated irradiation,
the pencil beam positions can be monitored by the MWPCs as it is done for static targets.
As long as there is no real-time correlation between the MWPC signals and the motion
acquisition, an additional system is required that would cause an interlock if a breakdown of
the gating system occurs. An investigation of the detectability of a failed motion mitigation
in the IBT-PET data is presented in the following sections by means of basic experiments.
5.1.1 Failure in gated beam delivery
Experiment description
An experiment with a target geometry (100mm×100mm×30mm PMMA), motion direction
and motion amplitude as described in section 3.3.1 was carried out. The target performed
of a cos2 motion with a maximal elongation of ±10mm perpendicular to the incident beam
direction. Motion compensation was planned to be performed by means of gated beam
delivery using a 10% inhalation gating window. The treatment plan includes ions of two
similar energies to be delivered to a line segment with raster point coordinates between
(0mm,−17mm) and (0mm, 35mm). 60 rescans along that interval have been scheduled for
each energy resulting in 3180 raster points per energy. Considering the mean target elongation
within the gating window the ions are deposited in the middle of the target. According to
the recommendations by Bert et al. (2009) the width of the pencil beam was enlarged for the
gated beam delivery to a FWHM of about 10mm. Acquired in-beam PET data comprise the
time of irradiation and a 5min decay measurement with ongoing target motion.
The progress of the irradiation is documented by the logged motion, gating and spill signals
which are illustrated in figure 5.1. Motion mitigated beam delivery was performed correctly
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Figure 5.1: Documentation of the gated irradiation by means of the gating signals related to the
target elongation and the spill signals. The beam is delivered when spill and gating signal overlap.
Since there was a hang-up of the gating sensor after approximately 125 s (16 spills) the irradiation
proceeded irrespective of the motion signal.
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for the first energy slice (spill 1 to 12), i.e. the target was just then irradiated when both
gating and spill signal overlapped. Due to the fact that the gating sensor went out of operation
after circa 650 raster points in the second energy slice, the remaining ions have been delivered
irrespective of the actual target position.
Comparison between measured and simulated β+-activity distribution
Actually, deviations from the planned dose distribution should be assessable by a comparison
between measured and simulated β+-activity distribution (cp. figure 2.10). Thus, a LUT
for the 4D simulation program was generated from the logged motion signal, raster scan
coordinates and nextpoint signals and it was used for the calculation of predicted PET data.
Both measured and simulated listmode data streams have been reconstructed by the 4D
MLEM algorithm using 9 amplitude-sorted motion phases. To illustrate the expected shape of
the initially planned β+-activity distribution for correct motion mitigation, a second listmode
data stream was simulated. The scheduled raster points with the logged nextpoint signals
and a static target with elongation according to the gating window have been assumed for
generating the corresponding LUT. Data have been reconstructed by a 3D MLEM algorithm,
and the resulting β+-activity distribution was transformed into the reference position with
target at mid elongation.
A comparison between the measured and the two simulated β+-activity distributions re-
constructed for an arbitrary time interval in the decay measurement (100–300 s after the end
of the irradiation) is presented in figure 5.2. The smaller peak-plateau activity ratio in the
simulated distributions should be neglected here. Too many 10C and 11C target fragments
are simulated in the entrance channel. This is an inherent characteristic of the utilized POS-
GEN database which has already been verified by Priegnitz (2012). However, the distal peak
position, relevant for range verification, matches exactly between simulated and measured
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Figure 5.2: Measured (left) and simulated (middle) β+-activity distribution with approximately
the same lateral width and position in the target for the inaccurate gated beam delivery (incident
particles from the left). A simulated static target where the incident beam matches the scheduled
lateral positions for all raster points results in a more confined β+-activity distribution and a better
homogeneity in the peak region (right). Horizontal grey lines indicate the planned lateral field width
and help to guide the eye. Vertical black lines mark the extracted profiles shown in figure 5.3.
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Figure 5.3: Lateral profiles parallel to the motion direction and intersecting the peak region as indi-
cated in the β+-activity distributions in figure 5.2. Results from measurement (black) and simulation
(red) with failed gating show similar shifted position and skewness while the profile from the static
simulation (green) is almost centred in the target and has symmetric, steep gradients. Profiles are
normalized to their maximum value.
β+-activities. The β+-activity distributions from the inaccurately gated treatment exhibit
a pronounced blurring in motion direction, particularly at positive y-coordinates. Blurring
seems to be of similar amount in measured and simulated results, especially when taking the
different pencil beam widths into account. Solely for the static simulation, the β+-activity
is confined to the planned target region and the homogeneity in the peak area is consider-
ably improved. These findings are also clearly validated by the extracted profiles shown in
figure 5.3. The expected symmetric box shape with steep gradients is reproduced by the
static simulation. The two profiles from the inaccurate gating are modified in the same way.
Their skewness can be understood as a superposition of a box-shaped profile from the fraction
delivered with correct gating and the symmetric blurring from the cos2 motion with shifted
centre of mass from the second fraction with failed gating.
Conclusion
The presented experiment demonstrates that treatment errors related to deficient motion
mitigation cannot reliably be discovered by IBT-PET using the hitherto existing workflow.
A comparison between a measured and simulated β+-activity distribution is insufficient for
such cases since the information about the actual beam delivery serves directly as input
for the LUT used in the 4D simulation. Thus, treatment errors are also reproduced by
the simulation. Remedy could be provided by means of an additional simulation where the
scheduled treatment plan is delivered to the static target volume under consideration of the
real time structure given by the nextpoint signals.
5.1.2 Failure in lateral target tracking
Systematic experiments have been carried out to investigate the detectability of a failed
lateral target tracking. Two different types of failures have been imitated:
- a breakdown of the tracking system leading to an uncompensated beam delivery and
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- a worst case scenario of a phase-shifted tracking, i.e. the pencil beam is (according to
a sign error) compensated to the opposite direction than the target is elongated.
To potentially confirm the failed motion compensation, the measured β+-activity distribu-
tions are compared to a static reference measurement within this experiment campaign.
Target geometries and treatment plans
Different to the experiment presented in the previous section for the failed gating, special
target geometries have been designed to allow for an immediate visualization of potential
failures in the tracking process for the 20mm peak-to-peak cos2 motion. The main difference
is the reduced lateral target size. The line-shaped treatment plans were adapted to fit almost
exactly into the target under consideration of the finite pencil beam width. Due to the
omitted lateral target margins, the beam will partly miss the phantom if lateral tracking is
performed inaccurately. A second phantom of suitable size is positioned in the FOV of the
PET scanner and is utilized to absorb the ions which miss the target. A related β+-activity
distribution is then generated in this second phantom.
In a first experiment setup a moving PMMA target of 80mm× 50mm× 47mmwas planned
to be irradiated with a laterally tracked 12C pencil beam. The treatment plan includes 60
rescans along a line segment between the lateral coordinates of −22mm and 22mm. A sec-
ond PMMA block (called stopper in this experiments) of 100mm× 100mm× 30mm was
positioned distal to the target and remained in its static position. An image of the motion
table enabling the relative motion between the two phantoms and showing their position-
ing is given in figure C.5 (page 119). This setup is a rough approximation to anatomical
characteristics when compact NSCLCs move inside the lungs which are simply replaced by
air in this experiment. A mismatch between tumour position and ion beam should lead to
a considerable overshoot in the less dense surrounding lung tissue and to the generation of
β+-emitters in the distal thoracic wall.
To include the imitation of the adjacent and also moving but less dense lung tissue a
second phantom geometry was designed which is shown in figure 5.4. The target consists of a
graphite cuboid of 92mm× 40mm× 30mm where the carbon ion beam of about 313AMeV
Figure 5.4: Inhomogeneous phantom composed of a graphite target (black) and laterally attached
PE stoppers (white). Dimensions are given in mm. The phantom is moved parallel to the y-direction
while the pencil beam impinges parallel to the x-axis.
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is stopped after having passed the 80mm thick PMMA wedges for a potential distal tracking.
According to the target width of 40mm, the treatment plan includes only lateral raster scan
coordinates between −17mm and 17mm which have been scheduled to be rescanned 60
times. Ions missing the graphite target are stopped in the laterally attached and also moving
polyethylene (PE) phantoms of 148mm× 40mm× 30mm. The related β+-activity peak is
formed at a larger depth than in the graphite target due to the lower density of PE.
Interpretation of reconstructed β+-activity distributions
For both target geometries 4 different experiments have been performed. The treatment plan
was once delivered to the static phantoms. A measurement with correct tracking demon-
strates that similar confined β+-activity distributions can be generated under target motion.
Failures in the tracking system have been emulated by omitting the tracking at all and by
performing a phase-shifted tracking with an offset of 180◦. Images were reconstructed by
the 4D MLEM algorithm with 9 amplitude-sorted motion phases and using IBT-PET data
acquired during the irradiation and within the next 300 s with ongoing target motion.
Relative motion of homogeneous PMMA phantoms Results for the PMMA targets
are summarized in figure 5.5. The β+-activity is mainly concentrated in the small (moving)
proximal PMMA phantom. For the irradiation with static target and for the correct tracking,
v
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Figure 5.5: Reconstructed β+-activity distributions in the PMMA target (left dashed contour) and
the PMMA stopper (right dashed contour) for the different irradiation scenarios. Images are summed
over 10 voxels in z-direction and scaled to their individual maximum. Profiles extracted parallel to
the motion direction (y-axis) and shown in figure 5.6 are indicated by vertical grey lines.
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Figure 5.6: β+-activity profiles intersecting the PMMA target (dashed) and PMMA stopper (solid)
parallel to the motion direction extracted from the distributions shown in figure 5.5. Profiles have
been calculated as a summation over 8 voxels in x- and 10 voxels in z-direction and are scaled to the
maximum value in the target.
there appears only a small amount of background β+-activity in the stopper generated by
light projectile fragments that may escape the phantom. Without lateral tracking, a certain
amount of the delivered ions misses the moving phantom and penetrates the stopper at
the more lateral segments which are temporarily not covered by the moving phantom. In
this case, the β+-activity is formed in the stopper just directly behind the target. In the
worst case of phase-shifted tracking, the β+-activity spots in the stopper are also spread
to positions lateral to the mid-elongated target. Their lateral size as well as their relative
activity values are almost doubled in comparison to the experiment without any tracking.
With increasing amount of β+-activity in the stopper, the lateral gradients of the β+-activity
in the target phantom are getting smaller. Profiles proceeding parallel to the motion direction
and intersecting the high activity regions near the Bragg peak in the target and stopper are
plotted in figure 5.6 and illustrate the discussed characteristics. The presented β+-activity
distributions can also be differentiated on a more quantitative scale by e.g. comparing several
properties of the profiles as given in table 5.1. Especially the NRMSE values of the stopper
profiles are extremely large for the deficient tracking scenarios and the width of the profile
in the target is considerably reduced.
Table 5.1: Comparison of several properties of the profiles shown in figure 5.6. The NRMSEs relative
to the profiles of the static reference were calculated according to (3.9). Width80% denotes the full
width of the target profiles at 80% of their maximum value and Max the maximum value of the stopper
profile relative to the maximum of the corresponding target profile.
Target Stopper
NRMSE Width80% NRMSE Max
Static — 37.8mm — 0.11
Correct tracking 1.3% 37.8mm 8.6% 0.12
No tracking 5.9% 30.1mm 60.3% 0.26
Phase-shifted tracking 9.5% 21.0mm 134.6% 0.47
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Graphite-PE phantom Similar clear results have been obtained from the experiments
utilizing the graphite-PE phantom. Figure 5.7 displays the reconstructed β+-activity distri-
butions in the phantom for the different irradiation scenarios. Measurements from the static
reference and the correct tracking match again quite well. The β+-activity is limited to the
graphite target. Without tracking the lateral activity gradients are decreased in the graphite
phantom and an additional small amount of β+-activity is found in the adjacent PE stoppers.
For phase-shifted tracking, the induced activity region in the whole phantom is almost dou-
bled in lateral size in comparison to the static reference. Related to the peak-to-peak motion
amplitude, a considerable amount of β+-activity is induced in the PE stoppers on a lateral
scale of up to 20mm. Profiles intersecting the high β+-activity regions near the Bragg peak
position in the target and stoppers have been extracted from the four measurements and are
shown in figure 5.8. Some selected properties of these profiles are summarized in table 5.2.
Like for the PMMA stopper in the previous experiment, the NRMSEs in the PE stoppers are
a clear indicator for the deficient motion compensation. The maximum value in a stopper
profile relative to the corresponding one in the target has only a limited significance when
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Figure 5.7: Measured β+-activity distributions in the graphite target (dashed mid rectangle) and the
adjacent PE stoppers (upper and lower dashed rectangles). Images are formed by the summation over
10 voxels slices in z-direction and are scaled to their individual maximum value. Extracted profiles
shown in figure 5.8 are indicated by vertical grey lines intersecting the high activity regions in the
graphit target and PE stoppers.
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Figure 5.8: β+-activity profiles extracted from the four distributions shown in figure 5.7. The profiles
intersect the graphite phantom (dashed) or the PE stoppers (solid) parallel to the motion direction
and have been calculated as summation of 8 voxels in x- and 10 voxels in z-direction. The target and
the stopper profile of one measurement are scaled to their common maximum value.
Table 5.2: Comparison of some properties of the profiles shown in figure 5.8. The NRMSEs relative
to the profiles of the static reference were calculated according to (3.9). Width80% denotes the full
width of the target profiles at 80% of their maximum value and Max the maximum value of the stopper
profile relative to the activity maximum in the corresponding target profile.
Target Stopper
NRMSE Width80% NRMSE Max
Static — 27.1mm — 0.17
Correct tracking 1.4% 27.9mm 2.3% 0.17
No tracking 4.6% 20.8mm 27.9% 0.22
Phase-shifted tracking 11.6% 26.0mm 94.4% 0.47
interpreting the results related to the failed tracking scenarios, since β+-emitter yields are
unequal in the different materials (Priegnitz et al. 2012).
Discussion
Similar as presented for the failure in the gated beam delivery, the deficient tracking is only
reliably detectable if the resulting β+-activity distribution is compared to a static reference.
For real patient treatments, the static reference distribution needs to be created by means of
a simulation as it was shown in section 5.1.1. Due to the steep density gradients in the thorax
region, particle ranges might be strongly affected if deviations from the planned conditions
occure. Thus, an incorrect dose delivery is expected to be discovered when the measured
β+-activity distribution is compared to the simulated static reference.
Although the differences in the β+-activity distributions of the performed experiments are
obvious to the observer, the (semi-) automatic range comparison algorithm by Helmbrecht
et al. (2012) fails to detect them. The reason for that is plausible. For the additional lateral
activity related to a failed lateral target tracking, there is no relevant amount of activity at
the same position in the reference distribution to which the measured one could be compared
to. The same holds true for each comparison between a confined β+-activity distribution with
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steep gradients and a laterally smeared β+-activity distribution, which might be related to an
incorrect motion mitigation or a deficient data handling prior the reconstruction process. In
all cases, the algorithm would not raise any alarm, but this is highly appreciated. Similarly,
the amount of activity found in the PMMA stopper directly behind the target might be
too low in comparison to the target activity to be considered for the definition of the distal
β+-activity fall-off within the individual profiles. Furthermore, even if the deviations would
have been identified by a certain algorithm, it might become difficult to assign them to their
actual origin, because there are more degrees of freedom when motion is taken into account.
For instance, a β+-activity located distal to (behind) the planned target volume could arise
from the failed lateral tracking as illustrated by the PMMA target and stopper geometry, but
a tumour shrinkage might also lead to a relevant amount of β+-activity distal to the planned
target volume.
The presented experiments without tracking have also clearly demonstrated the drawback
of solely using the rescanning technique for motion mitigation under active beam delivery.
Additional safety margins are required in the treatment plan, and a misplaced dose at the
outer parts of the treatment field has to be accepted when trying to homogenize the dose
inside the target volume.
5.2 Deficient correlation between motion and PET data
The occurrence of blurred β+-activity distributions is not solely an indication for an inac-
curate motion mitigation. Physiological processes like the biological washout that might be
another possible origin for an additional smearing of the β+-activity should also be neglected
in the following examination. An incorrect consideration of the intra-fractional target motion
might also have a strong influence on the blurring in the reconstructed image. There are two
main tasks to be fulfilled prior to the actual 4D IBT-PET data reconstruction to realize a
successful motion handling:
- the extraction of the real, complex motion patterns and the related creation of the cor-
responding transformation matrices and attenuation corrections from the 4D planning
CT image and
- the assignment of the PET listmode data to the correct motion phases by means of a
suitable surrogate signal.
For the first task there exist several commercial and open source software packages which
enable a suitable handling of 4D patient CT images. The second task demands a time
correlation between both data streams. At the experimental in-beam PET facility at GSI,
there does not exist any dedicated hardware module for the combination of both data streams.
Instead, the synchronisation had to be done manually as described in appendix D. As shown
below, a slight delay in one signal branch, which might also occur at a commercial system,
can seriously influence the image quality.
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Figure 5.9: Section of the cos2 (left) and cos4 (right) motion signal of the moving point source and
its shifting ∆t by up to 300ms in time to induce a slightly incorrect correlation with the listmode
PET data.
Systematic point source experiment
The consequences of a deficient correlation between the motion information and the listmode
PET data stream was systematically analysed by means of a moving 22Na point source of
945 kBq. Its 1D motion pattern was either of cos2 and cos4 shape with a peak-to-peak ampli-
tude of 20mm and a period time of 4 s. The listmode PET data and the motion information
had been recorded simultaneously by the different data acquisition systems and both data
streams were synchronized afterwards. The motion information was artificially shifted by
multiples of 50ms to induce a delay ∆t relative to the original data stream as it is illus-
trated in figure 5.9. The PET listmode data have been divided into 9 amplitude-sorted and
time-sorted motion phases, each according to the time-shifted motion information and were
reconstructed by the 4D MLEM algorithm. The results from the amplitude-sorted listmode
data are visualized in figure 5.10. The blurring of the β+-activity distributions parallel to
the motion direction increases with rising time delay ∆t while delays with up to 100ms seem
to be tolerable. The specific influence of the asymmetric cos4 motion becomes already vis-
ible in the reconstructed β+-activity distribution for ∆t ≥ 250ms which corresponds to a
period fraction of 6.25%. The blurring effect is quantified in table 5.3 by the ratio of the
FWTM values, similar as it was introduced in section 3.2.2. For measurements including
the asymmetric cos4 motion with the larger gradients in the motion curve, the β+-activity
distributions are more affected by the incorrect correlation than those from the cos2 motion.
If time-sorted motion phases are used, an incorrect correlation between the motion and the
PET data by about 100ms (2.5% of the motion period) will already lead to a FWTM ratio
above 1.1, since there remains even for the correct correlation an increased motion influence
after the reconstruction in comparison to the amplitude-sorted motion phases (cp. figure 3.14
and 3.15).
Discussion
For the temporal correlation between the motion and PET data, it is not reasonable to state
a tolerable inaccuracy in terms of an absolute time offset. The influence of an deficient
correlation onto the final β+-activity distribution depends on several motion parameters
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Figure 5.10: Reconstructed β+-activity distributions of the 22Na point source performing a cos2-
(top) or cos4-shaped (bottom) motion. An increasing (from left to right) time offset of 0ms to 300ms
was added to the corresponding motion signal before sorting the listmode data into the 9 amplitude-
sorted motion phases. The according blurring in the motion direction (y) is quantified by the ratio of
the FWTM values of the distribution (FWTMy/FWTMx) which is given in the lower right corner.
like the peak-to-peak amplitude, the period time and the exact motion pattern with all
irregularities. These parameters determine the gradients in the motion curve and thus the
absolute deviation in elongation for a certain time delay. The amount of coincidences that
is sorted into wrong motion phases and the absolute difference in the transformation vectors
for the correct and wrong motion phase determine the blurring in the final image. Also the
Table 5.3: FWTM ratios (FWTMy/FWTMx) for β+-activity distributions of the point source that
have been reconstructed with 9 amplitude- or time-sorted motion phases. Listmode PET data were
assigned to these phases according to the cos2- or cos4-shaped motion signal which was delayed relative
to the exact synchronized motion signal by ∆t.
∆t: 0ms 50ms 100ms 150ms 200ms 250ms 300ms
9 amplitude-sorted motion phases
cos2 motion: 1.02 1.03 1.04 1.12 1.24 1.49 1.68
cos4 motion: 1.06 1.08 1.10 1.22 1.50 1.71 1.92
9 time-sorted motion phases
cos2 motion: 1.05 1.06 1.11 1.17 1.29 1.41 1.62
cos4 motion: 1.07 1.08 1.12 1.25 1.36 1.54 1.79
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inaccurate attenuation correction for coincidences that are sorted into a wrong motion phase
influence the result but should be of minor importance.
The examined tolerance for a wrong temporal correlation between the PET and motion
data of more than 50ms seems to be fairly high. However, the limited accuracy for real-
time tumour motion detection and the related unavoidable mis-sorting of coincidences into
motion phases strengthen clearly the aim to aspire the best achievable accuracy in signal
correlation. The verification of the correct correlation is desired when evaluating 4D IBT-
PET data of patients. A quite simple and effective method would be the attachment of
a point source with low β+-activity to the moving body surface. The source activity can
only be reproduced as a circular-shaped β+-activity in the reconstructed image if there is
a correct motion correlation. Otherwise, a data reconstruction in small intervals of a few
ten milliseconds and the subsequent fit of the source position could be used to extract the
immanent motion signal. However, such a usage of a radioactive source is debatable due to
the additional radiation exposure to the patient. The correct correlation between the PET
and motion acquisition systems should at least be verified with the presented point source
method as one part of the daily routine checks.
5.3 Recommendations for the 4D IBT-PET workflow
A suitable workflow based on the comparison between a measured and an expected, sim-
ulated β+-activity distribution (cp. figure 2.10) had been developed and was successfully
applied under clinical conditions for the examination of IBT-PET data taken from static and
well fixated target volumes (Enghardt et al. 2004a). An ingenious algorithm (Helmbrecht
et al. 2012) allows to semi-automatically identify and quantify local deviations between the
two distributions by comparing their 1D profiles parallel to the beam direction. Mismatches
between the two distributions are typically related to anatomical changes during the frac-
tionated therapy. Such a hypothesis can be verified by an according CT image modification
and recalculation of the β+-activity distribution (Parodi and Enghardt 2002; Parodi 2004).
The same workflow but with adapted an 4D reconstruction algorithm (cp. section 3) and a
4D simulation program (cp. section 4) is intended to be applied for intra-fractionally moving
targets. However, within the previous sections it was demonstrated by dedicated experiments
that special circumstances could result in a misleading interpretation of the 4D IBT-PET
data.
- A similar shape may appear in the measured and simulated β+-activity distribution
although a crucial error occurred within the motion mitigation (cp. section 5.1.1). A
potential failure in the dose delivery is reproduced by the simulation software due to
the direct incorporation of the beam monitoring information in the simulation input
parameters.
- Deviations between the two β+-activity distributions may occur like e.g. shown in sec-
tion 5.1.2, but they are not detectable by the comparison algorithm planned to be used
105
5 Interpretation of 4D IBT-PET data with respect to deficient motion mitigation or
data processing
for semi-automatic evaluation. This would always be the case if one of the distributions
is prolonged in a direction perpendicular to the incident beam. Since the predominant
motion direction in the thoracic and abdominal region is in cranio-caudal direction,
a blurring perpendicular to the incident beam direction is more likely than in paral-
lel direction and might be caused by a deficient motion compensation or insufficient
reconstruction accuracy.
- Blurred β+-activity distributions might be generated from the measured 4D IBT-PET
data after a deficient motion correlation (cp. section 5.2). The simulation would not
reproduce such a blurring as long as the motion mitigation worked well and the next-
point data are correlated correctly with the motion information. Consequently, the
attempt to explain this detectable deviation between the two distributions by unex-
pected anatomical changes and related CT image modifications will fail.
The following briefly summarized suggestions and recommendations may prevent the ob-
server from a mis-interpretation of the 4D IBT-PET data.
1. Perform a consistency check of the input parameters under consideration of the applied
motion mitigation technique when creating the LUT for the simulation program. For
a gated beam delivery this could e.g. be an examination whether the nextpoint signals
have only been acquired at certain motion states of the target.
2. Perform an additional simulation of the beam delivery with original rasterpoint co-
ordinates delivered to the static target (i.e. to the CT image phase that belongs to
the treatment plan) under consideration of the the actual time structure of the treat-
ment progress given by the recorded nextpoint signals. This results in a β+-activity
distribution with intended ranges and lateral dimension.
3. Compare the measured β+-activity distribution not only to the simulated distributions
but also to those acquired from previous fractions. It is unlikely that the same motion
mitigation errors are reproduced twice in a similar way.
4. The results of the comparison algorithm should be rated critically. A declaration of no
objection might also be related to the fact that certain activity is only found in one of
the two distributions. Make also use of more intuitive comparison algorithms like the
calculation of difference images (as shown in figure 4.13) from the simulated and mea-
sured β+-activity distribution to ensure a more reliable statement for the comparison
of the field edges.
5. If possible, apply the range verification algorithm to 1D profiles which are almost par-
allel to the predominant motion direction.
6. Evaluate other comparison algorithms, like that from Kuess et al. (2012), with respect
to their applicability to 4D IBT-PET data, i.e. whether they can detect the differences
between the measured and simulated distributions which are not accessible by the
algorithm of Helmbrecht et al. (2012).
7. Ensure a correct correlation between the listmode PET data and the motion data by
at least daily routine checks. The benefit from the inclusion of an immanent motion
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signal into the PET data by means of a point source of low β+-activity attached to the
patient surface should be tested if the additional radiation exposure is justifiable.
8. By means of dedicated hardware changes in accordance with the Medical Devices Act
the motion information could directly be included into the listmode data stream. A
certain free bit in the listmode words could be used to switch between encoding coin-
cidences or motion information, similar as it is done for the timewords (cp. figure 2.9).
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6 Summary and outlook
IBT is a promising treatment option for radio-resistant tumours and those in close vicinity
to OARs. The inverse depth-dose profiles of ion beams with the tunable Bragg peak position
in the tissue allow for tumour conformal dose distributions. This enables a potential dose
escalation in the tumour volume under simultaneous sparing of the surrounding normal tissue.
Often occurring cancer types with high fatality rates like NSCLC or hepatocellular carcinoma
could most effectively benefit from the potential dose escalation. Such target volumes in
the thorax and upper abdominal region undergo intra-fractional motion, mainly related to
respiration. Since the particle range in the patient depends strongly on the composition and
density of the penetrated tissue and this tissue might undergo continuous density changes
during a breathing cycle, IBT becomes prone to misdosage when treating intra-fractionally
moving targets. Thus, an exact dose delivery demands high standards for quality assurance.
These include reliable motion monitoring and mitigation techniques, but also a non-invasive
dose monitoring system is highly desired.
The positron emission tomography, which can be performed as in-beam, in-room or off-
line measurement, is the only non-invasive, in vivo and in situ method for an indirect dose
monitoring that has been applied under clinical conditions so far. For static tumour entities
treated at the former medical beamline at GSI, a suitable IBT-PET workflow was devel-
oped which is mainly based on the comparison between the measured, radiation induced
β+-activity distribution in the patient and another one that is predicted by a Monte-Carlo
simulation. Within this thesis, an upgrade of both the reconstruction of the 3D β+-activity
distribution and the simulation of the adequate PET listmode data stream was realized for
intra-fractionally moving targets. The performance of the newly implemented 4D reconstruc-
tion and simulation algorithms was evaluated in detail by means of extensive measurement
campaigns with moving radioactive sources and irradiated phantoms as well as accompanying
simulation studies.
For the reconstruction of IBT-PET data taken from moving target structures, a 4D MLEM
and a gated co-registration algorithm have been implemented taking into account the spe-
cial geometry of the double-head PET scanner Bastei. With analogue computing time and
under similar operation expense, i.e. the generation of motion phase sorted listmode data,
related attenuation and scatter corrections and transformation matrices, it was shown in a
simulation study that the 4D MLEM outperforms the gated co-registration method in terms
of generating better local contrast recoveries. The general applicability of the algorithm for
different motion patterns was demonstrated by the successful reduction and disappearance of
the motion influence in the reconstructed β+-activity distributions from moving radioactive
sources. For 1D cos2 and cos4 motion with certain peak-to-peak amplitudes, it was clearly
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illustrated by systematic point source measurements that the motion influence can be more
effectively reduced with the same number of motion phases if amplitude-sorted phases are
applied. Additionally, it was revealed that the reduction of motion related activity blurring
is mainly dependent on the mean residual motion, which is a quantity that combines the
dependence on the peak-to-peak amplitude, the asymmetry of the real motion pattern, the
number of applied motion phases and the method of motion phase sorting. Choosing param-
eters to obtain a mean residual motion of about half of a PET crystal size was found to be a
worthwhile thumb rule to achieve acceptable results. Furthermore and most importantly, it
has been demonstrated from measurements with moving PMMA targets of dedicated geome-
tries and which had been irradiated using several motion mitigation techniques that relevant
characteristics of the induced β+-activity distributions are reproduced correctly after a 4D
MLEM reconstruction. These are in particular the lateral field position and gradients as well
as the particle range. They can also be deduced with a sufficient accuracy if only a reduced
and clinically relevant counting statistic is available.
Within a second part of the thesis, the first simulation algorithm for the calculation of
motion phase sorted listmode PET data has been implemented. By means of the correct
processing of a variety of additional input information in comparison to the program for static
targets, it is capable to simulate all available motion mitigation techniques, the creation and
decay of β+-emitters at motion-dependent positions and finally the scanner-specific listmode
data streams. The proper functionality of the 4D simulation software was verified in a detailed
phantom study including the sophisticated motion mitigation by depth-compensated tracking.
In summary, this thesis contributes on a large scale to a potential future application of the
IBT-PET dose monitoring for intra-fractionally moving targets by providing the required al-
gorithms for the β+-activity reconstruction and simulation. Both algorithms are mandatory
to apply afterwards the approved comparison method for the interpretation of the 4D IBT-
PET data. However, selected and well-designed experiments were presented which demon-
strated impressively that under certain circumstances the comparison might result in wrong
or at least misleading conclusions. Appropriate recommendations for an adapted evaluation
procedure were given in the thesis.
Except for one experiment with rotational movement, the investigated motion patterns in
this thesis were restricted to 1D cos2 and cos4 functions without any irregularity. Systematic
examinations of the achievable accuracy in the reconstructed β+-activity distributions from
more realistic, multi-directional motion patterns including several irregularities should be
one of the next objectives for improving the 4D IBT-PET dose monitoring. Especially, the
quantification of the influence of an imprecise motion detection on the reconstruction and
simulation results is of high priority, since the assessment of the exact tumour motion in real
time, its matching with the 4D planning CT image and the performance of a correct motion
compensation will be one of the main challenges in the future when delivering ion beams to
moving targets. Finally, 4D IBT-PET investigations incorporating real treatment plans, 4D
patient CT images and breathing curves are desired to rate the expectable benefit from a 4D
IBT-PET dose monitoring.
110
7 Appendix
Contents
A Transformation matrices . . . . . . . . . . . . . . . . . . . . . . . . 111
A.1 Composition of transformation matrices . . . . . . . . . . . . . . . . 111
A.2 Storage of transformation matrices . . . . . . . . . . . . . . . . . . . 113
A.3 Transformation matrices for rotation . . . . . . . . . . . . . . . . . . 114
B Noise reduction in analogue signals by FFT-based filtering . . . 114
C Motion tables and corresponding motion patterns . . . . . . . . . 116
C.1 Rotational motion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
C.2 Motion table with stepping motor for precise 1D motion patterns . . 117
C.3 Motion table enabling relative target movement . . . . . . . . . . . . 119
D Synchronisation of PET, motion and beam monitoring data . . 120
E Sorting PET data by time or amplitude and calculating corre-
sponding mean offsets . . . . . . . . . . . . . . . . . . . . . . . . . . 121
A Transformation matrices
A.1 Composition of transformation matrices
In general, β+-activity images comprising Nx × Ny × Nz voxels are handled as 1D vectors
with Nvox elements when calculating the transformed images. Voxels with static set-up
components remain at their position under transformation and those belonging to a movable
part are partitioned into the different voxels that intersect the transformed voxel volume.
The element dij of an Nvox×Nvox transformation matrix denotes the fraction of voxel j that
is transformed into voxel i.
The following examples illustrate the composition of transformation matrices in a fictitious
2D image space consisting of 9 voxels (pixels) of which the 2 coloured ones belong to a moving
structure that undergoes a rigid transformation indicated by the coloured arrows.
• Static image space:
1 2 3
4 5 6
7 8 9
⇒

1 0 0 0 0 0 0 0 0
0 1 0 0 0 0 0 0 0
0 0 1 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0
0 0 0 0 1 0 0 0 0
0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 1 0 0
0 0 0 0 0 0 0 1 0
0 0 0 0 0 0 0 0 1

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• Shifting by an integer number of voxels parallel to axis:
1 2 3
4 5 6
7 8 9
⇒

1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0
0 0 0 0 1 0 0 0 0
0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 1 0 0
0 1 0 0 0 0 0 1 0
0 0 1 0 0 0 0 0 1

• Shifting by an arbitrary number of voxels parallel to axis:
1 2 3
4 5 6
7 8 9
⇒

1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0
0 0.7 0 0 1 0 0 0 0
0 0 0.7 0 0 1 0 0 0
0 0 0 0 0 0 1 0 0
0 0.3 0 0 0 0 0 1 0
0 0 0.3 0 0 0 0 0 1

• Shifting by an arbitrary number of voxels in an arbitrary direction:
1 2 3
4 5 6
7 8 9
⇒

1 0.28 0 0 0 0 0 0 0
0 0.12 0.28 0 0 0 0 0 0
0 0 0.12 0 0 0 0 0 0
0 0.42 0 1 0 0 0 0 0
0 0.18 0.48 0 1 0 0 0 0
0 0 0.18 0 0 1 0 0 0
0 0 0 0 0 0 1 0 0
0 0 0 0 0 0 0 1 0
0 0 0 0 0 0 0 0 1

By this geometrical approach of overlapping volumes, even arbitrary non-rigid transfor-
mations are feasible. The third case (shifting by an arbitrary number of voxels parallel to
axis) is relevant for the investigated experimental setups with 1D motion patterns where the
targets move parallel to the y-direction.
Basically, for voxels filled with air no reason exists to shift them. They shouldn’t contain
a considerable amount of β+-activity. However, they might do in regions close to volumes
with a high β+-activity because of the partial volume effect due to limited spatial resolution.
To conserve the lateral gradients of the β+-activity in the phantoms, it has been decided to
shift all voxels in the image space positioned laterally to the moving targets. This is feasible
for the performed experiments, since there is nothing else than air and the motion platform
which is transformed anyway. For a potential application of the 4D MLEM algorithm to
patient data, one has to look carefully at the transformation matrices and transition maps
created from 4D CT scans. The consequences for shifting also the adjacent voxels by the
transformation matrix for the fictitious 2D image space are shown below:
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1 2 3
4 5 6
7 8 9
⇒

1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0
0 0.7 0 0 0 0 0 0 0
0 0 0.7 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0
0 0.3 0 0 0.7 0 0 0 0
0 0 0.3 0 0 0.7 0 0 0

Whole voxels (8th and 9th) or parts of them (5th and 6th) are positioned outside of the field
of view while other voxels are empty after transformation (2nd and 3rd). These voxels are
located at the peripheral areas of the image space. One has to make sure that the image
space is large enough to keep those voxels far away from the regions of high β+-activity. The
empty voxels might additionally be compensated by out-of-FOV corrections (Langner et al.
2008).
A.2 Storage of transformation matrices
The size of the transformation matrix is defined by the image space consisting of Nvox =
Nx ×Ny ×Nz voxels. Each voxel has the possibility to be (partly) transformed into one of
these voxels. This results in transformation matrices with a dimension of Nvox ×Nvox. Most
of the matrix values are equal to zero, since a single voxel can only be split up into a limited
number of voxels. For rigid translation where the voxel shape and volume is conserved under
transformation a maximum number of 8 matrix elements per column have a non-zero value.
There exist many methods for storing those large-scale sparse matrices (Barrett et al. 1994).
Computer memory is effectively used by storing non-zero matrix elements only. The simplest
way is saving the matrix in triplet form. A non-zero matrix element is described by its value,
its row index and its column index. Other elements are equal to zero. The exemplary matrix
at the end of appendix A.1 for shifting the two moving and laterally adjoined voxels 2 and 3
by 1.7 voxel lengths parallel to a coordinate axis would contain following triplets (counting
indices from 0 to 8):
Value: 1 1 0.7 0.7 1 0.3 0.7 0.3 0.7
Row index: 0 3 4 5 6 7 7 8 8
Column index: 0 3 1 2 6 1 4 2 5
Triplets have been stored in NetCDF format. The exact image space dimensions (number
of voxels in each direction and the size of the voxels) have been added for testing whether the
matrix can be applied to a certain image and will generate valuable transformation results.
During the 4D reconstruction the handling and processing of transformation matrices is done
by means of the fast performing CSparse package (Davis 2006) which is used for reading
the triplet form, calculating normalization and compressing the matrices to a more dense
(Compressed Column Storage) format. Further routines allow for a comfortable application
of the matrices to the PET images by matrix-vector multiplication.
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A.3 Transformation matrices for rotation
For pure translational rigid motion the intersection volumes of 2 voxels are always rectangular
cuboids whose volume can easily be calculated. For rotational motion the intersection volume
has in general the shape of an irregular polyhedron. In the performed experiments the rotation
axis is parallel to one coordinate axis (z-axis). The intersection volume is then determined
as prism volume, V = b ·h, with height h equal to the voxel height and a polygonal base area
b. Consequently, the calculation of the volume can be broken down to a 2D consideration (in
the x-y plane). One has to specify the intersecting areas of two arbitrarily oriented squares
(which are a special type of polygons). The area b of the resulting polygon can be calculated
with the Gaussian trapezoidal function
2 · b =
n∑
i=1
(yi + yi+1) · (xi − xi+1), (7.1)
where xi and yi are the counter-clockwise labelled coordinates of the n polygon vertices and
the index n + 1 is equal to the index 1 in a closed polygon. The calculation of the vertices
of the polygon can be done by so-called polygon clipping algorithms, e.g. by the Sutherland-
Hodgman algorithm (Sutherland and Hodgman 1974). Smith (2012) provides a code that clips
a polygon given by its vertices to a unit pixel grid and calculates the intersection areas with
each pixel in the grid. This code was slightly adapted and integrated into a routine for the
creation of the transformation matrices. For proof-of-principle experiments the whole image
space was rotated by a certain angle. The following example demonstrates the population of
matrix elements for an image space consisting of one voxel slice only and that is rotated by
30◦ around an axis intersecting the image plane in the perpendicular direction at the common
vertex of voxel 5, 6, 8 and 9. Two voxels are highlighted for better understanding.
1 2 3
4 5 6
7 8 9
⇒

0.15 0.40 0 0 0 0 0 0 0
0 0.15 0.76 0 0 0.02 0 0 0
0 0 0.15 0 0 0.13 0 0 0
0.40 0.31 0 0.15 0.13 0 0 0 0
0 0.13 0.02 0 0.58 0.27 0 0 0
0 0 0 0 0 0.58 0 0 0.27
0 0 0 0.76 0.02 0 0.15 0 0
0 0 0 0.02 0.27 0 0.13 0.58 0
0 0 0 0 0 0 0 0.27 0.58

B Noise reduction in analogue signals by FFT-based filtering
The analogue signal of the displacement sensor contains high frequency noise. This may
cause misassignment of listmode date to the motion phases. For well-defined and analytically
prescribed regular motion patterns the signal can be smoothed quite well by a corresponding
fitting function. Otherwise a low pass filtering in the frequency domain can be applied after a
FFT-based filtering to eliminate the high frequency noise. The filter function w for the signal
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frequencies f of the utilized parabolic low pass filter is described in the frequency space by
w(f) =
1−
f2
f2c
for f ≤ fc,
0 for f > fc,
(7.2)
where fc stands for a selectable cutoff frequency. This cutoff frequency is adjusted by the
integer parameter m in the formula
fc =
1
m ·∆t , m ≥ 2. (7.3)
∆t denotes here the time interval between two data points belonging to the noisy signal.
For experiments with the rotating motion table, data were sampled at a frequency of
100Hz. A cutoff frequency with a value of approximately 50 times of the motion frequency
(1/3.8Hz ≈ 0.26Hz) was chosen. This results in a value of 8 for the parameter m. FFT
filters with higher fc values tend to retrace the noise in the signal. Lower cutoff frequencies
do not approximate very well the curvature and extrema of the periodic signal. Figure B.1
shows a section of the analogue voltage signal from the displacement sensor and the influence
of the chosen cutoff frequency onto the FFT filtered signal for 3 exemplary values of fc.
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Figure B.1: Results of parabolic FFT-based filtering (red) of the acquired motion signal (black) for
3 cutoff frequencies. A cutoff frequency of 50Hz (left) is too high, since the filtered function graph
retraces the signal fluctuations as shown in the inset diagram. For too low values (right), relevant
frequencies are rejected and the measured signal is not well approximated.
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C Motion tables and corresponding motion patterns
C.1 Rotational motion
Figure C.2: Sketch of the coupling (blue) between the motor drive (rotation axis at ~M) with rotation
angle ϕ2 and the rotation of the platform (rotation axis at coordinate (0,0) and rotation angle ϕ1)
in a right handed coordinate system (left). The connection rod of length s2 transmits the motion
between the coupling points C1 and C2 at the distances s1 and rM from the respective rotation axes.
An image of the motion table is overlain by the two rotation axes and the considered distances (right).
The motion table for rotational motion used for experiments in section 3.2.1 is driven by an
electric motor. By means of its supply voltage, the motion period is freely adjustable. The
coupling between the motor and the platform is outlined in figure C.2 within the right-handed
coordinate system (x¯, y¯). The angle ϕ1 of the platform is a function of the rotation angle ϕ2
of the motor. The lengths of the con-rods s1, s2 and rM can be set by screws in elongated
mounting hole and are fixed during an experiment. The length of s3 changes continuously by
the position of the coupling point C2 related to the angle ϕ2. The coordinates of the coupling
point C1 follow immediately from that.
The coordinates of the coupling point C2 are given by the formula
~C2 = ~M + rM ·
(
cosϕ2
sinϕ2
)
. (7.4)
With that, the length s3 can be deduced from the relation
s23 = C22x¯ + C22y¯ = (Mx¯ + rM · cosϕ2)2 + (My¯ + rM · sinϕ2)2 , (7.5)
and the angle ϕ′1 from
tanϕ′1 =
C2y¯
C2x¯
= My¯ + rM · sinϕ2
Mx¯ + rM · cosϕ2 . (7.6)
With equation (7.5) and the law of cosines adapted for the triangle with the sides s1, s2 and
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s3 the angle ϕ′′1 is given in the formula
cosϕ′′1 =
s21 − s22 + s23
2 · s1s3 =
s21 − s22 + (Mx¯ + rM · cosϕ2)2 + (My¯ + rM · sinϕ2)2
2 · s1
√
(Mx¯ + rM · cosϕ2)2 + (My¯ + rM · sinϕ2)2
. (7.7)
Finally, the rotation angle ϕ1 of the motion platform in dependence of ϕ2 can be calculated
by using equations (7.6) and (7.7)
ϕ1 = ϕ′1 + ϕ′′1
= arctan My¯ + rM · sinϕ2
Mx¯ + rM · cosϕ2 + arccos
s21 − s22 + (Mx¯ + rM · cosϕ2)2 + (My¯ + rM · sinϕ2)2
2 · s1
√
(Mx¯ + rM · cosϕ2)2 + (My¯ + rM · sinϕ2)2
.
(7.8)
It has to be noted that the angle ϕ1 in equation (7.8) is not the rotation angle α of the
platform which is used in the transformation matrices. The angle α is defined in the left-
handed coordinate system of the PET scanner which is here indicated with the subscript.
Following relations hold true: α = 0 for yPET = x¯ = 0 and α = pi2 for xPET = y¯ = 0. That
means |α| = ∣∣ϕ1 − pi2 ∣∣.
C.2 Motion table with stepping motor for precise 1D motion patterns
A motion table has been developed to emulate motion patterns as given by (2.13). This in-
house made motion table is shown in figure C.3. A stepping motor drives a dedicated target
holder made up of PMMA along a linear axis. The protruding target support of 6mm thick-
ness allows for well-defined attenuation correction. It is the only part of the whole system
that is placed in the FOV when the motion table has been adjusted to perform a target mo-
Figure C.3: Motion table for 1D motion patterns driven by a stepping motor along a linear axis.
Components are labelled in the left figure. The right image shows the motion table with displacement
sensor operating at the treatment site including the double-head PET scanner. The marked (left-
handed) coordinate systems allow for better understanding of the motion table orientation in between
the two detector heads. Motion proceeds parallel to the y-axis.
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Definition of
motion parameters
User-defined motion
limits (to avoid crash
with laser sensor)
Emergency stop
Reference movement
(left or right limit switch)
Free movement for
defined start position y0 
Online monitor
Start after certain
spill or time
Counted spills and
nextpoint signals
Immediate motion start
or with certain spill
Figure C.4: Screenshot of the graphical user interface of CosMoS in an early version 1.1 with some
highlighted functionalities.
tion in the left-right direction in BEV at the fixed horizontal beamline at GSI. This motion
along the y-axis in the left-handed coordinate system of the PET scanner would correspond
to a cranio-caudal motion within a patient treated in conventional supine position. An at-
tached laser displacement sensor (Model OD100-35P840, SICK Vertriebs-GmbH, Düsseldorf,
Germany) records the actual elongation of the target holder and generates a surrogate signal
which controls the motion mitigated beam delivery by means of gating or tracking.
The developed LabVIEW control software CosMoS (which stands for COSinusartige MO-
torSteuerung) for the stepping motor records the motion and other signals like the nextpoint
signals, the trigger signals for a predefined gating window and the beam status from the
accelerator. The latter one allows an optional triggering of the motion start at exhalation
(Φ0 = pi/2) or inhalation (Φ0 = 0) with the begin of the first spill. Arbitrary values can be
chosen for the start position y0, the peak-to-peak amplitude a and the period time τ , both
for n equal to 1 or 2. A screenshot of the graphical user interface of CosMoS version 1.1 is
shown in figure C.4. The motion table is equipped with several safety measures. Besides an
emergency stop, inner limit switches can be set by the user to avoid an accidental crash with
the mounted displacement laser sensor or other equipment nearby. These switches can be
turned off for reference movement when the platform is driven to one of the limit switches at
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the end of the linear axis. An online motion monitor gives a visual feedback to the user who
operates the motion table from the control room, i.e. outside of the experiment bunker.
The functionality of the motion table has been considerably increased in the recent past.
In the current version 2.0, an analytically described variation of amplitude, frequency and
baseline has been incorporated. The related investigations are beyond the scope of this thesis.
This thesis does only refer to experiments with regular motion patterns described by (2.13).
C.3 Motion table enabling relative target movement
Figure C.5: Motion table for relative motion between two targets. Components are labelled in the
right image which shows the setup for one of the presented experiments in section 5.1.2. A bridge device
spans the moving platform and carries a static target (here made of 100mm×100mm×30mm PMMA).
Another one (labelled in orange and consisting of 80mm× 50mm× 47mm PMMA) is positioned on
the platform in front of the static target. A laser displacement sensor measures continuously the
distance to the platform which is driven by an electric motor. A draft (not to scale) on the left shows
the coupling between the motor drive with rotation centre at M and the motion platform by means
of the connection rod of length s.
For performing experiments with targets moving relative to each other (where one is at
rest), a motion table from GSI, also dedicated for 1D motion patterns, has been used. As
shown in figure C.5, it consists of a moving platform which is slightly tilted against the
treatment couch by about 2.2◦ to move exactly parallel to the incident beam. This angle
is neglected within all other experiments. An additional bridging device allows to position
phantoms at arbitrary fixed positions in the field of view of the camera directly next to
moving targets. The motion of the platform is provided by a coupling to an electric motor.
A sketch of that coupling is also shown in figure C.5 with a right-handed coordinate system
(x¯, y¯). The location of the coupling point C of the connection rod with length s is described
by the radial distance r from the centre of the rotation axisM and the continuously changing
rotation angle ϕ. The distance of the moving platform xp from the origin of the coordinate
system (x¯, y¯) is described as
xp = x1 + x2
= r cosϕ+
√
s2 − (y1 + y2)2
= r cosϕ+
√
s2 − (r sinϕ+ y2)2,
(7.9)
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where y2 and s are fixed quantities of about 25mm and 155mm and r can be adjusted on a
limited scale. For emulating a peak-to-peak amplitude of 20mm during experiments a radial
distance r of 10mm was chosen. The exact motion calculation according to (7.9) results in a
peak-to-peak amplitude of the moving platform of 20.27mm. Considering the manufacturing
accuracy of the motion table and the accuracy for length determination of s and y2 a peak-to-
peak amplitude of 20mm has been assumed for data evaluation when interpreting the voltage
signal of the laser displacement sensor.
D Synchronisation of PET, motion and beam monitoring data
A reliable synchronisation between the listmode PET data stream and the logged motion
signal is essential for an accurate sorting of acquired coincidences into the corresponding
motion phases leading to reconstructed images without motion artefacts (section 3). The
creation of the LUT serving as input for the 4D simulation program (section 4) requires
additionally a correct synchronization of data acquired from the beam monitoring and motion
compensation systems. In all cases, synchronization was achieved manually by means of
the spill signals provided from the accelerator side as TTL pulses which are tapped by the
different data streams. The so-called signal 46 and signal 51 indicate the start and the end
of a (potential) beam extraction cycle, respectively. These signals are one part provided by
the MEFI bus (Machine, Energy, Focus, Intensity) and can be gathered at different crates in
the therapy control room and in the treatment room.
Figure D.6 shows an example of the different data streams with their corresponding spill sig-
nals which have been acquired from the gated irradiation presented in section 5.1.1. Since the
motion was driven and recorded by the motion table with stepping motor (cp. appendix C.2),
the data acquisition was started with the begin of the motion that coincided with the begin-
ning of the first particle-containing spill. Motion monitoring can also be performed by the
laser displacement sensor. In those cases, the motion data acquisition is started prior the
first empty spill. A potential energy adaptation by the wedge system for depth-compensated
tracking was logged on the same time scale. For off-beam source measurements (cp. sec-
tion 3.2), artificial timing signals 46 and 51 were provided from the main control room.
These signals have been logged by the PET and motion acquisition system and were used for
synchronization as usual.
Since timing signals in the PET or motion logging are sometimes acquired with a delay of
some tens of milliseconds, a reliable synchronization is not feasible by simply calculating the
offset for a certain single signal. The time offsets between the different data streams were
defined as the mean time difference for all available signals 46 and 51, exclusive the delayed
ones. This manually performed synchronization is extremely time-consuming and prolongs
unnecessarily the whole 4D IBT-PET workflow. For a future clinical application, a universal
interface that allows the parallel recording of the different signals by a single system should
be aspired. Commonly, new commercially available particle treatment facilities offer at least
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Figure D.6: Illustration of the different data streams belonging to the measurement with failed
gating presented in section 5.1.1. The PET listmode data acquisition (a) was started about 46 s
before the irradiation began with 5 initial empty spills (dark grey). Motion (b) was started with
the first spill delivering particles. Thus, the 5 empty spills are not logged by the motion table. The
acquisition of SAM (Steuerung und Auslese Modul) data starts with the first empty spill and includes
the recording of nextpoint signals (c). As it is clearly visible in the listmode and nextpoint data,
the gated irradiation performed as expected for 16 spills and broke down with the begin of the 17th
spill. From that moment on, particles have been delivered throughout the whole spills irrespective
of the motion state. Two spills (12th and 22nd of those marked in light grey) are shortened due to
the interrupt by the end-of-plane signal which indicats that all raster points of one energy have been
delivered.
a coupling between the gating equipment and the beam control system. These universal
beam triggering systems could be used for a simultaneous acquisition of the signals from the
accelerator, motion acquisition, beam monitoring and potential range compensation. Thus,
only a single data stream needs to be correlated to the in-beam or in-room PET signals or
to the motion and PET data from an off-line PET measurement.
E Sorting PET data by time or amplitude and calculating
corresponding mean offsets
After synchronizing the PET listmode data stream with the motion signal, the datawords can
be sorted into different motion phases. Two potential methods are available. Their influence
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has been investigated in more detail in section 3.2.2.
The conventional way of sorting is referred to as sorting by time or sorting by phase and
is based on the proportional division of each motion cycle into a user-defined number N of
intervals with equal length in time. To define the length of a motion cycle, the trigger times
indicating its start and end have to be extracted. These triggers are typically set at the
reversal points of the motion with maximum elongation as shown in figure E.7. In a next
step, the times ti are defined when a new motion phase i starts and the listmode data stream
can be directly split into several files according to the embedded time stamps. The start of
the first phase t1 is equal to the trigger time for the begin of the motion cycle and the N th
phase stops with the next trigger time. Sorting by time has the advantage to accumulate
similar statistics in all motion phases but several phases might comprise a rather large residual
motion amplitude.
For sorting by amplitude, the global minimum and maximum value of the voltage or position
signal (depending on used motion table) were defined. By convention, the phase definition
is performed in that way that the extremal elongations correspond to the mid of the en-
compassed amplitude interval of the related phase (cf. figure E.7). Thus, the peak-to-peak
amplitude is divided by N−1 to define the constant amplitude interval per phase. With that
knowledge the minimal and maximal amplitude value belonging to a certain phase can easily
be calculated. Taking the motion information into account, it is possible to identify the times
ti when the new motion phases will start and thus to assign the single listmode data to a
certain phase. The reduced mean residual motion within the motion phases in comparison
to the sorting by time leads to a better reduction of motion artefacts when same parameters
had been used for reconstruction. However, as obviously visible in the lower right graph
Figure E.7: Illustration of sorting a listmode data stream into 7 motion phases according to the
time (left) or amplitude (right) for a cos4 motion with 20mm peak-to-peak amplitude (top). Black
diamonds in the upper left graph indicate the extracted trigger times for the start of new motion
cycles. Amplitude intervals have always been chosen in that way that reversal points are placed in
the middle of the minimum and maximum amplitude interval (upper right).
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of figure E.7, different numbers of coincidences are assigned to the different motion phases
due to the shorter and longer residence times of the target volume within certain amplitude
intervals. Especially those phases including the reversal points of the motion contain larger
parts of the original listmode data stream. This imbalance is considered by a reasonable
scaling during the 4D MLEM reconstruction.
Ideally, the same way of PET data sorting is applied as for the 4D planning CT image
which provides the phase-specific attenuation and scatter correction for the β+-activity re-
construction. Furthermore, the transformation matrices need to be extracted from the 4D
CT image. Irrespective of the concrete 3D motion pattern of the real patient breathing curve,
the target volume will always be represented at its mean residence position in the correspond-
ing CT image. This fact was also taken into account for the investigated 1D cos2 and cos4
motion patterns when positioning the targets into the different motion phases for calculating
the artificial 4D CT images, attenuation corrections and transformation matrices. For a 1D
motion described by the function f(t) the mean residence position in phase i is given as
yi =
1
ti+1 − ti ·
∫ ti+1
ti
f(t) dt, (7.10)
where ti and ti+1 are the times when the target enters and leaves the ith motion phase, respec-
tively. For motion patterns according (2.13) the integration can be performed analytically
by following expressions:
f(t) = cos2(t) : yi =
1
2 +
sin(2ti+1)− sin(2ti)
4 · (ti+1 − ti) (7.11)
f(t) = cos4(t) : yi =
3
8 +
sin(2ti+1)− sin(2ti)
4 · (ti+1 − ti) +
sin(4ti+1)− sin(4ti)
32 · (ti+1 − ti) . (7.12)
An example for the mean residence positions calculated according to these equations is sum-
marized in table E.1 for 9 motion phases of the cos2- and cos4-shaped motion pattern with
maximal elongation of ±10mm.
Table E.1: Mean residence positions for targets performing 1D cos2 and cos4 motion patterns with
maximal elongation of ±10mm and considering 9 motion phases. These offset vectors are necessary
for the creation of the corresponding attenuation corrections and transformation matrices.
Mean offsets for cos2 motion Mean offsets for cos4 motion
Phase Time-sorted Amplitude-sorted Time-sorted Amplitude-sorted
1 9.207mm −9.580mm 8.471mm −9.736mm
2 4.899mm −7.597mm 1.248mm −7.639mm
3 −1.701mm −5.036mm −6.364mm −5.053mm
4 −7.506mm −2.514mm −9.606mm −2.525mm
5 −9.798mm 0.000mm −9.996mm −0.008mm
6 −7.506mm 2.514mm −9.606mm 2.508mm
7 −1.701mm 5.036mm −6.364mm 5.031mm
8 4.899mm 7.597mm 1.248mm 7.593mm
9 9.207mm 9.580mm 8.471mm 9.579mm
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